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  ‘At	  the	  final	  stage	  you	  teach	  me	  that	  this	  wondrous	  and	  multi-­‐coloured	  universe	  can	  
be	  reduced	  to	   the	  atom	  and	  that	   the	  atom	  itself	  can	  be	  reduced	  to	   the	  electron.	  All	  
this	  is	  good	  and	  I	  wait	  for	  you	  to	  continue.	  But	  you	  tell	  me	  of	  an	  invisible	  planetary	  
system	  in	  which	  electrons	  gravitate	  around	  a	  nucleus.	  You	  explain	  this	  world	  to	  me	  
with	  an	  image.	  I	  realise	  then	  that	  you	  have	  been	  reduced	  to	  poetry’	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Abstract	  
	  Hypertension	   is	   a	   major	   risk	   factor	   implicated	   in	   the	   development	   of	  cardiovascular	   disease	   and	   is	   often	   associated	   with	   endothelial	   dysfunction.	  	  Studies	   have	   shown	   that	   hydrogen	   sulfide	   (H2S)	   elicits	   beneficial	   actions	   in	   the	  regulation	   of	   vascular	   homeostasis	   where	   it	   modulates	   improved	   vascular	   tone.	  Evidence	  suggests	  that	  reactive	  oxygen	  species	  (ROS)	  may	  regulate	  the	  expression	  and	   activation	   of	   H2S-­‐generating	   enzymes	   within	   the	   vascular	   endothelium.	  Endothelial	  NADPH	  oxidase	  4	  (Nox4)	  is	  an	  enzyme	  that	  specifically	  generates	  the	  ROS,	  hydrogen	  peroxide	  (H2O2).	   It	  was	  therefore	  hypothesised	  that	  Nox4-­‐derived	  ROS	  may	  be	  involved	  in	  the	  regulation	  of	  H2S	  generation	  in	  the	  endothelium.	  Here	  it	   was	   shown,	   in	   human	   umbilical	   vein	   endothelial	   cells	   (HUVECs),	   that	   Nox4	  regulates	  the	  expression	  of	  a	  major	  H2S	  producing	  enzyme,	  Cystathionine	  γ-­‐lyase	  (CSE)	   at	   the	   mRNA	   and	   protein	   level.	   Furthermore,	   this	   was	   shown	   to	   be	  dependent	  on	  the	  direct	  binding	  of	  the	  Activating	  Transcription	  Factor	  4	  (ATF4)	  to	  an	   intronic	   enhancer	   region	   of	   the	   CSE	   gene.	   Nox4	   was	   also	   demonstrated	   to	  regulate	   CSE	   expression	   through	   the	   haem-­‐regulated	   inhibitor	   kinase	  (HRI)/eukaryotic	  translation	  initiation	  factor	  2α	  (eIF2α)/ATF4	  signalling	  module.	  Finally,	   CSE	   mRNA	   and	   protein	   expression	   were	   increased	   in	   endothelial	   cells	  isolated	  from	  endothelial-­‐specific	  Nox4	  transgenic	  mice	  (eNox4	  Tg)	  and	  using	  wire	  myography	   it	   was	   demonstrated	   that	   eNox4	   Tg	   mouse	   aortae	   exhibit	   a	   hypo-­‐contractile	  phenotype	  in	  response	  to	  phenylephrine,	  compared	  to	  Wild	  type	  (WT)	  littermates.	  This	  phenotype	  was	  ablated	  when	  vessels	  were	  incubated	  with	  the	  CSE	  inhibitor,	   Propargyl-­‐glycine	   (PPG).	   To	   conclude,	   these	   data	   demonstrate	   a	   novel	  role	  for	  Nox4	  in	  the	  regulation	  of	  CSE	  and	  hence	  vascular	  tone	  in	  endothelial	  cells.	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Abbreviations	  	  
.OH:	  Hydroxyl	  Radicals	  3-­‐MST:	  3-­‐Mercaptopyruvate	  Sulfurtransferase	  ACh:	  Acetylcholine	  AdNox4:	  Adenoviral	  Nox4	  AdBGal:	  Adenoviral	  beta-­‐Galactosidase	  	  AngII:	  Angiotensin	  II	  ANS:	  Autonomic	  Nervous	  System	  ATF4:	  Activating	  Transcription	  Factor	  4	  ATP:	  Adenosine	  Triphosphate	  	  BH4:	  Tetrahydrobiopterin	  Ca2+:	  Calcium	  CaM:	  Calmodulin	  CAT:	  Cysteine	  Aminotransferase	  CBS:	  Cystathionine	  β-­‐Synthase	  CD31:	  cluster	  of	  differentiation	  31	  cGMP:	  Cyclic	  Guanosine	  Monophosphate	  ChIP-­‐Seq:	  Chromatin	  Immunoprecipitation-­‐Sequencing	  ChIP:	  Chromatin	  Immunoprecipitation	  CMEC:	  Cardiac	  Microvascular	  Endothelial	  Cells	  CO:	  Carbon	  Monoxide	  COX1/2:	  Cyclooxygenase	  1/2	  	  CSE-­‐/-­‐:	  CSE	  Null	  Mouse	  CSE:	  Cystathionine	  γ-­‐Lyase	  csNox4	  Tg:	  Cardiac	  Specific	  Nox4	  Overexpressing	  Mice	  Ct:	  Cycle	  Threshold	  CVD:	  Cardiovascular	  Disease	  DPI:	  Diphenyleneiodonium	  chloride	  EDHF:	  Endothelium	  Derived	  Hyperpolarising	  Factor	  EDRF:	  Endothelium	  Derived	  Relaxing	  Factor	  eIF2α:	  Eukaryotic	  Translation	  Initiation	  Factor	  2α	  eNOS:	  Endothelial	  Nitric	  Oxide	  Synthase	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eNox4	  Tg:	  Endothelial	  Specific	  Nox4	  Overexpressing	  Mice	  eNox4-­‐/-­‐:	  Endothelial	  Specific	  Nox4	  Null	  Mice	  	  ER:	  Endoplasmic	  Reticulum	  FAD:	  Flavin	  Adenine	  Dinucleotide	  GCN2:	  General	  Control	  Non-­‐derepressible-­‐2	  Kinase	  GPx:	  Glutathione	  Peroxidase	  GSH:	  Reduced	  Glutathione	  GSSG:	  Oxidised	  Glutathione	  	  GTP:	  Guanosine	  Triphosphate	  GYY4137:	  Morpholin-­‐4-­‐ium	  4-­‐Methoxyphenyl(Morpholino)	  Phosphinodithioate	  H2O2:	  Hydrogen	  Peroxide	  H2S:	  Hydrogen	  Sulphide	  HBSS:	  Hanks	  Balanced	  Salts’	  Solution	  Hcy:	  Homocysteine	  HEK293:	  Human	  Embryonic	  Kidney	  Cells	  HO:	  Haem	  Oxygenases	  	  HRI:	  Haem-­‐regulated	  inhibitor	  kinase	  HUVEC:	  Human	  Umbilical	  Veins	  Endothelial	  Cells	  IE:	  Intronic	  Enhancer	  IKCa:	  Intermediate	  Calcium	  Gated	  K+	  Channels	  iNOS:	  Inducible	  Nitric	  Oxide	  Synthase	  IP:	  Prostaglandin	  I2	  Receptor	  ISR:	  Integrated	  Stress	  Response	  K+:	  Potassium	  Ions	  KATP:	  ATP-­‐gated	  Potassium	  Channels	  	  KCl:	  Potassium	  Chloride	  KEAP1:	  Kelch-­‐like	  ECH-­‐associated	  Protein	  1	  Kir:	  Inward	  Rectifying	  K+	  Channels	  L-­‐NAME:	  NG-­‐Nitro-­‐L-­‐Arginine-­‐Methyl	  Ester	  L-­‐NMMA:	  NG-­‐Monomethyl-­‐L-­‐Arginine	  L-­‐NNA:	  L-­‐Nitroarginine	  MEFs:	  Mouse	  Embryonic	  Fibroblasts	  mm	  Hg:	  Millimetres	  of	  Mercury	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MOI:	  Multiplicity	  of	  Infection	  mRNA:	  messenger	  RNA	  MS:	  Methionine	  Synthase	  N5-­‐MTHF:	  N-­‐5-­‐Methyltetrahydrofolate	  NAC:	  N-­‐Acetyl	  Cysteine	  NADPH:	  Nicotinamide	  Adenine	  Dinucleotide	  Phosphate	  NaHS:	  Sodium	  Hydrosulphide	  NaS:	  Sodium	  Sulphide	  nNOS:	  Neuronal	  Nitric	  Oxide	  Synthase	  NO:	  Nitric	  Oxide	  NOS:	  Nitric	  Oxide	  Synthase	  Nox:	  Nicotinamide	  Adenine	  Dinucleotide	  Phosphate	  Oxidase	  Nrf2:	  Nuclear	  Factor	  Erythroid	  Derived	  O.E:	  Overexpression	  O2-­‐:	  Superoxide	  ORF:	  Open	  Reading	  Frame	  PBS:	  Phosphate	  Buffered	  Saline	  PCR:	  Polymerase	  Chain	  Reaction	  PDE5A:	  Phosphodiesterase	  5A	  PDGF:	  Platelet-­‐derived	  Growth	  Factor	  PE:	  Phenylephrine	  	  PEG-­‐Cat:	  Catalase−Polyethylene	  Glycol	  PERK:	  PKR-­‐like	  ER	  Kinase	  PGI2:	  Prostacyclin	  Phox:	  Phagocyte	  Oxidase	  PI3K:	  Phosphatidylinositol-­‐3-­‐kinase	  	  PIC:	  Pre-­‐initiation	  complex	  pKa: Acid	  Dissociation	  Constant	  PKG:	  Protein	  Kinase	  G	  PKR:	  Protein	  kinase	  double-­‐stranded	  RNA-­‐dependent	  kinase	  PLP:	  Pyridoxal	  5-­‐Phosphate	  Poldip2:	  δ–interacting	  protein	  2	  Pol	  II:	  RNA	  polymerase	  II	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PPG:	  Propargylglycine	  QPCR:	  Quantitative	  Reverse	  Transcription	  Polymerase	  Chain	  Reaction	  ROS:	  Reactive	  Oxygen	  Species	  S-­‐:	  Thiolate	  SAH:	  S-­‐adenosylhomocysteine	  SAHH:	  S-­‐adenosylhomocysteine	  hydrolase	  SAM:	  S-­‐Adenosylmethionine	  SDS:	  Sodium	  Dodecyl	  Sulfate	  Ser51:	  Serine	  51	  sGC:	  Soluble	  Guanylate	  Cyclase	  SKCa:	  Small	  Calcium	  Gated	  K+	  Channels	  SMC:	  Smooth	  Muscle	  Cell	  SO2H:	  Sulfinic	  Acid	  SO3H:	  Sulfonic	  Acid	  SOD:	  Superoxide	  Dismutase	  SOH:	  Sulfenic	  Acid	  SP1:	  Specific	  Protein	  1	  SSH:	  Hydropersulphide	  Moiety	  tBHP:	  Tert-­‐Butylhydroperoxide	  Tg:	  Transgenic	  	  TxA2:	  Thromboxane	  A2	  uORF:	  Untranslated	  Open	  Reading	  Frame	  UPR:	  Unfolded	  Protein	  Response	  VEGF:	  Vascular	  Endothelial	  Growth	  Factor	  Vmax:	  Maximal	  Velocity	  VSMC:	  Vascular	  Smooth	  Muscle	  Cell	  vWF:	  	  von	  Willebrand	  Factor	  WT:	  Wild	  Type	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1.1	  Cardiovascular	  Disease	  
	  Cardiovascular	  disease	  (CVD)	  remains	  a	  leading	  cause	  of	  morbidity	  and	  mortality	  in	  Western	   countries	   and	  generates	   a	   large	   economic	  burden1.	  A	  number	  of	   risk	  factors	  have	  been	  identified	  for	  CVD	  including	  hypertension,	  smoking	  and	  diabetes	  mellitus	  and	  of	   these,	  hypertension	   is	   the	  most	  prevalent	  risk	   factor	  worldwide2.	  Despite	   this,	   the	  aetiology	  of	  hypertension	  remains	   incompletely	  understood	  and	  thus	   an	   impetus	   toward	   further	   scientific	   exploration	   into	   the	   biochemical	   and	  physiological	  mechanisms	  of	  the	  disease	  has	  been	  established.	  	  Perturbations	   in	   the	   normal	   homeostatic	   function	   of	   the	   endothelium,	   termed	  endothelial	  dysfunction,	  have	  been	  repeatedly	  recognised	  as	  a	  common	  participant	  in	   a	   number	   of	   CVD	   states	   including	   hypertension3.	   Indeed,	   traditional	   CVD	   risk	  factors	   are	   often	   associated	   with	   endothelial	   dysfunction	   and	   it	   seems	   that	   this	  may	  precede	  disease	  formation4.	  A	  detailed	  investigation	  of	  endothelial	  function	  in	  (patho)physiology	   may	   therefore	   provide	   the	   insights	   required	   for	   improved	  diagnostic	   and	   therapeutic	   interventions.	   An	   assessment	   of	   endothelial	   function	  may	   also	   present	   a	   useful	   prognostic	   marker	   for	   the	   identification	   of	   patients	  predisposed	  to	  long-­‐term	  CVD	  events5.	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1.2	  Blood	  Vessel	  Anatomy	  	  Arteries	  and	  veins	  are	  structurally	   layered	   into	  three	  distinct	  regions	   identifiable	  as	   the	   tunica	   adventitia,	   media	   and	   intima	   (Figure	   1.1).	   The	   tunica	   adventitia	  represents	   the	  outermost	  vessel	   layer	  and	   is	  composed	  of	  collagen,	  elastic	   fibres,	  nerves	  and	  fibroblasts.	  The	  middle	  layer,	  known	  as	  the	  tunica	  media,	  occupies	  the	  greatest	  area	  of	   the	  vessel	  wall	  and	   is	   composed	  of	   smooth	  muscle,	   collagen	  and	  elastic	   fibres.	   The	   tunica	   media	   is	   responsible	   for	   most	   of	   the	   mechanical	  properties	  of	   the	  vessel,	  where	  smooth	  muscle	  controls	  constriction	  and	  dilation,	  elastic	   fibres	  help	   to	  maintain	  blood	   flow	  by	  expanding	   the	  vessel	  wall	   (as	  blood	  pressure	  increases)	  and	  collagen	  ensures	  that	  excessive	  expansion	  and	  dilation	  of	  vessels	  is	  prevented.	  The	  tunica	  intima	  lines	  the	  luminal	  surface	  of	  the	  vessel	  and	  is	  composed	  of	  a	  monolayer	  of	  cells	  known	  as	  the	  vascular	  endothelium.	   In	  healthy	  vessels	   the	   endothelial	   cells	   of	   the	   intima	   are	   flat,	   elongated	   and	   aligned	   in	   the	  direction	  of	   flow6.	  The	  endothelium	  has	  a	  number	  of	  physiological	   functions	   that	  will	  now	  be	  discussed.	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Figure	  1.1:	  Artery	  Anatomy.	  A	  schematic	  diagram	  displaying	  the	  structure	  of	  an	  artery	   composed	   of	   the	   Tunica	   Intima,	   Media	   and	   Adventitia.	   The	   endothelium	  lines	  the	  luminal	  surface	  of	  the	  vessel	  and	  comprises	  the	  Intimal	  layer.	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homeostasis.	   As	   such,	   the	   endothelium	   represents	   a	   highly	   versatile	   and	  multifunctional	   ‘organ’	   system.	   Like	   other	   organs	   the	   endothelium	   varies	   in	   its	  morphological	  and	  functional	  activity	  depending	  on	  the	  vascular	  bed	  in	  which	  it	  is	  situated.	   Thus	   structural	   and	   molecular	   endothelial	   heterogeneity	   exists	   on	   an	  organ-­‐to-­‐organ	  basis	  and	  even	  within	  different	  regions	  of	   the	  same	  tissue8,	  9.	  The	  importance	  of	  the	  endothelium	  within	  the	  cardiovascular	  system	  is	  highlighted	  by	  the	   many	   diseases	   that	   arise	   from	   its	   dysfunction	   such	   as	   atherosclerosis,	  hypertension	  and	  metastatic	  disease4,	  10.	  	  	  The	   endothelium	   in	   its	   quiescent	   state	   plays	   a	   fundamental	   role	   in	   regulating	   a	  number	  of	  homeostatic	  vascular	  processes7.	  Of	  these,	  the	  most	  widely	  studied	  and	  well-­‐established	   function	   is	   in	   its	   control	   of	   blood	   flow	   and	   tissue	   perfusion	  through	  the	  modulation	  of	  vascular	  tone.	  The	  endothelium	  controls	  vascular	  tone	  by	   releasing,	   and	   reacting	   to,	   a	   number	   of	   vasoactive	   mediators	   that	   balance	  vasodilation	   and	   vasoconstriction.	   Alterations	   in	   this	   balance	   lead	   to	  pronunciations	   in	   the	   phenotype	   to	  which	   the	   vasoactive	   substance	   favours.	   For	  example	   Nitric	   Oxide	   (NO)	   release	   favours	   a	   vasodilatory	   phenotype,	   whereas	  angiotensin	  II	  (AngII)	  promotes	  vasoconstriction11.	  In	  addition	  to	  the	  regulation	  of	  blood-­‐pressure,	   the	   endothelium	   is	   intimately	   involved	   in	   coordinating	   blood	  haemostasis	  and	  coagulation.	  Here,	  the	  basal-­‐state	  endothelium	  acts	  to	  preserve	  a	  non-­‐thrombogenic	  blood-­‐tissue	  interface	  by	  preventing	  thrombosis,	  thrombolysis,	  platelet	  adherence	  and	  immune	  cell	  recruitment.	  By	  contrast,	  in	  its	  activated	  state,	  the	   endothelium	   causes	   a	   dynamic	   shift	   in	   phenotype,	   moving	   away	   from	   the	  maintenance	  of	  blood	  fluidity	  toward	  a	  pro-­‐coagulant	  and	  pro-­‐thrombotic	  milieu12.	  The	   activated	   endothelium	   achieves	   this	   through	   the	   release	   of	   von	  Willebrand	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factor	  (vWF),	  platelet	  activating	  factor	  and	  thromboplastin10.	  In	  a	  similar	  process,	  the	   endothelium	   controls	   vascular	   inflammation	   and	   host	   defence	   by	   permitting	  the	   release	   of	   various	   cytokines	   and	   promoting	   cell	   adhesive	   and	   permeability	  properties	   upon	   its	   activation13.	   Finally,	   the	   endothelium	   has	   further	   roles	   in	  regulating	   neovascularisation	   through	   its	   engagement	   in	   angiogenesis	   via	   a	  proliferative	  response	  to	  vascular	  endothelial	  growth	  factor	  (VEGF)14.	  	  	  
1.3	  The	  Endothelium	  and	  Vascular	  Tone	  	  As	   mentioned	   above,	   the	   endothelium	   can	   direct	   changes	   in	   vascular	   tone	   and	  therefore	  blood	   flow	  through	   its	   release	  and	  response	   to	  a	  number	  of	  vasoactive	  agents11.	   This	   process	   of	   modulating	   blood	   flow	   is	   fundamental	   in	   permitting	  individual	   tissues	  and	  organs	   to	  meet	   their	   changing	  metabolic	  demands	  both	  at	  rest	   and	   under	   stress	   conditions.	   To	   achieve	   this	   a	   number	   of	   biosystems	   and	  molecules	   that	   comprise	   metabolic,	   humoral	   and	   neuro-­‐adrenergic	   components	  have	  evolved.	  	  Indeed,	  the	  control	  of	  vascular	  tone	  can	  be	  envisaged	  as	  an	  intimate	  interplay	   between	   autonomic	   nervous	   output	   and	   local	   endothelium-­‐directed	  vasomotor	   actions.	   	   The	   autonomic	   nervous	   system	   (ANS)	   acts	   to	   innervate	   and	  modulate	   the	   vessel	   dynamics	   of	   small	   arteries	   and	   arterioles	   and	   therefore	  contributes	  to	  maintaining	  physiological	  vascular	  tone	  and	  blood	  pressure.	  This	  is	  achieved	  by	  a	  smooth	  muscle	  response	  to	  various	  neuro-­‐adrenergic	  mediators	  that	  permit	   vasorelaxation	   through	   the	   activation	   of	   β-­‐adrenergic	   receptors	   or	  vasoconstriction	  through	  binding	  α1	  adrenergic	  receptors15.	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To	   complement	   the	   ANS-­‐induced	   regulation	   of	   blood	   pressure	   the	   endothelium	  exerts	   local	   homeostatic	   control	   of	   vessel	   dynamics	   through	   its	   sensing	   of	  haemodynamic	  forces	  and	  in	  its	  response	  to	  various	  humoral	  agents.	  In	  its	  resting	  state,	   the	   endothelium	  maintains	   a	   balance	   between	   vasodilator	   molecules,	   that	  elicit	   their	   actions	   through	   smooth	   muscle	   cell	   relaxation,	   with	   vasoconstrictor	  agents	   that	   oppose	   this	   dilation	   by	   causing	   smooth	   muscle	   contraction.	  Vasodilatory	  molecules	  include	  endothelium-­‐derived	  relaxing	  factors	  (EDRF)	  such	  as	  NO16	  and	  prostacyclin17	  as	  well	  as	  endothelium	  derived	  hyperpolarising	  factors	  (EDHF)18	  that	  include	  hydrogen	  peroxide	  (H2O2)19	  and	  hydrogen	  sulphide	  (H2S)20.	  By	   contrast	   constrictor	   agents	   include	   catecholamines21,	   angiotensin	   II22,	  thromboxanes23	  and	  endothelin	  124.	  The	  balance	  of	  vasodilators	  and	  constrictors	  achieved	   by	   a	   normal	   functioning	   endothelium	  ultimately	   leads	   to	   precise	   tissue	  perfusion	  under	  physiological	  conditions.	  If	  perturbations	  in	  the	  levels	  or	  activities	  of	  these	  mediators	  occur,	  such	  as	  in	  states	  of	  endothelial	  dysfunction,	  it	  can	  result	  in	  a	  number	  of	  vascular	  diseases	  such	  as	  atherosclerosis	  and	  hypertension4.	  	  
1.4	  Endothelium-­‐derived	  Vasodilators	  	  As	  mentioned	  above	  a	  number	  of	  vasodilatory	  mediators	  exist,	  some	  of	  which	  are	  produced	  by	  the	  endothelium25.	  	   These	  endothelium-­‐derived	  factors	  can	  broadly	  be	   defined	   as	   endothelium-­‐derived	   relaxing	   factors	   (EDRF),	   of	   which	   NO	   is	   the	  prototypical	   example16.	   Other	   endothelium-­‐derived	   substances	   that	   can	   be	  distinguished	   from	   EDRF	   by	   the	   ability	   to	   cause	   vascular	   smooth	   muscle	   cell	  hyperpolarisation	   are	   termed	   endothelium-­‐derived	   hyperpolarising	   factors	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(EDHF)26.	   In	   the	   following	   sections	  a	  detailed	  account	  of	  both	  EDRFs	  and	  EDHFs	  will	   be	   given	   as	   well	   as	   a	   discussion	   of	   gasotransmitter	   molecules	   and	   their	  potential	  contribution	  to	  these	  categories.	  	  	  
1.4.1	  Nitric	  Oxide	  (NO)	  	  In	   1980,	   Furchgott	   and	   Zawadzki	   published	   their	   seminal	   research	   into	   the	  function	   of	   the	   endothelium	   in	   vasomotion.	   Here	   it	   was	   demonstrated	   that	   an	  intact	  endothelium	  is	  absolutely	  required	  for	  the	  mediation	  of	  acetylcholine	  (ACh)-­‐	  induced	   vasorelaxation	   in	   rabbit	   aortic	   rings,	   since	   vessels	   denuded	   of	   their	  endothelium	   failed	   to	   relax	   to	   ACh	   and	   in	   fact	   became	   more	   contractile.	   These	  observations	  defined	  a	  role	  for	  the	  endothelium	  in	  the	  production	  of	  a	  vasoactive	  substance	   termed	  EDRF27.	   	   Subsequent	   research	   efforts	   culminated	   in	  Furchgott,	  Ignarro	   and	  Murad	   being	   awarded	   a	   Nobel	   prize	   in	   1988	   for	   the	   discovery	   and	  characterisation	  of	  NO	  as	  the	  elusive	  EDRF16.	  	  Since	  then	  the	  NO	  field	  has	  expanded	  exponentially	  and	  many	   important	  physiological	   roles	  have	  been	  ascribed	   to	   this	  gaseous	  mediator28.	  	  	  NO	  is	  synthesized	  enzymatically	  by	  a	  family	  of	  enzymes	  collectively	  termed	  Nitric	  Oxide	   Synthases	   (NOS).	   The	   NOS	   family	   encompasses	   three	   distinct	   isoenzymes	  encoded	   by	   separate	   genes	   that	   include	   neuronal	   NOS	   (nNOS,	   NOS-­‐I),	   inducible	  NOS	  (iNOS,	  NOS-­‐II)	  and	  endothelial	  NOS	  (eNOS,	  NOS-­‐III).	  Within	   the	  vasculature,	  multiple	   NOS	   isoforms,	   in	   particular	   nNOS	   and	   eNOS	   are	   expressed29.	   In	   the	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endothelium	  eNOS	  is	  the	  predominant	  isoform	  and	  will	  therefore	  form	  the	  focus	  of	  this	  discussion.	  	  	  	  	  Endothelial	  NOS	  is	  a	  constitutively-­‐expressed	  enzyme	  that	  utilises	  the	  amino	  acid	  L-­‐arginine	   as	   a	   substrate	   for	   the	   production	   of	   NO	   and	   L-­‐citrulline	   under	  physiological	   conditions30,	   31.	   A	   number	   of	   agonists	   have	   been	   shown	   to	   induce	  endothelium–dependent	   relaxations	   through	   eNOS	   activation	   such	   as	   ACh,	  serotonin	   and	   VEGF32.	   These	   stimuli	   induce	   eNOS	   activity	   by	   enhancing	  intracellular	  calcium	  concentrations.	  Here,	  calcium	  (Ca2+)-­‐bound	  calmodulin	  (CaM)	  binds	  to	  and	  displaces	  eNOS	  from	  caveolin,	  a	  protein	  that	  sequesters	  eNOS	  within	  membrane	   invaginations	   known	   as	   caveolae.	   The	   binding	   of	   Ca2+/calmodulin	   is	  generally	   considered	   to	   promote	   the	   movement	   of	   electrons	   from nicotinamide	  adenine	  dinucleotide	  phosphate	  (NADPH)	  to	  flavin	  molecules	  in	  the	  NOS	  reductase	  domain.	  These	  electrons	  then	  pass	  into	  the	  oxygenase	  domain,	  where	  they	  reduce	  haem	  iron,	  permitting	  NO	  synthesis	  from	  L-­‐arginine	  (Figure	  1.2).	  In	  order	  for	  this	  series	   of	   reactions	   to	   occur	   correctly,	   eNOS	   needs	   to	   form	   a	   homodimer.	   Dimer	  formation	   is	   promoted	   by	   the	   binding	   of	   tetrahydrobiopterin	   (BH4),	   an	   eNOS	  cofactor.	   	   Indeed,	   loss	   of	   BH4	   results	   in	   eNOS	   uncoupling	   and	   subsequent	  generation	   of	   the	   reactive	   oxygen	   species	   (ROS),	   superoxide	   (O2-­‐).	   Therefore,	  effective	   eNOS	   activation	   requires,	   NADPH,	   oxygen,	   BH4	   and	   the	   substrate	   L-­‐arginine33.	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the	   eNOS	   gene,	   as	   these	   mice	   displayed	   enhanced	   systemic	   blood	   pressure	  compared	  to	  WT	  controls36.	  	  	  
1.4.2	  Prostanoids	  	  	  The	   Prostaglandins	   represent	   a	   family	   of	   oxygenated	   20-­‐carbon	   fatty	   acid	  metabolites	  of	  arachidonic	  acid	  that	  play	  a	  role	  in	  a	  number	  of	  vascular	  processes	  including	  vasodilation,	  vasoconstriction	  and	  platelet	  aggregation.	  They	  are	  formed	  by	  the	  action	  of	  cyclooxygenase	  enzymes	  (COX-­‐1	  and	  COX-­‐2)	  on	  arachidonic	  acid	  derived	  from	  membrane	  lipids	  such	  as	  phosphatidylcholine.	  Prostaglandin	  H2	  is	  a	  common	   precursor	   for	   five	   major	   signalling	   fatty	   acids,	   which	   include	   the	  vasoconstrictor	   molecule,	   thromboxane	   A2	   (TxA2),	   and,	   of	   pertinence	   to	   this	  section,	  the	  vasodilator	  Prostacyclin	  (PGI2)17.	  PGI2	  is	  produced	  in	  endothelial	  cells	  by	  the	  action	  of	  prostacyclin	  synthase	  in	  response	  to	  a	  variety	  of	  stimuli	  including	  bradykinin,	   adenine	   nucleotides	   and	   ACh37.	   In	   cultured	   endothelial	   cells	   PGI2	   is	  generated	  along	  with	  TxA2	  at	  a	  proposed	  ratio	  of	  5:1	  highlighting	  the	  importance	  of	   this	   prostanoid	   in	   endothelial	   cells38.	   	   Once	   formed,	   PGI2	   can	   mediate	   its	  vasodilatory	   actions	   by	   increasing	   cyclic	   adenosine	   monophosphate	   (cAMP)	  signalling	   in	  VSMCs	  through	  binding	  to	  the	  prostaglandin	  I2	  receptor	  (IP)	  (Figure	  1.6)39.	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1.4.3	  Endothelium-­‐derived	  Hyperpolarising	  Factor	  	  Nitric	   oxide	   and	   PGI2	   are	   well-­‐established	   EDRFs	   that	   play	   a	   central	   role	   in	  vasodilation.	   In	   1988	   however,	   Chen	   and	   Weston	   described	   the	   existence	   of	  another	  endothelium-­‐derived	  species	  that	  elicited	  vasodilation	  by	  hyperpolarising	  VSMCs	  in	  rat	  blood	  vessels40.	  The	  functional	  effects	  of	  this	  substance	  subsequently	  lead	  to	   its	  appellation;	  Endothelial	  Derived	  Hyperpolarising	  Factor	  (EDHF)41.	  The	  characterisation	  of	  EDHF	  came	  from	  studies	  in	  which	  the	  combined	  administration	  of	   NOS	   and	   COX	   inhibitors	   did	   not	   fully	   ablate	   vascular	   relaxation	   responses	   to	  endothelial	   agonist	   such	   as	   bradykinin	   and	   ACh	   ex	   vivo	   and	   in	   vivo42.	   These	  observations	  were	  further	  investigated	  in	  mice	  deficient	   in	  both	  eNOS	  and	  COX-­‐1	  where	  it	  was	  shown	  that	  ACh-­‐induced	  vasodilation	  was	  preserved	  in	  eNOS/COX-­‐1	  null	  mice43.	   The	   hyperpolarisation	   activity	   of	   EDHF	  has	   been	   emphasised	   by	   the	  observation	   that	   the	   calcium-­‐activated	   potassium	   channel	   blockers,	   Apamin	   and	  Charybdotoxin	  (as	  well	  as	  membrane	  depolarisation	  induced	  by	  high	  extracellular	  potassium)	  ablate	  the	  residual	  EDHF	  responses	  when	  NO	  and	  PGI2	  are	  perturbed41-­‐
43.	  	  The	   precise	   nature	   of	   EDHF	   remains	   contentious,	   indeed	   a	   number	   of	   different	  molecules	   and	   mechanisms	   have	   been	   proposed	   and	   it	   is	   likely	   that	   EDHF	  represents	   a	   combination	   of	   these.	   	   Edwards	  et	  al	   proposed	   that	   potassium	   ions	  (K+)	  might	   function	   as	   an	  EDHF.	   They	   showed	   that	   endothelium-­‐derived	  K+	   ions	  increased	  in	  the	  myoendothelial	  space	  following	  endothelial	  stimulation	  with	  ACh,	  an	  effect	  that	  was	  blunted	  by	  Apamin	  and	  Charybdotoxin,	  inhibitors	  of	  endothelial	  small	   (SKCa)	   and	   intermediate	   (IKCa)	   calcium-­‐gated	  K+	   channels	   respectively.	  The	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extracellular	   accumulation	   of	   K+	   was	   associated	   with	   VSMC	   hyperpolarisation	  elicited	   through	   the	   opening	   of	   inward	   rectifying	   K+	   channels	   (Kir)	   and	   the	  activation	  of	   the	   sodium/potassium	  ATPase	  pump	  present	  on	  VSMC	  membranes.	  Inhibitors	  of	  these	  channels	  and	  pumps	  such	  as	  ouabain	  and	  barium	  abolished	  the	  hyperpolarisation	  of	  VSMCs	  (Figure	  1.6)44.	  	  	  Another	  candidate	  for	  EDHF	  is	  H2O2	  (Figure	  1.6).	  Matoba	  et	  al	  demonstrated	  that	  human	   mesenteric	   arteries	   denuded	   of	   their	   endothelium	   hyperpolarised	   in	  response	   to	   exogenous	   H2O2	   in	   a	   dose-­‐dependent	   manner.	   Indeed,	   vascular	  relaxation	   in	   response	   to	   the	   endothelial	   agonist	   bradykinin	   was	   significantly	  blunted	   by	   treatment	  with	   the	   peroxidase	   enzyme,	   catalase,	  which	   also	   reduced	  membrane	  hyperpolarisation.	  In	  order	  to	  rule	  out	  any	  effect	  of	  NO	  and	  PGI2,	  all	  of	  these	   studies	   were	   performed	   under	   the	   blockade	   of	   COX	   and	   NOS	   with	  indomethacin	  and	  L-­‐nitroarginine	  (L-­‐NNA)	  respectively19.	  To	  further	  verify	  a	  role	  for	   H2O2	   as	   an	   EDHF,	   these	   findings	   were	   recapitulated	   in	   mice45.	   Moreover,	  studies	  conducted	  in	  mice	  deficient	   in	  BH4	  revealed	  that	  endothelium-­‐dependent	  relaxation	   to	   ACh	   occurred	   in	   both	   WT-­‐	   and	   BH4-­‐deficient	   phenotypes.	  Interestingly,	   this	   relaxation	   could	   be	   inhibited	   by	   catalase	   and	   enhanced	   by	  superoxide	   dismutase	   (SOD)	   only	   in	   the	   BH4-­‐deficient	   mice.	   The	   authors	  concluded	   that	   during	   situations	   where	   eNOS	   becomes	   uncoupled,	   it	   generates	  ROS	   that	   can	  mediate	  vasorelaxation	   to	  compensate	   for	   the	   loss	  of	  NO46.	  Despite	  these	   observations,	   the	   source	   of	  H2O2	   has	   yet	   to	   be	   identified.	  However	   studies	  performed	   by	   Ray	   et	   al	   using	   an	   endothelial	   specific	   NADPH	   Oxidase	   4	   (Nox4)	  overexpressing	  mouse	   (eNox4	  Tg)	   suggest	   that	  H2O2	   derived	   from	  Nox4	  may	   be	  involved.	   Here,	   eNox4	   Tg	   mice	   were	   shown	   to	   display	   a	   low	   blood	   pressure	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phenotype	   that	   was	   accompanied	   by	   an	   enhanced	   aortic	   relaxation	   profile	   to	   a	  number	  of	  endothelial	  agonists,	  an	  effect	  that	  was	  reversed	  by	  catalase	  treatment.	  Although	  a	  mechanism	  was	  not	  identified	  it	  would	  appear	  that	  Nox4-­‐derived	  ROS	  were	   potentially	   acting	   as	   an	   EDHF	   since	   K+	   channel	   blockade	   also	   ablated	   the	  enhanced	  endothelial-­‐dependent	  relaxatory	  phenotype47.	  These	  data	  thus	  support	  previous	  findings	  by	  Matoba	  et	  al45.	  	  	   	  
1.5	  Gasotransmitters	  	  A	   gasotransmitter	   is	   a	   gaseous	   messenger	   molecule	   that	   participates	   in	   cell	  signalling.	   Three	   major	   gasotransmitters	   are	   known	   to	   exist:	   NO,	   CO	   and	   H2S48	  (Figure	  1.3).	  The	  discovery	  and	  characterisation	  of	  these	  three	  family	  members	  has	  altered	   the	   conventional	   paradigm	   of	   intercellular	   signalling.	   Unlike	   peptide	  signalling	   molecules	   that	   are	   often	   stored	   in	   vesicles,	   gasotransmitters	   are	  synthesised	   enzymatically	   on	   demand.	   Furthermore,	   peptide	   signals	   tend	   to	  mediate	  their	  function	  by	  binding	  to	  plasma	  membrane	  receptors	  such	  as	  receptor	  tyrosine	   kinases.	   By	   contrast,	   gasotransmitters	   diffuse	   across	  membranes	  within	  and	  between	  cells	  and	  then	  interact	  with	  their	  target	  directly	  via	  post-­‐translational	  modifications.	   These	   novel	  mechanisms	   of	   intercellular	   signalling	   have	   been	   the	  subject	  of	  much	  research,	  most	  notably	   in	  the	  NO	  field,	  but	  also	  more	  recently	   in	  H2S	  biology49.	  Gaseous	  signalling	  molecules	  exert	  a	  wide	  range	  of	  effects	  within	  a	  variety	  of	  cell	   types	   that	  can	   then	   lead	   to	  a	  plethora	  of	  phenotypic	  consequences	  such	  as	  angiogenesis,	  cell	  survival	  and	  the	  regulation	  of	  vascular	   tone49-­‐51.	  As	  NO	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has	  previously	  been	  discussed,	  this	  section	  will	  focus	  on	  CO	  and	  H2S	  in	  the	  control	  of	  vasomotion.	  
	  
Figure	   1.3:	   Gasotransmitters.	   A	   schematic	   diagram	   depicting	   major	  gasotransmitter	   and	   their	   respective	   enzymatic	   source.	   NO:	   Nitric	   Oxide,	   CO:	  Carbon	  Monoxide,	  H2S:	  Hydrogen	  Sulphide.	  NOS:	  Nitric	  Oxide	  Synthase,	  HO:	  Haem-­‐oxygenase,	   CSE:	   Cystathionine-­‐γ-­‐lyase,	   CBS:	   Cytathionine-­‐β-­‐synthase,	   3MST:	   3	  mercaptopyruvate	  sulphur	  transferase.	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Some	   groups	   suggest	   that	   this	   occurs	   in	   an	   endothelium-­‐dependent	   manner55.	  Despite	   these	   observations,	   the	   precise	   biochemical	   mechanisms	   through	   which	  CO	  induces	  vasodilation	  are	  not	  currently	  understood.	  	  
1.5.2	  Hydrogen	  Sulphide	  (H2S)	  	  H2S	  was	  first	  thought	  of	  as	  a	  toxic	  environmental	  pollutant	  until	  relatively	  recently	  when	   Abe	   and	   Kimura	   proposed	   it	   to	   be	   an	   endogenous	   signalling	   mediator	   in	  mammals56.	   	   Subsequent	   research	   efforts	   have	   established	   H2S	   as	   the	   third	  member	  of	  the	  gasotransmitter	  family	  of	  signalling	  molecules	  and	  have	  ascribed	  a	  number	  of	  physiological	  functions	  to	  it	  in	  systems	  as	  diverse	  as	  the	  cardiovascular,	  immunological	  and	  nervous	  system	  57.	  	  The	  chemical	  properties	  of	  H2S	  under	  physiological	  conditions	  have	  been	  studied;	  in	  aqueous	  solutions	  at	  pH	  7.4,	  H2S	  exists	  in	  a	  dissociated	  state	  with	  approximately	  two	  thirds	  of	  total	  H2S	  existing	  as	  hydrosulphide	  anions	  (HS-­‐)	  and	  protons	  (H+)	  and	  the	  remaining	  third	  as	  H2S	  undissociated	  gas.	  HS-­‐	  can	  subsequently	  form	  sulphide	  ions	  (S2-­‐)	  through	  further	  dissociation	  but	  only	  at	  high,	  non-­‐physiological	  pHs.	  S2-­‐	  are	   therefore	   considered	  negligible	   in	  physiological	   systems58.	  The	   term	  H2S	  will	  be	   used	   to	   collectively	   denote	   both	   H2S	   and	   HS-­‐	   anions	   in	   this	   thesis	   as	   it	   is	  unknown	   which	   of	   these	   is	   the	   most	   physiologically	   relevant	   species.	   H2S	   is	  lipophilic	  and	  can	  diffuse	  through	  membranes	  in	  a	  similar	  manner	  to	  NO	  and	  CO,	  although	  due	  to	  its	  dissociation	  at	  physiological	  pH,	  it	  is	  considered	  to	  be	  less	  lipid-­‐	  permeable	  than	  its	  other	  family	  members59.	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H2S	  is	  synthesised	  endogenously	  through	  the	  action	  of	  3	  enzymes:	  cystathionine	  β-­‐synthase	   (CBS),	   cystathionine	   γ-­‐lyase	   (CSE)	   and	   the	   combined	   action	   of	   3-­‐mercaptopyruvate	   sulfurtransferase	   (3MST)	   and	   cysteine	   aminotransferase	  (CAT)60.	   These	   enzymes	   have	   been	   shown	   to	   have	   tissue-­‐specific	   patterns	   of	  expression,	   with	   CBS	   playing	   a	   major	   role	   in	   H2S	   generation	   in	   the	   brain	   and	  nervous	   system61.	   By	   contrast,	   3MST	   is	  widely	   distributed	   in	  multiple	   cell	   types	  including	  neurons,	  hepatocytes,	  cardiac	  cells	  and	  endothelial	  cells62,	  63.	  	  Within	  the	  vascular	   system	   however,	   the	  major	   enzymatic	   source	   of	   H2S	   is	   CSE,	   which	   has	  been	  shown	  to	  be	  expressed	  and	  active	  in	  a	  number	  of	  vascular	  cell	  types	  including	  VSMCs64,	   perivascular	   adipose	   cells65	   and	   importantly,	   endothelial	   cells20,	   66,	   67.	  Initially	  however,	  CSE	  expression	  was	  thought	  not	  to	  occur	  in	  the	  endothelium	  but	  it	  is	  now	  clear	  that	  CSE	  is	  both	  expressed	  and	  active	  in	  this	  cell	  type63,	  64.	  	  	  CSE	   is	   a	   tetrameric	   protein	   that	   requires	   the	   binding	   of	   pyridoxal	   5-­‐phosphate	  (PLP	   or	   vitamin	   B6)	   in	   order	   to	   function68.	   It	   generates	   H2S	   from	   a	   number	   of	  substrates	  including	  cysteine,	  cystine	  and	  homocysteine69	  70.	  Figure	  1.4	  shows	  the	  substrates	  and	  products	  made	  by	  each	  of	  the	  H2S-­‐generating	  enzymes.	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an	   oxidant	  molecule	   through	   its	   initial	   reaction	  with	   ROS	   to	   form	   polysulphides	  (H2Sn).	   These	   polysulphides	   then	   oxidise	   cysteine	   residues	   on	   target	   proteins	  yielding	  the	  aforementioned	  persulphide	  moiety72,	  73.	  	  
	  
Figure	   1.5:	   Sulfhydration	   by	   H2S	   and	   Polysulphide.	   A	   schematic	   diagram	  depicting	  the	  proposed	  reaction	  mechanisms	  involved	  in	  hydropersulphide	  (-­‐SSH)	  formation.	   A)	   reduction	   of	   sulfenic	   acids.	   B)	   reduction	   of	   disulphide	   bonds.	   C)	  Polysulphide	  (H2Sn)	  induced	  thiol	  oxidation	  to	  –SSH.	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the	  CSE/H2S	  signalling	  system	  in	  the	  modulation	  of	  this	  process,	  specifically	  with	  respect	   to	  vasodilation.	  Exogenous	  application	  of	  H2S	  or	  polysulphides	   to	  vessels	  using	   donor	   compounds	   such	   as	   sodium	   sulphide	   (NaS),	   sodium	   hydrosulphide	  (NaHS)	   and	   the	   slow-­‐releasing	   H2S	   donor	   drug,	   GYY4137 (morpholin-­‐4-­‐ium	   4-­‐methoxyphenyl(morpholino)	   phosphinodithioate)	   have	   been	   shown	   to	   induce	  vasorelaxation	   in	   a	   plethora	   of	   ex	   vivo	   models65	   73,	   75-­‐77.	   Furthermore,	   the	   CSE	  substrate,	   cysteine,	   can	   induce	  vasorelaxation	   in	   rat	   aortae,	   an	  effect	   that	   can	  be	  blocked	   by	   the	   CSE	   inhibitor	   propargylglycine	   (PPG)78.	   The	   direct	   physiological	  relevance	  of	  the	  CSE/H2S	  pathway	  in	  vasorelaxation	  was	  subsequently	  confirmed	  in	   CSE-­‐null	   mice	   (CSE-­‐/-­‐)	   in	   vivo.	   Here,	   both	   homozygous	   and	   heterozygous	  deficiencies	   in	  CSE	   resulted	   in	  perturbed	  H2S	  profiles79.	   Indeed,	   endogenous	  H2S	  levels	  in	  the	  aorta	  and	  heart	  of	  homozygous	  CSE-­‐null	  mice	  were	  reduced	  by	  around	  80%	   and	   serum	   levels	   reduced	   by	   50%	   compared	   to	   WT	   littermate	   controls.	  Consistent	   with	   the	   involvement	   of	   the	   CSE/H2S	   pathway	   in	   vasomotion,	   CSE-­‐/-­‐	  mutants	  developed	  age-­‐dependent	  hypertension	  that	  began	  at	  7	  weeks	  of	  age	  and	  peaked	  at	  over	  135mm	  Hg	  at	  12	  weeks;	  this	  was	  approximately	  18mm	  Hg	  higher	  than	  the	  blood	  pressure	  of	  control	  mice.	  It	  was	  also	  shown	  that	  eNOS	  protein	  levels	  were	   not	   augmented	   in	   these	  mice,	   suggesting	   that	   the	   hypertensive	   phenotype	  was	  not	  due	  to	  a	  loss	  in	  eNOS-­‐mediated	  vasorelaxation	  but	  rather	  an	  effect	  of	  CSE	  ablation79.	   To	   further	  demonstrate	   that	   the	  H2S	   reduction	   (itself	   due	   to	   a	   loss	   in	  CSE	  expression)	  was	  responsible	  for	  the	  hypertensive	  phenotype,	  CSE-­‐/-­‐	  mice	  were	  intravenously	   injected	   with	   the	   H2S	   donor,	   NaHS.	   Following	   injection,	   mice	  demonstrated	  a	  dose-­‐dependent	  and	  transient	  reduction	  in	  systolic	  blood	  pressure	  confirming	  a	   role	   for	  H2S	   in	  blood	  pressure	   regulation.	   	   	   	   It	  was	  also	   shown	   that	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CSE-­‐/-­‐	   mice	   display	   blunted	   endothelium-­‐dependent	   vasorelaxation	   compared	   to	  WT	  littermates	  further	  confirming	  a	  role	  for	  endothelial	  CSE	  in	  vascular	  tone79.	  	  	  At	   the	   cellular	   and	  molecular	   level,	   studies	   have	   revealed	   that	  H2S	  may	   exert	   its	  vasodilatory	   actions	   in	  VSMCs	  where	   it	   has	   been	   shown	   to	   cause	   the	   opening	   of	  ATP-­‐gated	   K+	   channels	   (KATP)	   through	   S-­‐Sulfhydration	   leading	   to	   SMC	  hyperpolarisation	   and	   subsequent	   vasodilation71	   20.	   To	   add	   to	   these	   findings,	  studies	   using	   patch	   clamp	   techniques	   demonstrated	   that	   H2S	   could	   directly	  hyperpolarize	  VSMCs80.	  	  	  In	   addition	   to	  H2S-­‐induced	  hyperpolarisation	  of	   smooth	  muscle,	  H2S	   signalling	   is	  thought	   to	   be	   important	   in	   the	   endothelium,	   where	   it	   can	   induce	   EDHF-­‐type	  actions.	  In	  vitro	  experiments	  have	  shown	  that	  endothelial	  CSE	  can	  be	  activated	  by	  Ca2+/calmodulin	   in	   response	   to	   cholinergic	   stimulation	   or	   by	   the	   calcium	  ionophore,	  A23187	   leading	   to	  enhanced	  H2S	  production79.	  Moreover,	   stimulation	  of	   endothelial	   cells	  with	   ACh	   resulted	   in	   hyperpolarisation	   in	  WT	   but	   not	   CSE-­‐/-­‐	  endothelial	   cells.	   It	   was	   further	   demonstrated	   that	   inhibition	   of	   small	   and	  intermediate	  calcium	  gated	  K+	  channels	  present	  on	  the	  endothelium	  using	  apamin	  and	  charybdotoxin	  blocked	  ACh-­‐induced	  hyperpolarisation.	  By	  contrast,	  both	  WT	  and	  CSE-­‐/-­‐	  endothelial	  cells	  hyperpolarised	  in	  response	  to	  NaHS	  in	  an	  apamin-­‐	  and	  charybdotoxin-­‐sensitive	   manner20.	   These	   findings	   were	   further	   confirmed	   using	  patch	   clamp	   techniques81.	   At	   the	   whole	   vessel	   level,	   cholinergic	   stimulation	   of	  mesenteric	   arteries	   caused	   vasorelaxation,	   an	   effect	   that	   was	   blunted	   in	   CSE-­‐/-­‐	  mice.	   In	   vascular	   rings	  with	   an	   intact	   endothelium,	  NaHS-­‐induced	  dilatation	  was	  partially	   inhibited	   by	   the	   separate	   addition	   of	   apamin,	   charybdotoxin	   and	   the	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VSMC	   KATP	   channel	   blocker,	   glibenclamide.	   A	   combination	   of	   these	   inhibitors	  however	   completely	   ablated	   NaHS-­‐induced	   relaxation.	   By	   contrast,	   in	   vessels	  denuded	   of	   the	   endothelium,	   apamin	   and	   charybdotoxin	   had	   no	   effect	   on	  NaHS-­‐	  induced	   dilation	   but	   this	  was	   now	   completely	   blocked	   by	   glibenclamide	   alone20.	  Taken	  together,	  these	  data	  suggest	  that	  H2S	  functions	  to	  hyperpolarise	  both	  VSMC	  and	   endothelial	   cells	   through	   the	   activation	   of	   various	   K+	   channels.	   The	   precise	  contribution	   of	   VSMC-­‐expressed	   CSE	   and	   endothelial-­‐expressed	   CSE	   to	   this	  process	  is	  yet	  to	  be	  determined	  but	  current	  data	  suggest	  that	  both	  are	  important	  contributors	  to	  H2S-­‐induced	  vasorelaxation.	  	  In	  addition	  to	  eliciting	  endothelial	  and	  SMC	  hyperpolarisation,	  H2S	  has	  been	  shown	  to	  induce	  vasorelaxation	  by	  other	  mechanisms.	  Firstly,	  Predmore	  et	  al	  showed	  that	  NaS	   induced	   the	   production	   of	   NO	   in	   bovine	   aortic	   endothelial	   cells,	   an	   effect	  reported	   to	   result	   from	   increased	   eNOS	   phosphorylation	   at	   serine	   1177,	   a	   site	  consistent	  with	  its	  enhanced	  activation82.	  	  Interestingly,	  crosstalk	  between	  NO	  and	  H2S	  has	  also	  been	  observed	  at	   the	   level	  of	   cGMP.	  Coletta	  et	  al	  demonstrated	   that	  NaHS	   significantly	   enhanced	   cGMP	   levels	   in	   an	   L-­‐NAME	   dependent	   manner.	  Furthermore,	  NaHS	  inhibited	  phosphodiesterase	  5A	  (PDE5A)	  to	  a	  similar	  extent	  as	  Sildenafil,	  a	  synthetic	  PDE5	  inhibitor.	   It	  was	  concluded	  that	  NO	  acts	   in	  a	  classical	  manner	  to	  activate	  PKG	  through	  the	  sGC/cGMP	  pathway	  while	  H2S	  potentiates	  this	  effect	  by	  inhibiting	  cGMP	  degradation	  by	  PDE5A	  (Figure	  1.6)83.	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Figure	   1.6:	   Endothelial-­‐derived	   Relaxation	   of	   Smooth	   Muscle.	   A	   schematic	  diagram	  indicating	  the	  various	  mechanisms	  of	  endothelial	  cell-­‐induced	  relaxation	  of	  VSMCs.	  The	  endothelium	  responds	  to	  various	  agonists	  by	  producing	  a	  number	  of	  signalling	  molecules	   (black	   ovals).	   These	  mediators	   can	   diffuse	   through	   the	   cell	  membrane	  or	  move	  through	   ion	  channels	  and	  gap	   junctions	   into	  adjacent	  VSMCs	  where	  they	  activate	  a	  variety	  of	  signalling	  pathways	  that	  culminate	  in	  vasodilation.	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1.6.1	  Homocysteine	  Metabolism	  	  Intracellularly,	   hcy	   lies	   at	   the	   intersection	   between	   two	   metabolic	   pathways:	  remethylation	   and	   transsulfuration.	   These	   two	   pathways	   form	   part	   of	   a	   larger	  metabolic	  network,	  with	  the	  addition	  of	  the	  folate	  cycle85.	  Hcy	  is	  generated	  through	  the	   demethylation	   of	   the	   essential	   amino	   acid	   methionine.	   Here,	   methionine	   is	  converted	   to	   the	   universal	   methyl	   donor	   S-­‐adenosylmethionine	   (SAM)	   by	  Methionine	   adenosyl	   transferases	   (MAT1A)	   and	   is	   utilised	   as	   a	   substrate	   by	  various	  methyl	  transferases	  and	  therefore	  contributes	  to	  a	  number	  of	  biologically	  important	   methylation	   reactions.	   The	   by-­‐product	   of	   these	   reactions,	   S-­‐adenosylhomocysteine	   (SAH)	   is	   then	   hydrolysed	   to	   hcy	   by	   the	   enzyme	   S-­‐adenosylhomocysteine	   hydrolase	   (SAHH)85	   Hcy	   can	   then	   enter	   either	   the	  remethylation	   or	   transsulfuration	   pathway.	  During	   remethylation	   hcy	   acquires	   a	  methyl	  group	  from	  N-­‐5-­‐methyltetrahydrofolate	  (N5-­‐MTHF)	  in	  a	  reaction	  catalysed	  by	   the	   vitamin	   B12	   dependent	   enzyme,	   methionine	   synthase	   (MS)	   (Figure	   1.7).	  Alternatively,	   hcy	   can	   enter	   the	   transsulfuration	   pathway,	   which	   involves	   the	  initial,	   irreversible	   conversion	  of	  hcy	   to	   cystathionine	   in	  a	   condensation	   reaction	  with	  serine	  catalysed	  by	  CBS92.	  	  Cystathionine	  is	  then	  hydrolysed	  to	  cysteine	  and	  α-­‐	  ketobuterate	   by	   CSE.	   Subsequent	   to	   this,	   cysteine	   can	   then	   be	   anabolised	   to	  glutathionine	  (GSH)	  in	  a	  reaction	  involving	  the	  enzymes	  γ-­‐glutamyl	  cysteine	  ligase	  and	   glutathione	   synthetase84,	   85,	   92.	   The	   transsulfuration	   pathway	   thus	   links	   hcy	  metabolism	  to	  the	  generation	  of	  a	  major	  redox	  buffer	  within	  the	  cell	  (Figure	  1.7).	  	  The	  dual-­‐functionality	  of	  CBS	  and	  CSE	  in	  mediating	  both	  transsulfuration	  and	  H2S	  biosynthesis	   is	   particularly	   intriguing.	   Indeed,	   perturbations	   in	   CBS	   and	   CSE	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activity	   or	   expression	   are	   involved	   in	   hyperhomocysteinemia-­‐induced	   vascular	  damage93.	   In	   recent	   years,	   the	   discovery	   that	   both	   enzymes	   can	   use	   hcy	   as	   a	  substrate	   to	   generate	   H2S	   has	   further	   enhanced	   the	   complex	   aetiology	   of	   hcy	  related	  diseases	  and	  suggests	  that	  H2S	  production	  may	  be	  intimately	  linked	  to	  hcy	  metabolism94.	   Interestingly,	   CSE	   is	   known	   to	   have	   3	   splice	   variants	   whose	  biological	   significance	   remains	   unknown.	   It	   is	   tempting	   to	   speculate	   that	   these	  variants	  may	  be	  involved	  in	  orchestrating	  the	  differential	  activities	  of	  CSE.	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1.6.2	  Redox	  Regulation	  of	  Transsulfuration	  and	  H2S	  Production	  	  	  Although	  the	  functions	  of	  CBS	  and	  CSE	  in	  transsulfuration	  and	  H2S	  production	  have	  been	  characterised,	   little	   is	  known	  about	  the	  regulation	  of	  these	  enzymes	  at	  both	  the	   transcriptional	   and	   post-­‐translational	   level.	   	   However,	   an	   emerging	   body	   of	  literature	   suggests	   that	   ROS	   may	   be	   involved	   in	   both	   the	   partitioning	   of	   hcy	  metabolism	  and	  in	  the	  regulation	  of	  H2S	  production	  as	  discussed	  below.	  	  	  	  Methionine	   synthase	   and	   CBS	   appear	   to	   be	   differentially	   regulated	   by	   H2O2.	  Mosharov	  et	  al92	  demonstrated	  that	  H2O2	  was	  capable	  of	  increasing	  the	  flux	  of	  hcy	  through	  the	  transsulfuration	  pathway	  and	  suggest	  that	  this	  is	  because	  the	  activity	  of	   MS	   is	   reduced95	   and	   CBS	   is	   increased96	   in	   response	   to	   redox	   cues,	   thereby	  lowering	   hcy	   remethylation	   and	   promoting	   transsulfuration.	   These	   data	   are	  further	   supported	   in	   a	   study	   performed	   using	   neuronal	   cells.	   Here,	   the	   flux	   of	  radiolabeled	   [32S]methionine	   through	   the	   transsulfuration	   pathway	   and	  subsequent	  incorporation	  into	  GSH	  was	  measured	  in	  the	  presence	  and	  absence	  of	  the	  oxidising	  agents	  tert-­‐butylhydroperoxide	  (tBHP)	  and	  H2O2.	  Interestingly,	  it	  was	  shown	  that	  oxidants	  increased	  the	  incorporation	  of	  [32S]	  into	  GSH97,	  an	  effect	  that	  was	  recapitulated	  in	  T	  cells98.	  Collectively,	  these	  data	  suggest	  that	  ROS	  can	  increase	  GSH	  production	  by	  enhancing	  the	  activity	  of	  the	  transsulfuration	  pathway.	  	  In	  addition	  to	  the	  redox	  regulation	  of	  CBS,	  ROS	  have	  also	  been	  shown	  to	  contribute	  to	  the	  regulation	  of	  CSE,	  primarily	  at	  the	  gene	  expression	  level.	  Studies	  performed	  by	  Wang	  et	  al	   show	   that	  exogenous	  H2O2	   increased	   the	   luciferase	  activity	  of	  CSE	  promoter	   constructs	   in	  COS7	   cells,	   an	   effect	   that	  was	   recapitulated	  at	   the	  mRNA	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and	   protein	   level,	   although	   it	  was	   concluded	   that	   the	   ROS-­‐induced	   regulation	   of	  CSE	   was	   complex	   and	   biphasic99.	   To	   further	   support	   a	   role	   for	   ROS	   in	   the	  regulation	  of	  CSE	  transcription,	  it	  has	  been	  suggested	  that	  CSE	  expression	  is	  under	  the	  control	  of	  the	  redox-­‐driven	  transcription	  factor,	  Nrf2.	  Here,	  rat	  mesangial	  cells	  treated	  with	  platelet-­‐derived	   growth	   factor	  BB	   (PDGF)	   increased	  Nrf2	   activation	  and	   translocation	   to	   the	   nucleus,	   correlating	   with	   an	   up-­‐regulation	   in	   CSE	  expression.	  This	  observed	  increase	  in	  CSE	  expression	  was	  abolished	  in	  response	  to	  the	   ROS	   scavenger,	   N-­‐acetyl	   cysteine	   (NAC)	   and	   the	   broad-­‐spectrum	   NADPH	  oxidase	  inhibitor,	  DPI100.	  	  	  	  In	   addition	   to	   ROS-­‐induced	   transcriptional	   changes	   in	   CSE	   expression,	   ROS	  signalling	  can	  regulate	  CSE	  activity.	  A	  study	  published	  by	  Lin	  et	  al,	  who	  generated	  a	  cell-­‐trappable	   fluorescent	   H2S	   probe	   (SF7-­‐AM),	   interrogated	   the	   involvement	   of	  CSE	   and	   endogenous	   H2S	   production	   in	   VEGF-­‐stimulated	   HUVECs.	   Here	   it	   was	  demonstrated	   that	   VEGF	   increased	   CSE-­‐derived	   H2S	   production	   in	   a	   H2O2-­‐	  dependent	  manner.	  Moreover,	   Nox	   inhibition	   by	  DPI	   reduced	  H2S	   production	   as	  measured	  by	  a	  reduction	   in	  SF7-­‐AM	  activity	  upon	  VEGF	  stimulation.	  The	  authors	  concluded	   that	   crosstalk	   between	   H2S	   and	   H2O2	   may	   be	   an	   important,	   novel	  mechanism	   involved	   in	   angiogenesis101.	   Taken	   together	   these	   data	   highlight	   an	  emerging	   role	   for	   ROS	   in	   the	   modulation	   of	   metabolic	   flux	   through	   the	  transsulfuration	   pathway	   and	   in	   H2S	   biosynthesis	   via	   both	   transcriptional	   and	  post-­‐translational	  mechanisms.	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1.7	  Redox	  Biology	  	  
	  The	   evolution	   of	   aerobic	   organisms	   that	   utilise	   oxygen	   for	   their	   energetic	   needs	  has	   led	   to	   an	   extremely	   large	   diversification	   in	   the	   forms	   of	   life	   that	   have	  subsequently	   developed.	   This	   however,	   has	   not	   been	   without	   physiological	  consequence.	  	  An	  organism’s	  reliance	  upon	  mitochondrial	  function,	  metabolic	  flux	  and	   turnover	   as	   well	   as	   protein	   catalysis	   results	   in	   its	   exposure	   to	   varying	  concentrations	   of	   chemically	   reactive,	   potentially	   deleterious,	   oxidant	   molecules	  broadly	   defined	   as	   ROS102.	   The	   study	   of	   these	   oxidants	   and	   their	   cellular	   effects	  constitutes	  the	  growing	  field	  of	  Redox	  Biology.	  	  	  
	  Historically,	   the	   redox	   biology	   field	   has	   focused	   heavily	   on	   mitochondrial	  functionality	   in	   adenosine	   triphosphate	   (ATP)	   production	   and	   the	   consequent	  generation	  of	  ROS	  as	  potentially	  detrimental	  by-­‐products	  of	   this	  process.	   Indeed,	  the	  observation	   that	  ROS	  are	  generated	  as	  metabolic	  and	  enzymatic	   reaction	  by-­‐products	  led,	  in	  part,	  to	  initial	  ideas	  surrounding	  their	  damaging	  effects103.	  Support	  for	   this	   comes	   from	   extensive	   evidence	   demonstrating	   that	   perturbations	   in	  cellular	   redox	   state	   can	   be	   a	   cause	   or	   consequence	   of	   various	   diseases	   such	   as	  cancer,	   neurodegenerative	   disorders	   and	   cardiovascular	   disease104.	   In	   the	   broad	  context	  of	  cellular	  biology	  however,	  growing	  evidence	  indicates	  that	  cellular	  redox	  status	   can	   also	   regulate	   various	   homeostatic	   aspects	   of	   intracellular	   and	  extracellular	   function.	   Indeed,	   the	   last	   two	   decades	   have	   seen	   a	   reversal	   in	   the	  view	   that	  ROS	   are	   necessarily	   detrimental	   to	   cellular	   heath	   and	   viability105.	   This	  turnaround	   perhaps	   coincided	   with	   the	   characterisation	   of	   the	   Nicotinamide	  Adenine	  Dinucleotide	  Phosphate	  Oxidase	  (NAPDH	  oxidase/Nox)	  family	  of	  proteins	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that	  were	   found	  to	   function	  solely	   in	  the	  production	  of	  ROS106,	  107.	  This	  discovery	  therefore	   lent	   credence	   to	   the	   notion	   that	   ROS	   may	   be	   important	   regulators	   of	  evolutionarily-­‐conserved	   biological	   processes	   such	   as	   cell	   signalling	   and	   gene	  expression108.	  	  	  
As	  a	  result	  of	  these	  studies	  our	  current	  understanding	  of	  redox	  biology	  is	  therefore	  complicated	  and	  at	  times	  contradictory.	  It	  is	  currently	  known	  that	  different	  ROS	  or	  sources	  of	  ROS	  play	  opposing	  roles	  in	  various	  settings;	  some	  promote	  deleterious	  phenotypes	   whilst	   others	   appear	   to	   elicit	   beneficial	   effects.	   Deciphering	   the	  functions	   of	   different	   ROS	   in	   various	   systems	   such	   as	   the	   cardiovascular	   system	  has	   therefore	   been	   challenging,	   but	   many	   advances	   have	   been	   made	   in	  understanding	  both	  their	  physiological	  roles	  and	  mechanistic	  actions109.	  
	  
1.7.1	  Reactive	  Oxygen	  Species	  and	  Redox	  Signalling	  
	  Molecular	   oxygen	   is	   a	   biradical	   molecule	   that	   is	   able	   to	   accept	   electrons	   from	  multiple	  sources	  and	  ultimately	  become	  reduced	  to	  H2O.	  Partially	  reduced	  oxygen	  species	   are	   however	   highly	   reactive	   and	   these	   are	   collectively	   termed	   ROS.	   The	  various	   types	   of	   ROS	   that	   can	   be	   formed	   include;	   superoxide	   (O2-­‐),	   H2O2	   and	  hydroxyl	  radicals	  (.OH)	  (Figure1.8).	  In	  addition,	  oxygen	  can	  react	  with	  nitrogen	  to	  form	  Reactive	  Nitrogen	  Species	  (RNS)	  such	  as	  NO.	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Figure	   1.8:	  Reactive	  Oxygen	   Species.	  A	  diagrammatic	   illustration	  depicting	   the	  gradual	   reduction	   of	   oxygen,	   through	   its	   sequential	   gain	   of	   electrons,	   to	   form	  water.	  As	   oxygen	   is	   reduced	   various	  ROS	   are	   generated	   in	   the	  process	   including	  superoxide	  and	  hydrogen	  peroxide.	  	  	  	  Early	  observations	  that	  cell	  signalling	  pathways	  could	  be	  regulated	  by	  ROS	  led	  to	  a	  multitude	   of	   studies	   aimed	   at	   identifying	   their	   biochemical	   and	   mechanistic	  roles109,	  110.	   ROS	   are	   now	   known	   to	   act	   as	   secondary	  messengers	   in	   various	   cell	  signalling	   responses	   termed	   redox	   signalling.	   Due	   to	   inherent	   differences	   in	   the	  chemical	  properties	  of	  the	  differing	  types	  of	  oxidant	  species,	  not	  all	  ROS	  are	  able	  to	  function	  as	  efficient	  signalling	  mediators111.	  Indeed,	  the	  half-­‐life	  and	  lipid	  solubility	  properties	  of	  a	  specific	  type	  of	  ROS	  are	  important	  factors	  in	  determining	  whether	  it	  will	  be	  an	  efficient	  signalling	  molecule.	  For	  example	  superoxide	  has	  a	  short	  half-­‐life	  of	  10-­‐6	  seconds	  and	  is	  membrane	  impermeable	  thus	  limiting	  its	  signalling	  capacity.	  By	  contrast,	  H2O2	  is	  more	  stable	  and	  has	  a	  relatively	  long	  half-­‐life	  of	  10-­‐5	  seconds.	  In	  addition	  to	  this	  it	  can	  freely	  permeate	  biological	  membranes	  allowing	  relatively	  long	   range	   signalling105,	   111.	   Moreover,	   of	   the	   many	   types	   of	   ROS,	   H2O2	   has	   the	  greatest	   propensity	   to	   modify	   cysteine	   thiols	   on	   target	   proteins	   reversibly	  permitting	  signal	  transmission	  (as	  discussed	  below).	  Because	  of	  these	  properties,	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H2O2	  is	  thought	  to	  play	  a	  particularly	  important	  role	  in	  mediating	  redox	  signalling	  events112.	  	  In	  a	  similar	  manner	  to	  other	  cell	  signalling	  processes,	  physiological	  redox	  signals	  are	   transmitted	   through	   the	   reversible	   modification	   of	   target	   proteins.	   The	  presence	   of	   the	   sulphur-­‐containing	   amino	   acids	   methionine	   and,	   especially,	  cysteine	  within	   a	   peptide	   sequence	   are	   believed	   to	   be	   primarily	   responsible	   for	  transmitting	   these	   redox	   cues113.	   The	   chemical	   properties	   that	   permit	   cysteine	  residues	   to	   function	   as	   redox	   sensors	  within	   proteins	   have	   been	  widely	   studied	  and	  well	  characterised.	  It	  is	  now	  known	  that	  ROS	  cannot	  mediate	  the	  oxidation	  of	  all	   cysteine	   residues,	   but	   specifically	   target	   cysteine	   thiol	   groups	   displaying	   low	  pKa	   thiolate	   anions	   (S-­‐).	   	   The	   pKa	   of	   a	   given	   cysteine	   thiol	   is	   thought	   to	   be	  determined	  by	  the	  microenvironment	  to	  which	  it	   is	  placed	  within	  a	  protein,	  with	  surrounding	  basic	  amino	  acids	  tending	  to	  deprotonate	  adjacent	  thiol	  groups	  better	  than	  acidic	  amino	  acids105.	  	  	  A	  number	  of	  different	  types	  of	  ROS-­‐induced,	  post-­‐translational	  modifications	  exist	  and	   the	   nature	   of	   these	   modifications	   is	   dependent	   on	   multiple	   factors	   such	   as	  amino	  acid	  localisation	  within	  a	  protein	  and	  the	  length	  of	  time	  to	  which	  a	  cysteine	  thiol	  is	  exposed	  to	  ROS.	  These	  time-­‐dependent,	  ROS-­‐induced	  modifications	  can	  be	  seen	   as	   a	   sequential	   oxidation	   reaction	   which	   proceeds	   through	   sulfenic	   acid	  (SOH),	  Sulfinic	  acid	  (SO2H)	  and	  Sulfonic	  acid	  (SO3H)	  states114	  (Figure	  1.9).	  Of	  these	  oxidation	   states,	   sulfenic	   acid	   is	   the	   only	   reversible	   modification	   that	   can	   be	  reduced	  via	  the	  cell’s	  intrinsic	  antioxidant	  systems	  and	  is	  therefore	  considered	  to	  have	   physiological	   effects.	   Sulfinic	   and	   sulfonic	   acid	   modifications,	   on	   the	   other	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hand,	   occur	   under	   high	   levels	   of	   ‘oxidative	   stress’	   and	   are	   irreversible	   oxidation	  states	   termed	   hyperoxidation102.	   However,	   in	   the	   specific	   case	   of	   sulfinic	   acid	  oxidation	   of	   peroxiredoxin,	   this	   modification	   can	   be	   reversed	   by	   the	   enzyme	  sulfiredoxin115,	  116.	   In	   addition	   to	   these	  modifications,	   the	   localisation	   of	   cysteine	  residues	   within	   a	   proteins’	   tertiary	   or	   quaternary	   structure	   can	   result	   in	   ROS-­‐	  induced	  covalent	  intra-­‐	  and	  inter-­‐disulphide	  bond	  formation	  that	  can	  subsequently	  elicit	  a	  functional	  change	  (Figure	  1.9)117,	  118.	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1.7.2	  Antioxidant	  Systems	  	  The	  biological	  effects	  of	  ROS	  are	  countered	  by	   the	  actions	  of	  enzymatic	  and	  non-­‐enzymatic	   antioxidants	   that	   collectively	   form	   the	   cellular	   antioxidant	   system.	  Enzymatic	  antioxidants	  include;	  superoxide	  dismutase	  (SOD)	  that	  converts	  O2-­‐	  into	  H2O2,	   thereby	   removing	   the	   potentially	   damaging	   O2-­‐	   and	   promoting	   the	  production	   of	   H2O2-­‐mediated	   homeostatic	   signalling.	   Catalase	   and	   glutathione	  peroxidase	  (GPx)	  can	  subsequently	  scavenge	  H2O2	  119(Table	  1.1).	  	  
	  
Table	  1.	  1:	  Enzymatic	  antioxidants	  and	  the	  reactions	  they	  catalyse.	  	  Non-­‐enzymatic	  antioxidants	   include	  vitamins	  C	  and	  E	  as	  well	  as	   the	  major	   redox	  buffer	   glutathione	   (GSH).	   GSH	   is	   present	   at	  millimolar	   concentrations	   in	   the	   cell	  and	   scavenges	   ROS	   through	   the	   formation	   of	   oxidised	   GSH	   (GSSG).	   The	   ratio	   of	  GSSG:GSH	  can	  be	  used	  as	  a	  readout	  of	  the	  intracellular	  redox	  state.	   Indeed,	  when	  the	  cells	  intrinsic	  antioxidant	  system	  is	  overwhelmed	  by	  excessive	  ROS	  production,	  ‘oxidative	   stress’	   is	   induced	   which	   manifests	   in	   cellular	   damage	   and	   disease103	  
111(Figure	  1.10).	  	  
Enzyme systems  
Direct Reaction 
 








H2O2 + H2O2                                     2H2O + O2 
Peroxidase 
 
2GSH + H2O2                      GSSG + 2H2O 
Thioredoxin 
 
Trx(SH)2 + R-S-S-R             Trx-S2 + R-(SH)2 
Glutaredoxin 
 
2GSH + R-S-S-R                 2R-SH + GSSG 









GSSG + NADPH + H+                 2GSH + NADP+ 
Glutathione S-transferase 
 
GSH + R-X                                  GSR + X- + H+ 
Glucose-6-phospha e  
dehydrogenase (G6PD) 
 
Glucose-6-phospahte + NADP+          
6-phophogluconolactone + NADPH + H+ 
Xanthine oxidase Xanthine + H2O2                         Hypoxantine + H2O + 
O2 
 Uric Acid + H2O2                                      Xanthine + H2O + O2 
!
	   52	  
	  
Figure	   1.10:	   Vascular	   Oxidant	   and	   Antioxidant	   Production.	   A)	   normal	  physiological	   homeostasis	   maintains	   a	   balance	   between	   pro-­‐oxidants	   and	  antioxidants.	   B)	   Cardiovascular	   risk	   factors	   such	   as	   smoking	   and	   elevated	  homocysteine	  increase	  ROS	  production	  and	  subsequently	  tip	  the	  balance	  between	  oxidants	   and	   antioxidants	   in	   favour	   of	  ROS.	   This	   results	   in	   ‘oxidative	   stress’	   and	  vascular	  disease.	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from	   endothelial	   Xanthine	   oxidases	   that	   convert	   hypoxanthine	   to	   xanthine	   and	  then	   to	   uric	   acid	   in	   a	   process	   that	   generates	   O2-­‐	   and	   H2O2121.	   	   As	   mentioned	  previously	   eNOS	   is	   an	   enzyme	   that	   utilises	   L-­‐arginine	   as	   a	   substrate	   for	   NO	  generation	   via	   electron	   transfer	   from	   NADPH.	   Uncoupling	   of	   eNOS	   due	   to	   low	  levels	  of	  L-­‐arginine	  or	  reduced	  bioavailability	  of	  the	  eNOS	  co-­‐factor	  BH4	  results	  in	  electron	   transfer	   to	   O2	   instead	   of	   L-­‐arginine	   and	   subsequent	   O2-­‐	   formation32.	   In	  general,	   ROS	   derived	   from	   these	   processes	   are	   thought	   to	   be	   a	   result	   of	   mis-­‐regulated	  metabolic	   functions.	  By	   contrast,	  Nox	   family	   enzymes	   generate	  ROS	  as	  their	   sole	   biological	   function,	   an	   observation	   that	   suggests	   that	   ROS	  may	   play	   a	  physiological	  role122	  (Figure	  1.11).	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1.9	  NADPH	  Oxidases	  	  	  In	  humans,	  NADPH	  oxidases	  comprise	  a	  family	  of	  7	  multi-­‐subunit	  transmembrane	  proteins	   (Nox1-­‐5	   and	   duox	   1	   and	   2)	   whose	   primary	   role	   is	   to	   synthesise	   ROS	  within	  the	  cell107,	  122.	  Each	  family	  member	  is	  composed	  of	  a	  common	  catalytic	  Nox	  subunit	   that	   consists	   of	   at	   least	   6	   transmembrane	   alpha	   helicies	   and,	   with	   the	  exception	   of	   Nox5	   and	   duox1/2,	   all	   isoforms	   associate	  with	   the	   transmembrane	  protein,	   p22phox.	   Functionally,	   the	   Nox	   subunit	   shuttles	   electrons	   from	   NADPH	  down	  an	  electrochemical	  gradient	  across	  a	  membrane	  to	  molecular	  oxygen	  (O2)	  in	  a	   process	   involving	   one	   C-­‐terminal	   flavin	   adenine	   dinucleotide	   (FAD	   group)	   and	  two	   haem	   groups106,	  123.	   Oxygen	   is	   subsequently	   reduced	   to	   O2-­‐	   while	   NADPH	   is	  oxidised	  to	  NADP+	  and	  H+.	  Newly-­‐generated	  ROS	  can	  then	  be	  utilised	  by	  the	  cell	  in	  order	   to	   propagate	   a	   plethora	   of	   tightly-­‐controlled,	   intracellular,	   homeostatic,	  redox	  signalling	  responses	  107,	  122,	  124.	  	  Although	  all	  Nox	  isoforms	  contain	  an	  integral	  Nox	  subunit,	  that	  functions	  similarly	  at	   the	   biochemical	   level,	   studies	   have	   demonstrated	   that	   each	   family	  member	   is	  associated	  with	  a	  number	  of	  different	  regulatory	  proteins	  that	  are	  required	  for	  the	  fine-­‐tuning	   of	   ROS	   generation.	   For	   example,	   the	   prototypical	   Nox	   protein,	   Nox2	  which	   was	   first	   discovered	   in	   phagocytic	   immune	   cells,	   associates	   with	  transmembrane	   p22phox,	   cytosolic	   p40phox,	   p47phox,	   p67phox	   as	   well	   as	   the	  monomeric	  GTPase,	  Rac	  and	  the	  assembly	  of	  all	   these	  components	   is	  responsible	  for	  the	  Nox2	  induced	  ‘respiratory	  burst’	  seen	  in	  immune	  cells107.	  By	  contrast,	  Nox4	  has	  been	  reported	   to	  associate	  only	  with	   transmembrane	  p22phox,	  although	  more	  recently,	  a	  novel	  association	  between	  Nox4	  and	  polymerase	  δ–interacting	  protein	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2	   (Poldip2)	   has	   been	   described	   in	   VSMCs	   where	   it	   is	   thought	   to	   increase	   Nox4	  activity	  (Figure	  1.12)125,	  126.	  	  	  
	  
Figure	   1.12:	  NADPH	   Oxidase	   Family.	   A	   schematic	   representation	   of	   each	   Nox	  isoform	  and	  their	  associated	  subunits.	  	  Nox2	  associates	  with	  a	  number	  of	  cytosolic	  regulatory	   subunits	   including	   p40phox,	   p47phox,	   p67phox,	   whereas	   Nox4	   primarily	  only	   associates	  with	   the	  membrane	   protein	   p22phox.	   From:	   Nature	   reviews	   Drug	  Discovery127.	  	  In	  addition	  to	  these	  differences	  in	  molecular	  structure,	  each	  Nox	  isoform	  displays	  distinct	   tissue-­‐	  and	  developmental-­‐stage	  specific	  patterns	  of	  expression,	  different	  subcellular	   locations	   and	   markedly	   different	   mechanisms	   of	   activation.	   Nox2	  protein	  is	  found	  in	  a	  number	  of	  cell	  types	  including	  phagocytic	  immune	  cells128	  to	  cardiomyocytes,	  SMCs	  and	  endothelial	  cells122,	  129.	   It	   is	  expressed	  primarily	  at	   the	  plasma	  membrane	  and	  has	  been	  shown	  to	  be	  regulated	  by	  agonist-­‐induced	  post-­‐translational	   modifications	   such	   as	   phosphorylation130.	   By	   contrast,	   Nox4	   is	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located	  in	  VSMC	  as	  well	  as	  in	  the	  endothelium.	  Subcellularly,	  Nox4	  has	  been	  shown	  to	  occupy	  the	  endoplasmic	  reticulum	  (ER)	  of	  VSMCs130,	  131,	  as	  well	  as	   the	  nucleus	  and	   ER	   of	   HUVECs129	   132.	   It	   is	   currently	   believed	   that	   Nox4	   is	   a	   stress-­‐inducible	  protein	  whose	  activity	  is	  regulated	  at	  least	  in	  part	  at	  the	  gene	  expression	  level133.	  Its	  transcriptional	  regulation	  is	  thus	  considered	  to	  be	  the	  primary	  determinant	  of	  its	  ROS-­‐generating	  capacity107,	  133	  and	  as	  a	  consequence	  its	  expression	  and	  activity	  are	  under	  highly-­‐regulated	  and	   cell-­‐type	   specific	   control107.	  More	   recently,	   it	   has	  been	   demonstrated	   that	   the	   activity	   of	   Nox4	   may	   also	   be	   regulated	   post-­‐translationally	   by	   phosphorylation134,	   suggesting	   that	   the	   regulation	   of	   Nox4	  occurs	  at	  multiple	  levels	  and	  via	  various	  mechanisms.	  	  Finally,	  the	  type	  of	  ROS	  associated	  with	  each	  Nox	  isoform	  is	  also	  thought	  to	  differ.	  Whilst	  all	  Nox	  proteins	  make	  O2-­‐,	  some	  Noxs	  (such	  as	  Nox4	  and	  duox1/2)	  produce	  O2-­‐	   that	   is	   very	   rapidly	   converted	   to	   H2O2.	   The	   exact	  mechanism	   through	  which	  Nox4	  achieves	  this	  is	  still	  unclear	  although	  some	  studies	  suggest	  that	  the	  E	  loop	  of	  Nox4	  may	  be	   involved	   in	  mediating	  an	   intrinsic	  superoxide	  dismutase	  activity107,	  
122,	   135.	   Taken	   together,	   these	   differences	   in	   structure,	   activity,	   expression,	  regulation	   and	   the	   type	   of	   ROS	   produced	   may	   indicate	   that	   each	   Nox	   protein	  possesses	  its	  own	  distinct	  and	  defined	  functions	  129,	  130,	  136.	  	  	  
1.9.1	  Endothelial	  NADPH	  Oxidases	  	  Nox	  proteins	  are	  expressed	  in	  a	  cell	  type-­‐specific	  manner	  and	  in	  the	  endothelium,	  4	  Nox	   isoforms	   have	   been	   shown	   to	   be	   present;	  Nox1,	  Nox2,	  Nox4	   and	  Nox5137.	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The	   importance	   of	   these	   enzymes	   in	   vascular	   patho(physiology)	   is	   potentially	  indicated	   by	   the	   changes	   in	   their	   gene	   expression	   patterns	   that	   occur	   during	  disease.	  Thus,	  in	  general,	  Nox1	  and	  Nox2	  expression	  levels	  increase	  during	  disease,	  and	  loss-­‐of-­‐function	  studies	  have	  shown	  that	  removal	  of	  these	  Noxs	  tends	  to	  elicit	  beneficial	   effects	   in	   certain	   pathophysiological	   settings127.	   Apolipoprotein–E-­‐deficient	   mice	   (ApoE-­‐/-­‐)	   are	   often	   used	   as	   a	   model	   of	   atherosclerosis	   and	   these	  mice	   display	   endothelial	   dysfunction	   with	   associated	   reductions	   in	   NO	  bioavailability.	   Interestingly,	   ablation	   of	   ApoE	   in	   a	   P47Phox	   null	   background	  resulted	  in	  protection	  from	  lesion	  development.	  This	  suggests	  that	  the	  presence	  of	  Nox	   isoforms	   that	  associate	  with	  P47Phox	   in	  order	   to	   function,	   such	  as	  Nox2,	  may	  exacerbate	   the	   development	   of	   atherosclerosis138,	  139.	   Another	  model	   of	   vascular	  disease	   with	   a	   strong	   endothelial	   component	   is	   hypertension.	   Ang	   II	   is	   a	   major	  inducer	  of	  hypertension	  and	  as	  such	  is	  used	  routinely	  to	  model	  this	  disease.	  Indeed	  Nox1-­‐	   and	   Nox2-­‐derived	   O2-­‐	   is	   thought	   to	   inactivate	   NO	   and	   enhance	  hypertension140-­‐143	   and	   vascular	   dysfunction	   in	   angiotensin	   II-­‐induced	   stress144.	  Interestingly,	   AngII	   treatment	   up-­‐regulates	   Nox2	   expression	   and	   activity	   in	   the	  endothelium145	   and	   the	   targeted	   overexpression	   of	   Nox2	   increases	   blood	  pressure146.	   Furthermore	   Nox1	   null	   mice	   display	   a	   reduced	   blood	   pressure	  phenotype	  compared	  to	  WT	  littermates147.	  Taken	  together	  these	  data	  suggest	  that,	  while	  Nox1	  and	  Nox2	  have	  important	  physiological	  functions,	  their	  mis-­‐expression	  may	  promote	  perturbations	  in	  vascular	  function	  during	  disease.	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1.9.2	  Endothelial	  Nox4	  and	  Vaso-­‐protection	  	  Nox4	   is	   expressed	   in	   a	   number	   of	   vascular	   cell	   types	   and	   a	   diverse	   range	   of	  molecular	   and	   physiological	   effects	   have	   been	   attributed	   to	   its	   vascular	  expression148,	   149.	   Interestingly,	   unlike	   Nox1	   and	   Nox2,	   Nox4	   expression	   is	  considered	   to	   positively	   regulate	   vascular	   homeostasis47	   150,	   151.	   Indeed,	   Nox4	   is	  abundantly	   expressed	   in	   the	   endothelium	   and	   it	   is	   thought	   that	   this	   may	  underscore	   an	   important	   functional	   role	   for	   it	   in	   the	   vasculature129,	  149	   152.	   Thus,	  endothelial	  Nox4	  has	  been	  shown	  to	  participate	  in	  the	  regulation	  of	  vascular	  tone	  in	   multiple	   models	   and,	   as	   stated	   previously,	   endothelial-­‐specific	   Nox4-­‐	  overexpressing	  transgenic	  mice	  show	  improved	  endothelial	  function,	  vasodilation	  and	  lower	  blood	  pressure	  when	  compared	  to	  WT	  controls47.	  Furthermore,	  a	  recent	  study	   using	   Nox4-­‐null	   mice	   demonstrated	   that	   the	   ablation	   of	   Nox4	   expression	  reduced	   the	  activity	  of	   eNOS	  and	  perturbed	  NO	   formation151.	  These	  data	  may	  be	  consistent	   with	   the	   observation	   that	   H2O2	   can	   regulate	   aortic	   relaxation	   in	   an	  eNOS-­‐dependent	  manner153.	  	  	  In	   addition	   to	   regulating	   vascular	   tone,	   the	   endothelium	   also	   orchestrates	   key	  aspects	  of	  angiogenesis.	  Here,	  endothelial-­‐specific	  Nox4-­‐overexpression	  has	  been	  shown	   to	   increase	   angiogenesis	   in	   the	   ischemic	   hind	   limb	   of	   mice150,	   while	  conversely,	  studies	  in	  Nox4-­‐null	  mice	  revealed	  that	  Nox4	  expression	  is	  required	  to	  support	   exercise-­‐induced	   angiogenesis154.	   Moreover,	   blood	   flow	   recovery	   after	  femoral	   artery	   ligation	   was	   significantly	   blunted	   in	   Nox4-­‐null	   animals,	   an	   effect	  that	   was	   attributed	   to	   worsened	   endothelial	   cell-­‐mediated	   angiogenesis	   in	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matrigel	  plug	  assays151.	  Collectively	   these	  data	  suggest	   that	  endothelial	  Nox4	   is	  a	  constitutive	  generator	  of	  H2O2	  that	  positively	  affects	  vascular	  function.	  
1.10	  Summary	  	  To	  summarise,	  the	  endothelium	  can	  be	  considered	  as	  a	  multifaceted	  ‘organ	  system’	  that	  orchestrates	  a	  number	  of	  physiological	  vascular	  processes.	  In	  order	  to	  achieve	  this,	  it	  has	  evolved	  to	  produce	  (and	  respond	  to)	  a	  range	  of	  signalling	  mediators.	  Of	  these,	   NO	   elicits	   vascular	   protection	   on	   a	   number	   of	   levels	   including	   the	  modulation	  of	  vascular	  tone,	   inflammation	  and	  thrombosis.	   In	  recent	  years	   it	  has	  become	  apparent	  that	  other	  gasotransmitter	  family	  members	  such	  as	  CO	  and	  most	  notably	   H2S,	   also	   regulate	   similar	   processes	   and	   therefore	   represent	   novel	  potential	   therapeutic	   targets.	   Endothelial	   Nox4	   has	   also	   been	   implicated	   in	   the	  modulation	  of	  vasodilation	  and	  it	  is	  becoming	  apparent	  that	  ROS	  may	  be	  important	  physiological	  regulators	  of	  gasotransmitter	  signalling.	  Indeed	  the	  regulation	  of	  H2S	  generation	  by	  ROS	  is	  emerging	  as	  a	  novel	  research	  area	  that	  may	  yield	  important	  new	  insights	  into	  the	  (patho)physiological	  actions	  of	  gasotransmitters.	  	  	  
	  
	  1.11	  Hypothesis	  	  I	  hypothesise	  that	  Nox4	  may	  act	  as	  a	  physiological	  source	  of	  ROS	  that	  functions	  in	  the	  regulation	  of	  H2S	  production	  and/or	  hcy	  metabolism	  by	  enhancing	  CSE	  activity	  and/or	  expression	  in	  the	  endothelium.	  	  	  	  
	   60	  























	   61	  
2.1	  Introduction	  
	  This	  chapter	  details	  the	  general	  methods	  that	  were	  employed	  in	  this	  thesis.	  	  
	  
2.2	  Reagents	  	  All	   the	   reagents	   used	   in	   this	   thesis	   were	   ordered	   from	   Sigma	   Aldrich	   unless	  otherwise	  stated	  in	  the	  relevant	  section.	  	  
2.3	  Cell	  Culture	  
	  Standard	  tissue	  culture	  techniques	  were	  implemented	  for	  culturing,	  expanding	  and	  freezing	   down	   cells.	   Pooled	   Human	   Umbilical	   Veins	   Endothelial	   Cells	   (HUVECs)	  (Lonza)	  were	  seeded	  and	  cultured	  in	  pre-­‐coated	  (0.4%	  gelatin	  in	  PBS	  for	  1	  hour	  at	  37°C)	  T75	  tissue	  culture	  flasks,	  6-­‐cm	  dishes	  (seeding	  density	  1x106	  cells/well),	  24-­‐	  well	   (seeding	   density	   1x105	   cells/well)	   or	   96-­‐well	   (seeding	   density	   1x104	  cells/well)	  plates	  and	  grown	  in	  EBM-­‐2	  HUVECs	  media	  (Lonza).	  Human	  Embryonic	  Kidney	   cells	   (HEK293)	   were	   grown	   in	   T175	   flasks	   or	   24-­‐well	   plates	   in	   DMEM	  D6546	   media	   supplemented	   with	   10%	   Foetal	   Bovine	   Serum	   and	   1%	  Penstrep/Glutamine.	  Both	  cell	  lines	  were	  grown	  in	  a	  humidified	  37°C	  incubator	  in	  5%	  CO2.	  HUVECs	  were	  always	  used	  at	  passage	  8.	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2.4	  Quantification	  of	  gene	  expression	  
2.4.1	  RNA	  isolation.	  	  	  RNA	  was	  extracted	  from	  HUVECs	  using	  the	  SV	  total	  RNA	  isolation	  kit	  (Promega).	  In	  brief,	  HUVECs	  were	  scraped	  into	  200	  μl	  of	  SV	  RNA	  lysis	  buffer	  before	  being	  spun	  through	  Qiashredder	   columns	   (Qiagen)	   at	   13,000	   rpm	   for	   one	  minute.	   RNA	  was	  isolated	   according	   to	   the	   manufacturer’s	   specifications	   (Promega)	   with	   the	  addition	  of	  1	  µl	  of	  RNase-­‐free	  DNase	  (Promega)	  at	  the	  DNase	  incubation	  step.	  The	  resultant	   RNA	   was	   eluted	   into	   100μl	   nuclease-­‐free	   water	   and	   placed	   in	   a	  lyophiliser	  for	  40minutes	  to	  concentrate	  the	  RNA.	  RNA	  was	  re-­‐suspended	  in	  20	  μl	  nuclease-­‐free	  water	  before	  being	  quantified	  using	  a	  NanoDrop	  spectrophotometer	  (ND-­‐1000,	  Labtech	  International).	  	  
2.4.2	  Reverse	  Transcription	  –	  QPCR	  	  
	  Reverse	   transcription	   polymerase	   chain	   reaction	   (RT-­‐PCR)	   is	   a	   process	   used	   in	  order	   to	   amplify	   single-­‐stranded	   cDNA	   copies	   of	   an	   RNA	   template.	   Here,	   RNA	  isolates	   are	   converted	   enzymatically	   to	   single-­‐stranded	   cDNA	   molecules	   by	  hybridising	  oligodeoxythymine	  primers	   (Oligo(dT))	   to	   the	  polyadenine	   (Poly(A))	  tail	  of	  mRNA	  templates	  before	  extending	  the	  cDNA	  using	  the	  RNA-­‐dependent	  DNA	  polymerase,	  Reverse	  Transcriptase.	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2.4.3	  cDNA	  Synthesis	  	  To	  prepare	  cDNA,	  13	  μl	  of	  isolated	  RNA	  (500	  ng	  -­‐	  1	  μg)	  was	  incubated	  with	  1	  μl	  of	  Oligo(dT)18	  primers	  (1	  μg	  final)	  and	  1	  μl	  dNTPs	  (5	  mM	  final	  concentration)	  at	  70°C	  for	  3	  minutes	  in	  order	  to	  disrupt	  any	  secondary	  structure	  present	  within	  the	  RNA.	  The	  RNA	  was	  then	  incubated	  briefly	  on	  ice	  before	  the	  addition	  of	  4	  μl	  of	  5X	  Murine	  Leukaemia	  virus	  (MLV)	  RT	  buffer	  (Promega),	  0.5	  μl	  of	  the	  RNase	  inhibitor,	  RNasin	  (Promega)	  and	  0.5	  μl	  Reverse	  Transcriptase	  RT-­‐	  MLV	  enzyme	  (Promega)	  to	  give	  a	  final	   volume	   of	   20	   μl.	   Samples	  were	   incubated	   at	   42°C	   for	   90	  minutes	   and	   then	  heated	   to	   70°C	   for	   10	  minutes	   before	   the	   addition	   of	   80	   μl	   nuclease-­‐free	  water.	  Negative	   controls	   comprising	   equivalent	   amounts	   of	   RNA	  were	   also	   prepared	   in	  the	   absence	   of	   reverse	   transcriptase	   (-­‐RT).	   	   Both	   the	   cDNA	   and	   –RT	   reaction	  products	  were	  stored	  at	  -­‐20	  °C.	  	  
2.4.4	  Quantitative	  Real-­‐time	  (QPCR)	  
	  Quantitative	  real-­‐time	  PCR	  (QPCR)	  was	  implemented	  in	  order	  to	  quantify	  relative	  levels	   of	   mRNA	   expression.	   The	   process	   relies	   on	   the	   detection	   of	   fluorescence	  emitted	   by	   a	   fluorescent	   probe	   that	   increases	   proportionally	   to	   the	   amount	   of	  cDNA	   amplicons	   present	   at	   any	   one	   time.	   	   The	   cDNA	   generated	   by	   reverse	  transcription	   was	   amplified	   using	   fluorescent	   SYBR	   Green	   PCR	   technology	  (Applied	  Biosystems)	  with	  gene-­‐specific	  primers	  (detailed	  in	  Table	  2.1	  and	  2.3)	  on	  the	   Applied	   Biosystems	   StepOnePlus™	   Real	   Time	   PCR	   detection	   system.	   Each	  reaction	  was	  made	   up	   as	   follows;	   12.5	   μl	   Power	   SYBR®	  Green	   PCR	  master	  mix	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(2X)	  (Applied	  Biosystems),	  2.5	  μl	  of	  9	  μM	  gene-­‐specific	  forward	  primer,	  2.5	  μl	  of	  9	  μM	  gene-­‐specific	  reverse	  primer,	  5.5	  μl	  of	  water	  and	  2	  μl	  of	  cDNA	  or	  –RT	  control.	  	  	  Quantification	   of	   mRNA	   expression	   levels	   was	   determined	   using	   a	   plot	   of	   log	  fluorescence	   against	   cycle	   number.	   Here,	   a	   fixed	   fluorescence	   threshold	   or	   cycle	  threshold	  (Ct)	  was	  set	  in	  the	  linear	  phase	  of	  the	  observed	  exponential	  increase	  in	  the	  target	  PCR	  product.	  The	  Ct	  was	  thus	  determined	  as	  the	  cycle	  number	  at	  which	  fluorescence	  crosses	  the	  threshold.	  Relative	  mRNA	  expression	  was	  then	  quantified	  using	  the	  comparative	  Ct	  (∆∆Ct)	  method	  (equation	  shown	  below).	  Here,	  the	  target	  gene	   or	   gene	   of	   interest	   was	   normalised	   to	   a	   standard	   housekeeping	   gene	  (cytoskeletal	  β	  Actin	  unless	  otherwise	   stated)	   and	   this	   change	  was	   subsequently	  normalised	  to	  the	  Ct	  level	  of	  a	  calibrator	  or	  control	  sample.	  The	  specificity	  of	  each	  PCR	  product	  was	  determined	  by	  analysing	  the	  melt	  curve	  produced	  at	  the	  end	  of	  each	  QPCR	  reaction	  where	  a	  single	  melt	  curve	  indicated	  a	  single	  product,	  therefore	  validating	  the	  analysis.	  	  (∆∆Ct)=(Ct	  target(unknown	  sample)-­‐Ct	  standard(unknown	  sample))-­‐(Ct	  target(calibrator	  sample)-­‐Ct	  standard(calibrator	  sample))	  	  
2.5	  SDS	  PAGE	  (Immunoblotting)	  	  Sodium	   dodecyl	   sulfate	   polyacrylamide	   gel	   electrophoresis	   (SDS	  PAGE)/immunoblotting	   is	  a	   technique	  used	  to	  analyse	  the	  expression	  of	  proteins	  on	  a	  polyacrylamide	  gel	  and	  relies	  on	  the	  separation	  of	  these	  proteins	  according	  to	  molecular	  weight.	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2.5.1	  Sample	  Preparation	  	  Protein	   was	   extracted	   from	   HUVECs	   by	   scraping	   cells	   into	   1.5	   mls	   of	   ice	   cold	  phosphate	  buffered	  saline	  (PBS).	  Cell	  suspensions	  were	  centrifuged	  at	  0.4	  rcf	  for	  5	  minutes	  at	  4°C	  and	   then	  spun	  at	  maximum	  speed	   for	  10	  seconds	   to	  obtain	  a	  cell	  pellet.	   PBS	  was	   removed	   and	   cell	   pellets	  were	   re-­‐suspended	   in	   60	   μl	   of	   protein	  lysis	   buffer	   (2	   mM	   EGTA,	   5	   mM	   EDTA,	   30	   mM	   sodium	   fluoride,	   40	   mM	   β-­‐glycerophosphate,	  20	  mM	  sodium	  pyrophosphate,	  1	  mM	  sodium	  orthovanadate,	  1	  mM	  phyenylmethylsulfonyl	  –	   fluoride,	  3	  mM	  benzamidine,	  5	  μM	  pepstatin	  A	  and	  10	  μM	  leupeptin	   in	  25	  mM	  Tris-­‐HCL	  buffer;	  pH	  7.2)	  supplemented	  with	  protease	  inhibitor	  cocktail	  (5	  μl/ml).	  	  	  Protein	   concentration	   was	   determined	   using	   a	   Bradford	   assay	   (Bio-­‐Rad).	   This	  assay	   involves	   a	   change	   in	   absorbance	   of	   a	   Coomassie	   dye	   (Coomassie	   Brilliant	  Blue	  G-­‐250)	  upon	  protein	  binding.	  The	  absorbance	  increases	  proportionally	  to	  the	  amount	  of	  protein	  bound	  to	  the	  dye.	  To	  perform	  the	  assay,	  a	  standard	  curve	  was	  made	   using	   increasing	   concentrations	   of	   bovine	   serum	   albumen	   (BSA)	   (0-­‐50	  μg/ml)	  supplemented	  with	  2	  μl	  of	  lysis	  buffer/well	  (since	  the	  Bradford	  reagent	  is	  sensitive	   to	   detergents	   in	   the	   lysis	   buffer)	   in	   a	   total	   of	   200	   μl/well	   of	   Bradford	  reagent.	  2	  μl	  of	  protein	  sample	  of	  unknown	  concentration	  was	  then	  added	  to	  198	  μl	  Brandford	  reagent	  in	  triplicate	  wells.	  The	  plate	  was	  incubated	  in	  the	  dark	  for	  5	  minutes	   to	   allow	   the	   reaction	   to	   proceed	   and	   then	   read	   on	   a	  microplate	   reader	  (GENios	  pro;	  Tecan)	  at	  a	  wavelength	  of	  595	  nm.	  The	  protein	  content	  of	  the	  samples	  was	   deduced	   from	   the	   BSA	   standard	   curve.	   50	   μl	   of	   HUVEC	   lysates	   were	   then	  added	   to	  12.5	  μl	  5X	  Laemmli	  buffer	   (20%	  glycerol,	  4%	  SDS	   in	  250	  mM	  Tris-­‐HCL	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with	  10%	  β-­‐mercaptoethanol)	  and	  boiled	  for	  5	  minutes	  to	  denature	  the	  proteins.	  Where	  possible,	  samples	  to	  be	  blotted	  for	  Nox4	  alone	  were	  not	  boiled	  but	  rather	  added	   to	   12.5	   μl	   5X	   Laemmli	   buffer	   containing	   1	   mM	   Tris(2-­‐carboxyethyl)phosphine	   hydrochloride	   (TCEP)	   and	   left	   for	   15	   minutes	   at	   room	  temperature.	  Samples	  were	  then	  made	  up	  to	  a	  concentration	  of	  15-­‐25	  μg/30	  μl	  by	  dilution	  in	  1X	  Lemelli	  buffer	  and	  stored	  at	  -­‐80°C.	  	  	  	  	  
2.5.2	  Blotting	  	  	  	  10%	  resolving	  gels	  were	  cast	  and	  then	  topped	  with	  a	  stacking	  gel	   (See	  Table	  2.7	  for	  volumes	  and	  reagents	  used	  for	  gel	  casting).	  15-­‐25	  μg	  of	  protein	  was	  loaded	  into	  each	   well	   alongside	   6	   μl	   of	   molecular	   weight	   marker	   (PageRuler™)	   and	  electrophoresed	  in	  running	  buffer	  (25	  mM	  Tris-­‐base,	  192	  mM	  glycine,	  0.1%	  SDS)	  at	  120V	  for	  10	  minutes	  to	  ensure	  proteins	  migrate	  evenly	  through	  the	  stacking	  gel	  before	  the	  voltage	  was	  increased	  to	  200V	  until	  the	  dye	  front	  reached	  the	  bottom	  of	  the	   resolving	  gel.	  Wet	   transfer	  onto	  nitrocellulose	  membranes	  was	  performed	  at	  100V	   for	  70	  minutes	   in	   transfer	  buffer	   (25	  mM	  Tris-­‐base,	   192	  mM	  glycine,	   10%	  methanol).	  Membranes	  were	  subsequently	  stained	  with	  Ponceau	  S	  red	  to	  check	  for	  efficient	  transfer	  and	  loading	  before	  being	  washed	  in	  0.1%	  PBS-­‐Tween-­‐20	  (PBST)	  or	  Tris-­‐buffered	  salt	  solution	  containing	  0.1%	  Tween-­‐20	  for	  phosphoblots	  (TBST)	  and	  blocked	  for	  3	  hours	  with	  10%	  milk	  powder	  (Marvel	  Original)	  in	  0.1%	  PBST	  or	  TBST.	  Membranes	  were	  then	  probed	  using	  primary	  antibodies	  diluted	  in	  10%	  milk	  powder	  overnight	  at	  4°C.	  Membranes	  were	  then	  washed	  3	  times	  for	  20	  minutes	  in	  PBST/TBST	   and	   incubated	   at	   room	   temperature	   with	   a	   secondary	   horseradish	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peroxidase-­‐HRP	   conjugated	   antibody	   diluted	   in	   10%	   milk	   powder	   for	   2	   hours	  (primary	   and	   secondary	   antibody	   information	   is	   indicated	   in	   Tables	   2.8	   and	   2.9	  respectively).	  This	  was	  followed	  by	  enhanced	  chemiluminescence	  (ECL)	  detection	  and	  development	  of	  blots	  onto	  autoradiographic	  film	  (GE	  healthcare).	  Membranes	  were	   reused	   to	   re-­‐probe	   for	   other	   protein	   targets	   by	   washing	   for	   5	   minutes	   in	  PBST/TBST	  before	  the	  application	  of	  6	  ml	  Stripping	  buffer	  (Thermoscientific)	   for	  15	   minutes.	   Membranes	   were	   blocked	   in	   10%	   milk	   for	   30	   minutes	   before	  incubation	  with	  the	  next	  primary	  antibody.	  Densitometry	  was	  performed	  on	  each	  sample	  band	  using	  the	  ImageJ	  image	  analysis	  program.	  	  
2.6	  PCR	  	  PCR	  reactions	  were	  set	  up	  as	  follows;	  2	  μl	  cDNA,	  1	  μl	  (9	  μM)	  forward	  primer,	  1	  μl	  (9μM)	  reverse	  primer	  (primer	  details	  in	  Table	  2.5),	  12.5	  μl	  REDTaq®	  ReadyMix™,	  33.5	   μl	   H2O.	   PCR	   reactions	   were	   run	   as	   follows;	   35	   cycles	   of	   denaturation	   (30	  seconds	  at	  94	  °C),	  annealing	  (30	  seconds	  at	  56	  °C)	  and	  extension	  (30	  seconds	  at	  72	  °C).	   Resultant	   PCR	   products	   were	   separated	   at	   a	   constant	   voltage	   by	  electrophoresis	  on	  a	  1%	  agarose	  gel	  containing	  ethidium	  bromide	  (400	  ng/ml)	  in	  1xTAE	   buffer	   (40	  mM	   Tris-­‐acetate	   and	   1	  mM	   EDTA)	   and	   then	   visualized	   under	  ultraviolet	  light.	  A	  100bp	  ladder	  (Hpa	  II	  digest	  of	  pBluescript	  II	  SK+)	  was	  also	  run	  in	   order	   to	   identify	   DNA	   bands	   according	   to	   size.	   To	   distinguish	   between	   CSE	  variant	   2	   and	   3,	   DNA	   bands	   were	   excised	   from	   the	   gel	   and	   purified	   using	   the	  Qiagen	   gel	   extraction	   kit	   and	   resultant	   DNA	   sent	   for	   sequencing	   by	   Source	  Biosciences.	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2.7	  Adenoviral-­‐mediated	  Nox4	  Overexpression	  	  HUVECs	   were	   transduced	   with	   either	   an	   adenoviral	   β-­‐Galactosidase	  overexpressing	   control	   viral	   vector	   (AdBGal)	   or	   an	   adenoviral	   mouse	   Nox4	  overexpressing	   viral	   vector	   (AdNox4)	   (both	   generated	   in-­‐house)	   using	   a	  multiplicity	  of	  infection	  (MOI)	  of	  5,	  10	  or	  20	  for	  AdNox4	  or	  10	  and	  20	  for	  AdBGal.	  Each	  virus	  was	  diluted	  to	  its	  respective	  MOI	  (20	  for	  most	  experiments)	  in	  Optimem	  (Invitrogen)	  and	  2	  ml	  of	  this	  solution	  were	  applied	  to	  cells.	  Cells	  were	  placed	  in	  a	  37°C	  incubator	  for	  5	  hours	  after	  which	  the	  virus	  and	  Optimem	  were	  removed	  and	  replaced	  with	  4	  ml	  of	  EBM-­‐2	  HUVEC	  media	  and	   incubated	   for	  a	   further	  19	  or	  43	  hours	  (as	  indicated)	  or	  for	  Nox4	  time-­‐course	  experiments,	  cells	  were	  incubated	  in	  media	  for	  a	  further	  1,	  7	  or	  19	  hours	  after	  transduction	  and	  then	  harvested	  for	  RNA	  or	  protein.	  	  
2.8	  PEG-­‐Catalase	  with	  Nox4	  Overexpression	  	  HUVECs	   were	   treated	   for	   24	   hours	   with	   either	   500	   units/ml	   of	  Catalase−polyethylene	   glycol	   (PEG-­‐catalase)	   or	   vehicle	   control	   (H2O)	   diluted	   in	  EMB-­‐2	  HUVEC	  media.	  	  Following	  this,	  cells	  were	  transduced	  at	  an	  MOI	  of	  20	  with	  either	  AdBGal	  or	  AdNox4	  as	  described	  in	  section	  2.7.	  Optimem	  was	  supplemented	  with	  either	  500	  units/ml	  of	  PEG-­‐catalase	  or	  vehicle	  control	  (H2O).	  Cells	  were	  then	  placed	   in	   a	   37°C	   incubator	   for	   5	   hours	   after	   which	   Optimem	  was	   removed	   and	  replaced	   with	   4	   ml	   of	   EBM-­‐2	   HUVEC	   media	   supplemented	   with	   a	   further	   500	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units/ml	   of	   PEG-­‐catalase	   or	   vehicle	   control	   and	   incubated	   for	   19	   hours	   before	  harvesting	  for	  RNA.	  	  
	  
2.9	  DPI	  Treatment	  with	  Nox4	  Overexpression	  
	  HUVECs	  were	   transduced	   at	   an	  MOI	   of	   20	  with	   either	   an	   AdBGal	   or	   AdNox4	   as	  described	   in	   section	   2.7.	   Cells	  were	   then	   placed	   in	   a	   37°C	   incubator	   for	   5	   hours	  after	  which	  Optimem	  was	  removed	  and	  replaced	  with	  4	  ml	  of	  EBM-­‐2	  HUVEC	  media	  supplemented	  with	   10	   μM	  DPI	   or	   equal	   volumes	   of	   vehicle	   control	   (DMSO)	   and	  incubated	  at	  37°C	  for	  19	  hours	  before	  harvesting	  for	  RNA.	  	  	  
2.10	  ATF4	  Overexpression	  	  HUVECs	   were	   transiently	   transfected	   with	   PCDNA3.1	   expression	   vectors	  containing	   no	   ectopic	   cDNA	   (PCDNA3.1)	   or	   ATF4	   cDNA	   (pATF4)	   (Addgene).	  Transfections	   were	   carried	   out	   using	   the	   Turbofect	   transfection	   reagent	   kit	  following	  the	  manufacturer’s-­‐specifications	  (Thermoscientific).	  In	  brief,	  4	  μg/well	  of	   each	   plasmid	   construct	   (PCDNA3.1	   control	   or	   pATF4)	   was	   added	   to	   EBM-­‐2	  HUVEC	   media	   containing	   6	   μl/well	   Turbofect	   reagent	   and	   incubated	   at	   room	  temperature	  (RT)	  for	  20	  minutes	  whilst	  complexes	  formed.	  After	  which	  4	  ml	  of	  the	  Turbofect/plasmid	  complexes	  were	  added	  to	  each	  well	  and	  incubated	  for	  24	  hours	  before	  being	  harvested	  for	  either	  RNA	  or	  protein.	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2.11	  siRNA	  Transfections	  	  HUVECs	   were	   serum	   starved	   for	   1	   hour	   in	   2	   ml	   of	   Optimem	   before	   being	  transfected	   with	   targeted	   siRNA	   (Table	   2.10)	   or	   an	   equivalent	   concentration	   of	  control	  scrambled	  siRNA	  (all	  siRNA	  from	  Ambion	  Silencer	  Selects).	  Transfections	  were	   performed	   using	   the	   Lipofectamine	   2000®	   Transfection	   Reagent	   kit	  (Invitrogen)	   according	   to	   the	   manufacturer’s-­‐specifications.	   In	   brief,	   scrambled	  control	   or	   targeted	   siRNA	   were	   first	   diluted	   to	   the	   relevant	   concentration	   (as	  indicated	   in	   Table	   2.10)	   in	   Optimem	   and	   incubated	   at	   RT	   for	   5	   minutes.	   In	   a	  separate	  tube,	  Lipofectamine	  2000®	  reagent	  was	  mixed	  at	  a	  1	  in	  100	  dilution	  with	  Optimem	   and	   allowed	   to	   incubate	   at	   RT	   for	   5	   minutes.	   Following	   this,	   the	  Lipofectamine	   mix	   was	   added	   at	   a	   1:1	   ratio	   to	   the	   siRNA	   Optimem	   mixes	   and	  vortexed	   3	   times.	   Lipofectamine/siRNA	   mixtures	   were	   incubated	   at	   RT	   for	   30	  minutes	  whilst	   lipid/siRNA	  complexes	   formed.	  2	  ml	  of	   each	   lipid/siRNA	  mixture	  were	   applied	   to	   the	   designated	   wells	   of	   HUVECs	   and	   incubated	   for	   5	   hours.	  Optimem	   was	   then	   removed	   and	   replaced	   with	   4	   ml	   EGM-­‐2	   HUVEC	   culture	  medium	  and	  cells	  were	  placed	  back	  into	  the	  incubator	  for	  a	  further	  19	  or	  43	  hours	  (as	  indicated)	  before	  harvesting	  for	  RNA	  or	  protein.	  	  
2.12	   Transcription	   Factor	   and	   eIF2α	   Kinase	   Silencing	   with	   Nox4	  
Overexpression	  	  HUVECs	   were	   serum	   starved	   for	   1	   hour	   in	   2mls	   of	   Optimem	   before	   being	  transfected	  with	  20	  nM	  targeted	  siRNA	  designed	  against	  the	  transcription	  factors,	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SP1,	  NRF2	  and	  ATF4,	  or	  the	  eIF2α	  kinases,	  PERK	  and	  HRI,	  (Table	  2.10).	  Scrambled	  siRNA	   were	   used	   as	   controls.	   Transfections	   were	   performed	   using	   the	  Lipofectamine	   2000®	   Transfection	   Reagent	   kit	   as	   detailed	   in	   section	   2.11.	   Cells	  were	  then	  transduced	  at	  an	  MOI	  of	  20	  with	  either	  AdBGal	  or	  AdNox4	  as	  detailed	  in	  section	  2.7	  before	  harvesting	  for	  RNA	  or	  protein.	  	  
2.13	  Hydrogen	  Peroxide	  and	  Tert-­‐butylhydroperoxide	  Treatment	  	  HUVECs	   were	   treated	   with	   increasing	   concentrations	   of	   either	   H2O2	   or	   tert-­‐butylhydroperoxide	   (tBHP).	   	   H2O2/tBHP	   were	   diluted	   in	   EBM-­‐2	   HUVEC	   culture	  media	  to	  give	  final	  concentrations	  of	  1	  μM,	  10	  μM,	  and	  100	  μM.	  Control	  wells	  were	  treated	  with	  water	   (for	  H2O2)	   or	   decane	   (for	   tBHP).	   Cells	  were	   incubated	   for	   24	  hours	  and	  then	  harvested	  for	  RNA.	  	  
2.14	  Methionine/Cysteine	  Limitation	  and	  Glutathione	  Assays	  	  HUVECs	  were	  seeded	  into	  opaque-­‐white	  96-­‐well	  plates	  and	  incubated	  with	  control	  medium	   containing	   cysteine	   and	   methionine	   (DMEM-­‐11995)	   (Invitrogen),	   or	  medium	   depleted	   in	   cysteine	   and	   methionine	   (DMEM-­‐21013-­‐024)	   (Invitrogen).	  DMEM-­‐21013-­‐024	  was	  supplemented	  with	   filter-­‐sterilized	  584	  mg/ml	  Glutamine	  and	   110	   mg/ml	   Sodium	   Pyruvate	   (made	   up	   in	   sterile	   H2O)	   to	   match	   the	  components	   of	   control	   DMEM-­‐11995	   media.	   For	   experiments	   involving	  methionine	   and	  N-­‐acetyl	   cysteine	   (NAC)	   repletion,	  DMEM-­‐21013-­‐024	  media	  was	  supplemented	  with	  increasing	  concentrations	  of	  methionine	  or	  0.063	  mg/ml	  NAC	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before	  being	  filter-­‐sterilized.	  Cells	  were	  incubated	  with	  their	  respective	  media	  for	  24	   hours	   or	   for	   4	   and	  6	   hours	   (for	   time-­‐course	   experiments).	   	   Total	   glutathione	  levels	   were	   assayed	   using	   the	   Promega GSH/GSSG-­‐Glo™	   Assay	   kit	   following	   the	  manufacturer’s	   guidelines.	   Total	   GSH	   was	   determined	   by	   adding	   the	   reducing	  agent	  TCEP	  (1	  mM	  final	  concentration)	  to	  the	  reaction	  mix.	  Plates	  were	  read	  on	  a	  luminometer.	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2.16	  Cloning	  CSE	  Promoter	  Constructs	  	  A	   deletion	   series	   of	   luciferase	   reporter	   plasmid	   constructs	   containing	   different	  sized	  fragments	  of	  the	  human	  CSE	  promoter	  as	  well	  as	  a	  construct	  containing	  a	  CSE	  intronic	  enhancer	  (IE)	  element	  were	  generated	  as	  described	  below	  (IE	  construct	  (-­‐
764bp-­‐luc-­‐IE)	  was	  generated	  in	  house	  by	  Dr.	  Thomas	  Murray).	  	  	  	  The	  Pac	  clone	  RP11-­‐42O15,	  which	  comprises	  the	  human	  CSE	  locus,	  was	  obtained	  from	  the	  BACPAC	  Resources	  Center,	  CHORI.	  Using	  this	  as	  a	  template,	  genomic	  CSE	  promoter	   fragments	   were	   generated	   by	   PCR	   using Herculase	   II	   Fusion	   DNA	  Polymerase	  (Stratagene).	  The	   forward	  primers	  (6414F	  and	  764F)	   incorporated	  a	  KpnI	   restriction	   site	   within	   their	   5′	   ends,	   while	   the	   common	   reverse	   primer	  (+191R)	   incorporated	   an	   XhoI	   restriction	   site.	   	   After	   restriction	   digestion	   with	  KpnI	  and	  XhoI,	   the	   fragments	  were	  subcloned	   into	   the	  KpnI-­‐XhoI	  cloning	  sites	  of	  the	   promoterless	   luciferase	   reporter	   vector,	   pGL4.22	   (Promega),	   to	   generate	   -­‐
6414bp-­‐luc	  and	  -­‐764bp-­‐luc.	  To	  generate	  the	  2.4kb	  intronic	  enhancer	  fragment,	  the	  same	  Pac	  clone	  was	  used	  as	  a	  template	  for	  PCR	  using	  the	  primers,	  CSE	  Int	  Enh	  F/R,	  which	  both	  had	  BamHI	  sites	   incorporated	   into	   their	  5’	  ends.	  After	  digestion	  with	  BamHI,	  this	  fragment	  was	  inserted	  into	  the	  unique	  BamHI	  site,	  downstream	  of	  the	  SV40	   late	  poly	   (A)	   signal	   in	   -­‐764bp-­‐luc,	   to	   generate	   -­‐764bp-­‐luc-­‐IE	   (primer	  details	  are	   given	   in	   Table	   2.4),	   all	   constructs	   were	   sequence-­‐verified	   by	   Source	  Biosciences.	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2.17	  Reporter	  Assays	  	  
2.17.1	  ATF4	  Overexpression	  	  HEK293	  cells	  were	  seeded	  into	  24-­‐well	  plates	  at	  a	  density	  of	  1x105	  cells/well	  and	  transfections	  performed	  as	  follows;	  400	  ng	  of	  firefly	  luciferase	  construct	  (-­‐764bp-­‐
luc,	   -­‐6415-­‐luc	   or	   -­‐764bp-­‐luc-­‐IE),	   200	   ng	   pRL-­‐TK	   cotransfected	   reference	   plasmid	  and	  400	  ng	  of	  either	  ATF4	  overexpression	  plasmid	  or	  PCDNA3.1	  control	  plasmid	  were	   added	   to	   100	   μl	   of	   Optimem	   containing	   2	   μl	   Turbofect	   reagent.	   This	   was	  incubated	  for	  20	  minutes	  at	  room	  temperature	  to	  allow	  DNA/Turbofect	  complexes	  to	   form.	   100	   μl	   of	   each	   transfection	   mixture	   was	   added	   to	   each	   well	   and	   then	  topped	  up	   to	  1	  ml	  using	  DMEM	  D6546	  media	  and	   incubated	   for	  24	  hours	  before	  reporter	  assays	  were	  performed.	  	  
2.17.2	  Reporter	  Assay	  	  Luciferase	  reporter	  assays	  were	  performed	  using	  the	  Dual-­‐Glo®	  Luciferase	  Assay	  System	  (Promega)	  following	  the	  manufacturer’s-­‐specifications.	  In	  brief,	  cell	  culture	  media	   was	   removed	   from	   each	   well	   of	   a	   24-­‐well	   plate	   and	   75	   μl	   of	   PBS	   was	  subsequently	  added	   to	   the	   cells.	  75	  μl	  of	  Dual-­‐Glo®	  Luciferase	   reagent	  was	   then	  added	  and	  the	  plate	  left	  to	  incubate	  at	  RT	  in	  the	  dark	  on	  a	  rocker	  for	  15	  minutes.	  140	  μl	  of	  the	  PBS/Dual-­‐Glo	  mix	  was	  transferred	  to	  an	  opaque-­‐white	  96-­‐well	  plate	  and	  then	  read	  in	  a	  luminometer	  for	  Firefly	  activity.	  70	  μl	  of	  Dual-­‐Glo®	  Stop	  and	  Glo	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reagent	  was	  added	  to	  each	  well	  and	  the	  plate	  placed	  back	  on	  a	  rocker	  at	  RT	  for	  15	  minutes.	  The	  plate	  was	  then	  read	  for	  Renilla	  expression	  on	  a	  luminometer.	  	  	  	  
2.18	  Chromatin	  Immunoprecipitation	  
	  ChIP	  assays	  were	  performed	  by	  Dr.	  Alison	  Brewer	  using	  the	  SimpleChIP	  enzymatic	  Chromatin	   Immunoprecipitation	   kit	   (Magnetic	   beads:	   Cell	   signalling).	   In	   brief,	  T175	   tissue	   culture	   flasks	   containing	   approximately	   4x107	   HEK293	   cells	   were	  transfected	  with	  25	  μg	  total	  DNA,	  with	  50μl	  lipofectamine	  2000	  reagent.	  The	  DNA	  comprised	   12.5	   μg	   -­‐764bp-­‐luc-­‐IE	   and	   either	   12.5	   μg	   PCDNA3.1	   or	   pATF4	  (Addgene).	   Cells	   were	   incubated	   overnight	   in	   DMEM	   D6546	   media	   before	  crosslinking	   with	   675	   μl	   of	   37%	   formaldehyde	   for	   10minutes	   at	   room	  temperature.	  This	   reaction	  was	   stopped	  with	   the	   addition	  of	   2.5	  ml/flask	  of	   10x	  glycine	   solution	   and	   incubated	   for	   a	   further	   5	   minutes	   at	   room	   temperature.	  Subsequent	   nuclear	   and	   chromatin	   extraction	  was	   performed	   exactly	   as	   per	   the	  manufacturer’s	   instructions.	   10	   μg	   of	   the	   resultant	   chromatin	  was	   used	   for	   each	  immunoprecipitation.	  Each	   immunoprecipitation	  was	  performed	  using	   a	  positive	  control	  antibody	  to	  Histone	  H3	  (10	  μl),	  negative	  control	  rabbit	  normal	  IgG	  (1	  μl	   ;	  both	  antibodies	  provided	  in	  the	  kit)	  or	  ATF4	  (5	  μl;	  D4B8,	  Cell	  Signalling).	  	  PCR	   conditions	   used	   to	   amplify	   site	   A	   and	   site	   B	   were	   as	   follows;	   95°C	   for	   2	  minutes,	   23	   cycles	   of	   95°C	   for	   15	   seconds,	   55°C	   for	   15	   seconds,	   72°C	   for	   30	  seconds,	  followed	  by	  72°C	  for	  7	  minutes.	  PCR	  conditions	  used	  for	  negative	  control	  RPL30	  primers	  (provided	  in	  the	  kit)	  were	  95°C	  for	  2	  minutes,	  28	  cycles	  of	  95°C	  for	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15	   seconds,	   62°C	   for	   15	   seconds,	   72°C	   for	   30	   seconds,	   followed	   by	   72°C	   for	   7	  minutes.	   All	   PCR	   reactions	   were	   performed	   in	   20	   μl	   reaction	   volumes	   using	  REDTaq®	  ReadyMix™	  PCR	  Reaction	  Mix	  with	   final	  primer	  concentrations	  of	  200	  nM	  (See	  Table	  2.6	  for	  details	  of	  primers	  not	  included	  in	  the	  kit)	  	  
2.19	  Gene-­‐modified	  Mice	  	  An	  endothelial-­‐specific	  Nox4-­‐overexpressing	  transgenic	  mouse	  line	  (eNox4	  Tg)	  in	  which	   Nox4	   expression	   is	   driven	   by	   a	   Tie-­‐2	   promoter	   construct,	   and	   an	  endothelial-­‐specific	  Nox4	  null	  mice	  line	  (eNox4-­‐/-­‐),	  in	  which	  Cre-­‐recombinase	  was	  driven	  by	  a	  Tie-­‐2	  promoter	  were	  generated	  in	  our	  laboratory	  by	  Dr	  Alison	  Brewer.	  	  
2.20	  Animal	  Husbandry	  	  Mice	   were	   housed	   in	   a	   standard	   temperature	   and	   humidity	   controlled	   animal	  facility	   (BSU)	   with	   a	   12-­‐hour	   light/dark	   cycle	   (daylight	   from	   7am	   to	   7pm)	   and	  allowed	  free	  access	  to	  water	  and	  standard	  laboratory	  chow	  in	  accordance	  with	  the	  Housing	  and	  Care	  of	  Animals	  Used	  in	  Scientific	  Procedures	  Code	  of	  Practice.	  Same	  sex	  mice	  were	  housed	  up	  to	  5	  per	  cage.	  All	  experimental	  animals	  were	  used	  at	  ages	  8-­‐10	   weeks	   unless	   otherwise	   stated.	   Control	   ‘wild	   type’	   (WT)	   mice	   for	   each	  experiment	   represent	   age-­‐	   and	   sex-­‐matched	   litter	   mates	   on	   a	   C57Bl/6J	  background	  unless	  stated	  otherwise.	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2.21	  Genotyping	  	  Genotyping	  was	  used	  to	  determine	  the	  presence	  of	  the	  Nox4	  transgene	  or	  absence	  of	   the	  endogenous	  Nox4	  gene	   in	   isolated	  genomic	  DNA	  from	  individual	  mice.	  Ear	  punches	   were	   harvested	   under	   anesthesia	   (2.5%	   isoflurane/97.5%	   oxygen	   (2	  L/min))	  by	  BSU	  staff	  and	  stored	  at	  -­‐20°C	  until	  use.	  Ear	  punches	  were	  digested	  in	  a	  solution	  of	  10	  mg/ml	  proteinase	  K	   (Roche,	  UK)	   in	  a	  buffer	   containing	  0.1	  M	  Tris	  EDTA,	   0.1	   M	   Na2EDTA,	   1%	   SDS	   and	   0.15	   M	   NaCl,	   pH	   8.0	   for	   1	   hour	   at	   56°C.	  Resultant	   genomic	   DNA	   was	   precipitated	   in	   isopropanol,	   washed	   with	   80%	  ethanol	  and	  re-­‐suspended	  in	  50	  μl	  of	  nuclease-­‐free	  water.	  Amplification	  of	  genomic	  DNA	  was	  conducted	  using	  PCR	  in	  a	  thermal	  cycler	  (AB	  Applied	  Biosystems,	  UK)	  as	  follows:	  35	  cycles	  of	  denaturation	  (30	  seconds	  at	  94	  °C),	  annealing	  (30	  seconds	  at	  56	   °C)	   and	   extension	   (30	   seconds	   at	   72	   °C).	   Each	   reaction	   contained	   12.5	   μl	  REDTaq®	  ReadyMix™	  (Sigma),	  0.5	  μl	  gene-­‐specific	  forward	  primer	  (10	  μM	  stock),	  0.5	  μl	   gene-­‐specific	   reverse	  primer	   (10	  μM	  stock),	  0.5	  μl	  GAPDH	   forward	  primer	  (10	   μM	   stock),	   0.5	   μl	   GAPDH	   reverse	   primer	   (10	   μM	   stock)	   (see	   Table	   2.2	   for	  primer	   details),	   8.5	   μl	   water	   and	   2	   μl	   of	   genomic	   DNA.	   Resultant	   PCR	   products	  were	   separated	   at	   a	   constant	   voltage	   by	   electrophoresis	   on	   a	   1.5%	   agarose	   gel	  containing	   ethidium	   bromide	   (400	   ng/ml)	   in	   1xTAE	   buffer	   (40	  mM	  Tris-­‐acetate	  and	  1	  mM	  EDTA)	  and	  then	  visualized	  under	  ultraviolet	  light.	  A	  100bp	  ladder	  (Hpa	  II	   digest	   of	   pBluescript	   II	   SK+)	  was	   loaded	   alongside	   the	   genotyping	   samples	   to	  permit	  the	  identification	  of	  DNA	  bands	  according	  to	  size.	  	  	  
	   78	  
2.22	  Endothelial	  cell	  isolation	  	  
2.22.1	  Antibody	  Preparation	  	  50	  μl	  of	  well	  vortexed	  streptavidin	  coated	  Dynabeads	  (Invitrogen)	  were	  washed	  5	  times	   in	   Hanks’	   Balanced	   Salt	   Solution	   (HBSS)	   and	   then	   incubated	   at	   RT	  with	   a	  biotinylated	   antiCD31	   (cluster	   of	   differentiation	   31)	   antibody	   (R&D	   Sytems	  BAF3628)	  (50	  μg/ml)	  for	  1	  hour	  on	  a	  tube	  rotator	  to	  allow	  for	  biotin-­‐streptavidin	  interaction	  and	  subsequent	  antibody	  conjugation	  to	  the	  beads.	  After	  this	  the	  beads	  were	  washed	  gently	  3	  times	  in	  HBSS	  to	  remove	  any	  unbound	  antibody.	  
	  
2.22.2	  Collagenase	  A	  Digestion	  and	  Endothelial	  Cell	  Affinity	  Isolation	  	  8-­‐10	  week	  old	  male	  or	  female	  mice	  (WT,	  eNox4	  Tg)	  were	  given	  an	  intra-­‐peritoneal	  injection	   with	   45	   mg/kg	   pentobarbital	   to	   anaesthetise	   the	   animal	   terminally.	  Hearts	  were	  dissected	  out	  and	  2-­‐3	  whole	  hearts	   from	  either	  male	  or	  female,	  age-­‐matched	  WT	  and	  eNox4	  Tg	  mice	  were	  pooled	  according	  to	  genotype.	  Hearts	  were	  finely	  chopped	  into	  2mm3	  pieces	  in	  HBSS	  and	  allowed	  to	  collect	  at	  the	  bottom	  of	  a	  Sterilin	  tube	  on	  ice	  for	  two	  minutes.	  HBSS	  supernatant	  was	  carefully	  discarded	  and	  the	  remaining	  chunks	  of	  heart	  were	  washed	  twice	   in	  HBSS	  to	  remove	  any	  excess	  blood.	  Once	  washed,	  the	  heart	  pieces	  were	  added	  to	  10	  ml	  of	  HBSS	  containing	  100	  mg/ml	  collagenase	  A	  (Roche).	  This	  was	  then	  incubated	  at	  37°C	  in	  a	  shaker	  for	  20	  minutes	  during	  which	  heart	  digests	  were	  mixed	  by	  pipetting	  half	  way	  through	  the	  incubation.	   Heart	   chunks	  were	   then	   allowed	   to	   settle	   at	   the	   bottom	   of	   the	   tube,	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after	   which	   the	   collagenase	   A	   solution	   now	   containing	   any	   liberated	   cells	   was	  removed,	  added	  to	  a	  fresh	  tube	  and	  supplemented	  with	  1	  ml	  calf	  serum	  to	  stop	  the	  collagenase	  reaction.	  A	   fresh	  solution	  of	  HBSS	  containing	  collagenase	  A	  was	   then	  added	  to	   the	  heart	  chunks.	  This	  process	  was	  repeated	  twice	  more.	  This	  step	  was	  performed	  to	  allow	  extracellular	  matrix	  degradation	  and	  subsequent	  liberation	  of	  cardiac	   cell	   types	   without	   over-­‐digesting	   the	   cells.	   After	   the	   final	   incubation,	  digests	  were	  pooled,	  passed	  through	  a	  2	  μm	  cell	  strainer	  and	  spun	  at	  1200	  rcf	  for	  5	  minutes.	  The	  supernatant	  was	  carefully	  removed,	  taking	  care	  not	  to	  disturb	  the	  cell	  pellet.	   	  Cells	  were	  re-­‐suspended	   in	  500	  μl	  HBSS.	  For	  RNA	   isolations,	  50	  μl	  of	   this	  suspension	   was	   removed	   and	   added	   to	   700	   μl	   of	   Qiagen	   qiazol	   reagent	  (representing	   the	   input	   sample)	   and	   450	   μl	   added	   to	   the	   previously	   prepared	  antiCD31	   conjugated	   Dynabeads.	   Mixtures	   were	   placed	   on	   a	   tube	   rotator	   for	   3	  hours	   at	   RT	   to	   allow	   endothelial	   cell	   binding.	   After	   this	   any	   unbound	   cells	  were	  removed	  by	  washing	  3	   times	  with	  HBSS.	   Cells	   bound	   to	   the	  beads	   (representing	  the	  output	  sample)	  were	  then	  lysed	  in	  700	  μl	  qiazol	  reagent.	  For	  protein	  isolations,	  the	  entire	  cell	  suspension	  (500	  μl)	  was	  added	  to	  the	  previously	  prepared	  antiCD31	  conjugated	   Dynabeads	   and	   placed	   on	   a	   tube	   rotator	   for	   3	   hours	   at	   RT.	   Any	  unbound	   cells	  were	   removed	   by	  washing	   3	   times	  with	  HBSS.	   Cells	   bound	   to	   the	  beads	  were	  then	  lysed	  directly	  into	  60	  μl	  of	  protein	  lysis	  buffer.	  	  RNA	  was	  extracted	  from	  cardiac	  microvascular	  endothelial	  cells	  (CMEC)	  using	  the	  Qiagen	  RNeasy	   isolation	  kit.	   In	  brief,	  CMEC	  were	   incubated	  with	  700	  μl	  of	  Qiazol	  solution	   and	   vortexed	   vigorously	   for	   10	   seconds,	   beads	   were	   removed	   using	   a	  magnet	  and	  the	  remaining	  qiazol	  was	  spun	  through	  Qiashredder	  columns	  (Qiagen,	  UK)	   at	   13,000	   rpm	   for	   one	   minute.	   RNA	   was	   isolated	   according	   to	   the	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manufacturer’s	  specifications	  (Qiagen	  RNeasy).	  The	  resultant	  RNA	  was	  eluted	  into	  30	   μl	   of	   nuclease-­‐free	   water	   respectively	   and	   quantified	   using	   a	   NanoDrop	  spectrophotometer	  (ND-­‐1000,	  Labtech	  International,	  UK).	  	  Protein	  was	  extracted	  from	  CMEC	  by	  the	  addition	  of	  60	  μl	  of	  lysis	  buffer	  (detailed	  in	  section	  2.5.1)	  directly	  to	  the	  cells	  on	  the	  magnetic	  beads	  and	  incubated	  at	  room	  temperature	   for	   5	   minutes.	   Beads	   were	   subsequently	   removed	   using	   a	   magnet,	  protein	  concentration	  was	  determined	  using	  a	  Bradford	  assay	  before	  50	  μl	  of	  lysed	  CMEC	  sample	  were	  added	  to	  12.5	  μl	  5X	  Laemmli	  buffer	  and	  boiled	  for	  5	  minutes	  to	  denature	  the	  proteins.	  Protein	  samples	  were	  diluted	  to	  25	  μg/30	  μl	  in	  1X	  laemmli	  buffer	  and	  stored	  at	  -­‐80°C.	  	  	  
2.23	  Measuring	  H2S	  using	  the	  Unisense	  H2S	  Microsensor	  	  Hydrogen	   sulphide	   was	   measured	   using	   the	   Unisense	   H2S	   Microsensor	   probe	  following	  the	  manufacturer’s	  specifications.	  In	  brief,	  150-­‐200	  mg	  organ	  slices	  were	  incubated	   at	   37°C	  with	   a	   buffer	   containing	  1	  ml	  Hepes	   solution	   (pH	  7.4),	   60	  μM	  pyridoxyl	  5	  phosphate	  (PLP)	  and	  1	  mM	  cysteine.	  The	  Microsensor	  probe	  was	  then	  placed	  through	  a	  rubber	  stopper	  into	  a	  glass	  vial	  containing	  the	  organ	  and	  buffer.	  The	  reactions	  were	  allowed	  to	  proceed	  for	  up	  to	  1	  hour	  after	  organ	  addition	  and	  H2S	   standards	   were	   measured	   by	   incubating	   the	   probe	   with	   increasing	  concentrations	  (10	  μM,	  100	  μM,	  300	  μM,	  1	  mM)	  of	  NaHS.	  Data	  were	  collected	  on	  the	   Unisense	   Sensor	   Trace	   suite	   software.	   Analysis	   was	   made	   by	   taking	   the	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millivolt	  reading	  obtained	  30	  minutes	  after	  initial	  H2S	  detection.	  A	  diagram	  of	  the	  experimental	  set	  up	  used	  is	  shown	  in	  figure	  2.1.	  
	  
Figure	   2.1:	  Polarographic	   Micro-­‐sensor	   Setup.	   A	   schematic	   illustration	   of	   the	  experimental	  setup	  used	  for	  measuring	  H2S	  ex	  vivo.	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the	  vessels	  were	  stretched	  to	  the	  optimal	  pre-­‐tension	  condition	  (~2	  mN)	  using	  the	  DMT	   normalisation	   modules.	   Rings	   were	   then	   tested	   for	   contraction	   to	   60	   mM	  potassium	   chloride	   (KCl)	   before	   being	   washed	   3	   times	   and	   treated	   with	   10	   μM	  phenylephrine	   (PE)	   to	   induce	   contraction,	   this	   was	   maintained	   for	   20	   minutes	  before	  the	  addition	  of	  10	  μM	  acetylcholine	  to	  test	  the	  endothelium	  for	  its	  ability	  to	  relax	   the	   vessel.	   Aortic	   rings	   were	   then	   washed	   3	   times	   and	   incubated	   for	   30	  minutes	  in	  Krebs-­‐Ringer	  before	  the	  addition	  of	  20	  mM	  PPG	  to	  inhibit	  CSE	  or	  2000	  Unit/5	  ml	   of	   PEG-­‐catalase	   to	   scavenge	   H2O2,	  all	   diluted	   in	   Krebs-­‐Ringer.	   Vehicle	  controls	   composed	   of	   Krebs-­‐Ringer	   were	   run	   alongside	   each	   inhibitor	   and	  inhibitors	   were	   incubated	   with	   vessels	   for	   30	   minutes	   and	   20	   minutes	  respectively.	  This	  was	  then	  followed	  by	  a	  cumulative	  dose-­‐dependent	  contraction	  to	   PE	   (up	   to	   30	   μM).	   For	   eNox4-­‐/-­‐	   mice,	   no	   inhibitors	   were	   used	   and	   so	   after	  relaxation	   to	   ACh	   and	   subsequent	   wash	   steps,	   vessels	   were	   dose-­‐dependently	  contracted	  with	  PE.	  Results	  were	  then	  analysed	  using	  LabChart	  software.	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Table	  2.1:	  Primer	  sequences	  used	  for	  QPCR	  on	  HUVEC	  samples.	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Table	  2.3:	  QPCR	  primer	  sequences	  (mouse).	  	  
	  
Table	  2.4:	  Primer	  sequences	  used	  for	  cloning	  luciferase	  reporter	  constructs.	  	  
	  	  
Table	  2.5:	  Primer	  sequences	  used	  for	  PCR.	  
	  
	  
Table	  2.6:	  Primers	  used	  for	  ChIP	  assays.	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Table	  2.8:	  Primary	  antibodies	  and	  dilutions.	  	  
	  	  
Table	  2.9:	  Secondary	  antibodies	  and	  dilutions.	  
	  
	  
Table	  2.10:	  siRNAs	  and	  final	  concentrations	  used.	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Primary'Antibody Dilution' Species Company Catalog'Number
CSE 1%in%3000 Rabbit%(Polyclonal) Aviva% ARP46068_T100
CBS 1%in%3000 Rabbit%(Polyclonal) AbCam Ab96252
Nox4 1%in%2000 Rabbit In%house In%house
ATF4%(CREBI2) 1%in%2000 Rabbit%(Polyclonal) Santa%Cruz SCI200
p22Phox 1%in%2000 Rabbit%(Polyclonal) AbCam ab75941
Total%eIF2α 1%in%2000 Mouse%(Monoclonal) Santa%Cruz SCI133132
PiIeIF2α%(Ser51) 1%in%2000 Rabbit%(Polyclonal) Millipour 07I760
βGalactosidase 1%in%5000 Rabbit%(Polyclonal) AbCam Ab616
βActin 1%in%5000 Rabbit Sigma%
Secondary*Antibody Dilution* Species Company Catalog*Number
IgG$HRP(linked 1"in"5000 Goat"anti+Rabbit Cell"signalling"technologies 7074S
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3.1	  Introduction	  	  	  As	  discussed	  in	  chapter	  1,	  studies	  have	  identified	  a	  role	  for	  ROS	  in	  the	  regulation	  of	  hcy	   metabolism92,	   96,	   97,	   156	   and	   H2S	   production101	   in	   various	   cell	   types.	   The	  endogenous	   source	   of	   ROS	   that	   regulates	   these	   processes	   however	   remains	  elusive.	  	  
3.1.2	  NADPH	  Oxidase	  4	  as	  a	  Potential	  Source	  of	  ROS	  	  Nox	   enzymes	   represent	   physiological	   enzymatic	   generators	   of	   ROS	   that	   are	  expressed	  and	  active	  in	  a	  diverse	  range	  of	  cell	  types	  and	  systems122.	  Indeed,	  some	  studies	  have	  indirectly	  implicated	  Nox	  as	  a	  potential	  ROS	  source	  in	  the	  regulation	  of	  hcy	  metabolism	  and	  H2S	  biosynthesis,	  through	  the	  use	  of	  Nox	  inhibitors	  such	  as	  DPI100	   101,	  157.	   Of	   the	   7	  Nox	   family	  members,	   vascular	  Nox4	  has	   been	   extensively	  characterised	   as	   an	   endogenous	   generator	   of	  H2O2	   that	   participates	   in	   a	   diverse	  range	  of	  physiological	  intracellular	  signalling	  responses149.	  Interestingly,	  H2O2	  has	  been	   shown	   to	   regulate	   the	   expression	   and	   activity	   of	   some	   of	   the	   enzymes	  involved	  in	  hcy/H2S	  metabolism92,	  99.	  Moreover,	  direct	  genetic	  evidence	  supporting	  a	  role	  for	  Nox4	  in	  hcy	  metabolism	  comes	  from	  a	  large-­‐scale,	  genome-­‐wide	  screen	  which	   investigated	   the	   associations	   between	   high	   plasma	   hcy	   levels	   and	   over	  300,000	  single-­‐nucleotide	  polymorphisms	  (SNPs)	  in	  13,974	  women.	  The	  results	  of	  this	  study	  reaffirmed	  the	  role	  of	  a	  number	  of	  enzymes	  integral	  to	  hcy	  metabolism	  and	   further	   demonstrated	   highly-­‐significant	   associations	   between	   high	   hcy	  concentrations	  and	  polymorphisms	   in	  4	  novel	   genetic	   loci.	  One	  of	   these	   loci	  was	  that	   of	   Nox4157.	   Perhaps	   consistent	   with	   this,	   a	   striking	   observation	   was	   made	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from	   a	   micro-­‐array	   screen	   performed	   in	   our	   group158	   which	   compared	   the	  transcriptomes	  of	  hearts	  taken	  from	  cardiac-­‐specific	  Nox4	  transgenic	  mice	  and	  WT	  littermate	   controls.	   Significant	   changes	   in	   some	   of	   the	   enzymes	   known	   to	   be	  involved	   in	   hcy	  metabolism	  were	   identified.	   Of	   note,	   an	   expressed-­‐sequence-­‐tag	  (EST)	   corresponding	   to	   the	   CSE	   gene	   was	   very	   significantly	   elevated	   in	   Nox4	  transgenic	  (Tg)	  hearts	  compared	  with	  WT	  littermates.	  	  	  Finally,	   the	  gene	  expression	  of	  CSE	  has	  been	  shown	  to	  be	  ROS-­‐inducible	   in	  some	  systems99	   100.	   Moreover,	   Nox-­‐derived	   H2O2	   has	   been	   shown	   to	   regulate	   CSE	  derived	  H2S	  production	   in	  endothelial	   cells	   in	  vitro101.	   It	   is	   therefore	   tempting	   to	  speculate	   that	  Nox4,	  which	  specifically	  generates	  H2O2	  and,	  accordingly	  has	  been	  shown	   previously	   to	   generate	   significantly	   increased	   amounts	   of	   H2O2	   upon	   its	  overexpression	   in	   HUVECs47,	   may	   function	   in	   the	   regulation	   of	   hcy	   metabolism	  and/or	  H2S	  production	  in	  endothelial	  cells.	  	  
Aim	  	  To	  characterise	  the	  effects	  of	  Nox4	  mis-­‐expression	  on	  the	  expression	  of	  enzymes	  involved	  in	  hcy	  metabolism	  in	  the	  endothelium.	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3.2	  Results	  
3.2.1	   Characterising	   Adenoviral-­‐mediated	   Nox4	   Overexpression	   in	  
HUVECs	  
	  To	   begin	   to	   investigate	   the	   potential	   role	   of	   Nox4	   in	   the	   expression	   of	   hcy/H2S	  metabolism-­‐associated	   enzymes	   in	   HUVECs,	   experiments	   were	   performed	   to	  assess	  the	  efficiency	  of	  adenoviral-­‐mediated	  ectopic	  overexpression	  of	  Nox4.	  Nox4	  was	  transduced	  using	  three	  multiplicities	  of	  infection	  (MOI	  5,	  10	  and	  20)	  alongside	  a	  B	  Gal	  control	  overexpressing	  virus.	  	  Figure	  3.1A	  and	  B	  show	  that	  Nox4	  and	  B	  Gal	  can	  be	  overexpressed	  in	  a	  dose-­‐dependent	  manner	  and	  that	  an	  MOI	  of	  20	  induces	  the	  highest	  level	  of	  overexpression	  of	  both	  proteins.	  An	  MOI	  of	  20	  was	  selected	  for	  future	   experiments.	   Figure	   3.1A	   also	   shows	   that	   endogenous	   Nox4	   protein	  expression	  can	  be	  detected	  in	  HUVECs.	  
	  















MOI$ 5# 10# 20# 5# 10# 20#
KDa#
A" B"
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3.2.2	  Nox4	  Overexpression	  Induces	  the	  Transcription	  of	  CBS	  and	  CSE	  	  To	  determine	  whether	  a	   relationship	  exists	  between	   the	  expression	  of	  Nox4	  and	  the	  transcription	  of	  enzymes	  involved	  in	  hcy	  metabolism	  and	  H2S	  biosynthesis	   in	  the	   endothelium,	   Nox4	   was	   overexpressed	   in	   HUVECs	   and	   the	   expression	   of	  hcy/H2S	   metabolism-­‐associated	   enzymes	   was	   quantified	   by	   QPCR.	   Figure	   3.2	  shows	   the	   results	   obtained	   from	   these	   experiments.	   Figure	   3.2A	   indicates	   that	  Nox4	  was	  highly	  overexpressed	  at	   the	  protein	   level	   and	   that	   this	  did	  not	   change	  the	  mRNA	  expression	  of	  methionine-­‐	  and	  folate-­‐cycle	  associated	  enzymes	  (Figure	  3.2	  	  B-­‐E).	   	  By	  contrast,	  the	  transsulfuration-­‐associated	  enzymes,	  CBS	  and	  CSE,	  are	  highly	   significantly	   and	   robustly	   up-­‐regulated	   following	   24	   hours	   of	   Nox4	  overexpression	  (Figure	  3.2	  F,G).	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3.2.3	  Nox4	  Silencing	  Reduces	  CSE	  mRNA	  Expression	  	  To	  assess	  the	  physiological	  contribution	  of	  endogenous	  Nox4	  on	  the	  expression	  of	  hcy/H2S	  metabolism-­‐associated	  enzymes	   in	  HUVECs,	  Nox4-­‐silencing	  experiments	  were	  performed.	  Figure	  3.3	  indicates	  the	  results	  of	  these	  experiments.	  Figure	  3.3A	  shows	   that	  Nox4	  was	  significantly	   silenced	  at	   the	  mRNA	   level	   following	   targeted	  siRNA	   treatment.	   	   No	   significant	   changes	   in	   the	   expression	   of	   methionine	   and	  folate	  cycle	  enzymes	  were	  observed	  following	  Nox4	  silencing	  (Figure	  3.3	  B-­‐E).	  By	  contrast,	  there	  was	  a	  trend	  toward	  a	  reduction	  in	  the	  expression	  of	  CBS	  (Figure	  3.3	  F),	   and	   CSE	   expression	  was	   significantly	   reduced	   following	   Nox4	   silencing,	   with	  respect	  to	  scrambled	  siRNA	  controls	  (Figure	  3.3	  G).	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3.2.4	  CSE	  Protein	  Expression	  can	  be	  Detected	  in	  HUVECs	  	  There	   has	   been	   some	   debate	   as	   to	   whether	   significant	   CSE	   protein	   expression	  occurs	   in	   endothelial	   cells63,	   64.	   To	   investigate	   whether	   endogenous	   CSE	   protein	  was	   expressed	   in	   HUVECs,	   immunoblotting	   to	   detect	   CSE	   protein	   levels	   was	  performed.	  Figure	  3.4	  indicates	  that	  a	  band	  at	  the	  anticipated	  molecular	  weight	  for	  CSE	  (44	  KDa)	  is	  detected	  in	  HUVECs.	  To	  further	  confirm	  the	  identity	  of	  this	  band,	  siRNA-­‐mediated	   silencing	   of	   CSE	   protein	   reveals	   a	   depletion	   in	   its	   intensity,	  consistent	  with	  the	  expression	  of	  CSE	  protein	  in	  HUVECs.	  	  	  	  
	  	  
Figure	   3.4:	   Endogenous	   CSE	   protein	   Expression	   is	   Detectable	   by	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3.2.5	  Nox4	  Overexpression	  Increases	  CSE	  Protein	  Expression	  in	  HUVECs	  	  	  Nox4	  overexpression	  robustly	  up-­‐regulated	  CSE	  mRNA	  expression	   (figure	  3.2	  G).	  To	   determine	   whether	   this	   resulted	   in	   a	   corresponding	   increase	   in	   CSE	   protein	  expression,	  Nox4	  was	  overexpressed	  in	  HUVECs,	  and	  CSE	  protein	  expression	  was	  quantified.	   Figure	   3.5A	   and	   B	   indicate	   that	   CSE	   protein	   levels	   are	   significantly	  increased	  upon	  Nox4	  overexpression,	  compared	  to	  B	  Gal	  transduced	  control	  cells.	  	  
	  	  	  
Figure	  3.5:	  CSE	  Protein	  Expression	   is	   Increased	  Upon	  Nox4	  Overexpression.	  
A)	   A	   representative	   immunoblot	   showing	   CSE	   and	   Nox4	   protein	   expression	  following	  48	  hours	  Nox4	  overexpression	  (Nox4	  O.E)	  or	  B	  Gal	  overexpression	  (B	  Gal	  O.E)	   in	   HUVECs.	   B,C)	   Corresponding	   densitometric	   analysis	   for	   CSE	   and	   Nox4	  protein	  expression	  respectively.	  All	  data	  normalised	  to	  β	  Actin	  protein	  levels.	  N=3,	  *	  =	  P<0.05,	  **	  =	  P<0.01.	  Statistical	  analyses	  performed	  using	  an	  unpaired	  Students	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3.3.6	  Nox4	  Silencing	  Reduces	  CSE	  Protein	  Expression	  in	  HUVECs	  	  The	   silencing	   of	   endogenous	   Nox4	   significantly	   reduced	   CSE	   mRNA	   expression	  (figure	  3.3	  G).	  To	  determine	  whether	  this	  resulted	  in	  a	  concommitant	  reduction	  in	  CSE	  protein	  expression,	  Nox4	  was	  silenced	  in	  HUVECs	  and	  CSE	  protein	  levels	  were	  analysed	   by	   immunoblotting.	   Figure	   3.6	   shows	   that	   the	   silencing	   of	  Nox4	   for	   48	  hours	   significantly	   reduced	   CSE	   protein	   levels,	   consistent	   with	   the	   mRNA	   data	  obtained	   for	   the	   same	   experiment.	   This	   suggests	   that	   Nox4	   is	   a	   physiological	  regulator	  of	  CSE	  expression	  in	  endothelial	  cells	  in	  vitro.	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3.2.7	  CBS	  Protein	  Expression	  is	  Unaffected	  by	  Nox4	  Overexpression	  and	  
Silencing	  
	  Nox4	  overexpression	  significantly	   increased	  CBS	  mRNA	  expression	   (figure	  3.2	  F)	  although,	  by	  contrast,	  Nox4	  silencing	  did	  not	  significantly	  reduce	  CBS	  mRNA	  levels	  (a	   trend	   toward	   a	   reduction	   however	   was	   observed)	   (figure	   3.3	   F).	   To	   assess	  whether	  Nox4	  affects	  CBS	  protein	  expression	  in	  HUVECs,	  Nox4	  overexpression	  and	  silencing	   experiments	   were	   performed	   as	   described	   above.	   Figure	   3.7A	   and	   D	  demonstrate	   that	   CBS	   protein	   expression	   remains	   unchanged	   following	   Nox4	  overexpression	  and	  silencing	  respectively.	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Figure	   3.7:	   CBS	   Protein	   Expression	   Remains	   Unchanged	   Upon	   Nox4	   Mis-­‐
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3.2.8	  Endothelial	  Nox4	  is	  Highly	  Expressed	  Relative	  to	  Nox1	  and	  Nox2.	  	  It	  has	  previously	  been	  shown	  that	  Nox4	  is	  highly	  expressed	  in	  endothelial	  cells129.	  To	  confirm	  these	  previous	  observations	  and	  to	  determine	  the	  relative	  expression	  of	  endothelial	  Nox1,	  Nox2	  and	  Nox4,	  QPCR	  was	  used	  to	  measure	  the	  mRNA	  levels	  of	  these	  Nox	  isoforms.	  Figure	  3.8	  shows	  that	  Nox4	  is	  highly	  expressed	  compared	  to	  Nox1	  and	  Nox2,	  highlighting	  its	  potential	  functional	  importance	  in	  this	  cell	  type.	  	  
	  
Figure	  3.8:	  Endothelial	  Nox4	  is	  Highly	  Expressed	  Relative	  to	  Nox1	  and	  Nox2.	  QPCR	   data	   showing	   the	   relative	   mRNA	   expression	   of	   Nox1,	   Nox2	   and	   Nox4	   in	  HUVECs.	  All	  data	  normalised	  to	  β	  Actin	  mRNA	  expression.	  N=3.	  	  
3.2.9	   Silencing	  of	   p22phox	  Significantly	  Reduces	  CSE	  mRNA	  Expression	   in	  
HUVECs	  	  	  Nox4	  is	  the	  most	  abundantly	  expressed	  Nox	  isoform	  that	  associates	  with	  p22phox	  in	  the	   endothelium	   (Figure	   3.8).	   The	   Nox	   subunit	   of	   Nox4	   is	   stabilised	   by	   its	  association	  with	  the	  membrane	  protein	  p22phox	  159.	  To	  further	  investigate	  a	  role	  for	  Nox	  proteins	  in	  the	  transcriptional	  regulation	  of	  CSE,	  p22phox	  was	  silenced.	  Figure	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3.9A	   shows	   that	   p22phox	   was	   successfully	   silenced	   using	   siRNA	   and	   figure	   3.9B	  demonstrates	   that	   this	   silencing	   of	   p22phox	   significantly	   reduced	   CSE	   mRNA	  expression.	  These	  data	  further	  support	  a	  role	  for	  endogenous	  NADPH	  oxidase(s)	  in	  the	  physiological	  regulation	  of	  CSE	  expression	  and,	  consistent	  with	  the	  high	  level	  of	  expression	  of	  Nox4	  in	  the	  endothelium	  compared	  to	  other	  Nox	  isoforms,	  further	  point	  to	  the	  involvement	  of	  Nox4	  in	  this	  process.	  	  	   	  
	  	  	  
Figure	  3.9:	  CSE	  mRNA	  Expression	  is	  Reduced	  Following	  p22phox	  Silencing.	  A)	  A	   representative	   immunoblot	  and	  corresponding	  densitometric	  analysis	   showing	  p22phox	   protein	   expression	   following	   48	   hours	   p22phox	   silencing	   with	   siRNA	  (sip22phox)	  or	  scrambled	  siRNA	  controls	  in	  HUVECs.	  Data	  are	  normalised	  to	  β	  Actin	  protein	   levels.	   B)	   Corresponding	   QPCR	   data	   showing	   CSE	   mRNA	   expression	  following	  48	  hours	  p22phox	  silencing.	  Data	  normalised	  to	  β	  Actin	  mRNA	  expression.	  N=3,	  **	  =	  P<0.01.	  Statistical	  analyses	  performed	  using	  an	  unpaired	  Students	  t-­‐test.	  	  	  	  
3.2.10	  24	  Hours	  Exogenous	  H202	  Treatment	  Does	  Not	  Mimic	   the	  Effects	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production	   in	  HUVECs47.	   Furthermore,	   administration	   of	  H2O2	   to	   COS7	   cells	  was	  shown	  previously	   to	   increase	  CSE	  transcription99.	  Thus,	   in	  an	  attempt	   to	  confirm	  the	   involvement	   of	   H2O2	   in	   the	   Nox4-­‐induced	   up-­‐regulation	   of	   CSE	   expression,	  HUVECs	  were	  treated	  with	  increasing	  concentrations	  of	  H2O2	  for	  24	  hours.	  Figure	  3.10	  shows	  that	  CSE	  mRNA	  expression	  failed	  to	  increase	  significantly	  in	  response	  to	   all	   H2O2	   concentrations	   used,	   although	   a	   slight	   trend	   toward	   an	   increase	  was	  observed	  in	  all	  cases.	  	  	  
	  	  	  	  
Figure	  3.10:	  24	  Hour	  Treatment	  with	  Exogenous	  H2O2	  Does	  Not	  Significantly	  
Enhance	   CSE	   mRNA	   Expression	   in	   HUVECs.	   	   QPCR	   data	   showing	   the	   mRNA	  expression	   of	   CSE	   following	   24	   hours	   incubation	   of	   HUVECs	   with	   increasing	  concentrations	   of	   H2O2.	   All	   data	   normalised	   to	   β	   Actin	   mRNA	   expression.	   N=3,	  Statistical	  analysis	  performed	  using	  a	  one-­‐way	  ANOVA	  	  and	  a	  Tukeys	  post-­‐hoc	  test	  did	  not	  reveal	  any	  significant	  differences	  between	  groups.	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3.2.11	   Exogenous	   Tert-­‐Butylhydroperoxide	   Fails	   to	   Increase	   CSE	  mRNA	  
Expression	  	  	  	  H2O2	   is	   potentially	   labile	   and	   therefore	   to	   overcome	   the	   experimental	   caveats	  associated	   with	   H2O2	   instability,	   Tert-­‐butylhydroperoxide	   (tBHP),	   a	   peroxide	  donor,	  was	  utilised.	  Incubation	  of	  HUVECs	  with	  varying	  concentrations	  of	  tBHP	  did	  not	  however,	  increase	  CSE	  expression	  as	  shown	  in	  Figure	  3.11.	  	  	  
	  	  
Figure	  3.11:	  Exogenous	  tBHP	  Does	  Not	  Enhance	  CSE	  mRNA	  Expression.	  QPCR	  data	   showing	   the	   mRNA	   expression	   of	   CSE	   following	   24	   hours	   incubation	   of	  HUVECs	   with	   increasing	   concentrations	   of	   tBHP.	   All	   data	   normalised	   to	   β	   Actin	  mRNA	  expression.	  N=3,	  Statistical	  analysis	  performed	  using	  a	  one-­‐way	  ANOVA	  and	  a	  Tukeys	  post-­‐hoc	  test,	  did	  not	  reveal	  any	  significant	  differences	  between	  groups.	  	  	  	  
3.2.12	  The	  Nox	  Inhibitor,	  DPI,	  Enhances	  the	  Nox4-­‐induced	  Up-­‐regulation	  
of	  CSE	  	  Previous	  reports	  have	  shown	  that	  CSE	  expression	  can	  be	   inhibited	  by	   the	  broad-­‐spectrum	   Nox	   inhibitor,	   DPI	   in	   rat	   mesangial	   cells100.	   To	   further	   investigate	  whether	   the	   Nox4-­‐induced	   increase	   in	   CSE	   mRNA	   expression	   was	   due	   to	   a	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functional	   effect	   of	   Nox4,	   Nox4	   was	   overexpressed	   in	   HUVECs	   followed	   by	  incubation	   with	   10	   μM	   DPI.	   Figure	   3.12	   shows	   that	   the	   combination	   of	   Nox4	  overexpression	   with	   DPI	   treatment	   surprisingly	   resulted	   in	   a	   significant	  
enhancement	  in	  the	  Nox4-­‐induced	  up-­‐regulation	  in	  CSE	  mRNA	  expression.	  	  
	  	  	  
Figure	   3.12:	   DPI	   Exacerbates	   Nox4-­‐induced	   CSE	   Expression.	   QPCR	   data	  showing	   the	   mRNA	   expression	   of	   CSE	   following	   24	   hours	   Nox4	   overexpression	  (Nox4	  O.E)	   in	  the	  presence	  or	  absence	  of	  19	  hours	  DPI	  treatment	  compared	  to	  B	  Gal	  overexpression	   (B	  Gal	  O.E)	   in	  HUVECs.	  All	  data	  normalised	   to	  β	  Actin	  mRNA	  expression.	   O.E	   =	   Overexpression.	   N=3,	   ****	   =	   P<0.0001.	   Statistical	   analyses	  performed	  using	  one-­‐way	  ANOVA	  and	  a	  Tukeys	  post-­‐hoc	  test.	  	  	  	  
3.2.13	   PEG-­‐Catalase	   Reduces	   the	   Nox4-­‐induced	   Increase	   in	   CSE	   mRNA	  
Expression	  	  To	  determine	  whether	  Nox4-­‐derived	  H2O2	  was	  involved	  in	  secondary	  messenger-­‐signal	  mediated	  transcriptional	  activation	  of	  CSE,	  PEG-­‐Cat	  was	  applied	  to	  HUVECs	  that	  were	  overexpressing	  Nox4.	  Figure	  3.13	  shows	  that	  incubation	  of	  HUVECs	  with	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500units	   of	   PEG-­‐Cat	   resulted	   in	   a	   small	   but	   significant	   blunting	   in	   the	   Nox4-­‐	  induced	  transcriptional	  induction	  of	  CSE.	  	  	  
	  
Figure	   3.13:	   PEG-­‐Catalase	   Blunts	   Nox4-­‐induced	   CSE	   Expression.	   QPCR	   data	  showing	   the	   mRNA	   expression	   of	   CSE	   following	   treatment	   of	   HUVECs	   with	  500units	  of	  PEG-­‐Cat	  (500U	  PEG-­‐Cat)	  for	  48hours	  and	  Nox4	  overexpression	  (Nox4	  O.E)	  for	  24	  hours	  compared	  to	  a	  B	  Gal	  overexpression	  (B	  Gal	  O.E)	  control.	  All	  data	  normalised	   to	  β	  Actin	  mRNA	  expression.	  O.E	  =	  Overexpression.	  N=3,	   *	   =	  P<0.05,	  ****	   =	   P<0.0001.	   Statistical	   analyses	   performed	   using	   a	   one-­‐way	   ANOVA	   and	   a	  Tukeys	  post-­‐hoc	  test.	  	  	  
3.2.14	  A	  Functioning	  Transsulfuration	  Pathway	  is	  not	  Present	  in	  HUVECs	  	  CSE	   participates	   in	   both	   hcy	   metabolism	   and	   H2S	   biosynthesis.	   During	   hcy	  metabolism,	  methionine	  is	  first	  utilised	  as	  a	  methyl	  donor	  where	  its	  demethylation	  results	   in	   the	   formation	  of	  hcy.	  When	  methionine	   levels	  are	  high,	  hcy	  enters	   into	  the	   transsulfuration	   pathway,	   an	   effect	   mediated	   by	   an	   S-­‐adensylmethionine-­‐induced	   up-­‐regulation	   in	   CBS	   activity160.	   Hcy	   is	   subsequently	   converted	   into	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cysteine	   by	   the	   sequential	   action	   of	   CBS	   and	   CSE.	   Once	   generated,	   cysteine	   can	  then,	  for	  instance	  be	  used	  as	  a	  substrate	  for	  GSH	  synthesis.	  To	  begin	  to	  determine	  whether	   endothelial	   CSE	   participates	   in	   canonical	   transsulfuration	   activity	   (the	  conversion	  of	   hcy	   to	   cysteine),	   an	   assessment	   of	   the	   transsulfuration	   capacity	   of	  HUVECs	  was	  made	  by	  assessing	  intracellular	  GSH	  level.	  Figure	  3.14	  B	  and	  C	  show	  that	   incubation	  of	  HUVECs	  with	  medium	  lacking	  cysteine	  and	  methionine	  results,	  as	  expected,	  in	  a	  significant	  reduction	  in	  glutathione	  levels.	  This	  effect	  is	  rapid	  and	  detectable	   just	  4	  hours	  after	  cysteine	  depletion	   (Figure	  3.14	  B).	   In	  an	  attempt	   to	  recover	   GSH	   levels	   through	   transsulfuration,	   HUVECs	   were	   subsequently	  incubated	   with	   medium	   lacking	   cysteine	   but	   containing	   high	   concentrations	   of	  methionine,	  which	  would	  be	  expected	  to	  result	   in	  an	   increase	   in	   transsulfuration	  activity	  via	   enhanced	  CBS	  activity.	  However,	  Figure	  3.14	  B	  and	  C	  show	  that	  both	  increasing	   the	  dose	   and	   time	   to	  which	   cells	   are	   incubated	  with	  methionine	  does	  
not	  recover	  GSH	  levels,	  suggesting	  that	  the	  cysteine	  (and	  hence	  GSH)	  levels	  could	  not	  be	  replenished	  via	  the	  transsulfuration	  pathway	  in	  HUVECs.	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Figure	  3.14:	  Methionine	  Repletion	  Does	  Not	  Recover	  GSH	  Levels	  In	  HUVECs.	  
A)	   A	   schematic	   diagram	   depicting	   the	   demethylation	   and	   transsulfuration	  pathways	  indicating	  the	  presence	  of	  methionine	  and	  absence	  of	  cysteine	  as	  well	  as	  a	  loss	  in	  glutathione	  (GSH)	  arising	  from	  reduced	  cysteine	  bioavailability.	  B)	  Total	  GSH	   levels	   in	   HUVECs	   when	   cysteine	   and	   methionine	   are	   removed	   from	   tissue	  culture	  media	  (Met(-­‐)/Cys(-­‐))	  and	  when	  methionine	  is	  supplemented	  at	  increasing	  concentrations	  (Met(+)/Cys(-­‐))	  for	  24	  hours.	  C)	  Total	  GSH	  levels	  in	  HUVECs	  when	  cysteine	  is	  removed	  from	  tissue	  culture	  media	  and	  methionine	  is	  supplemented	  at	  0.4mg/ml	   (Met(0.4mg/ml+)/Cys(-­‐))	   for	   4	   and	   6	   hours.	   N=3,	   ****	   =	   P=<0.0001.	  Statistical	  analyses	  performed	  using	  one-­‐way	  ANOVA	  and	  a	  Tukeys	  post-­‐hoc	  test.	  	  	  To	   further	   confirm	   that	   the	   loss	   of	   GSH	   in	   HUVECs	   treated	   with	   media	   lacking	  cysteine	   and	   methionine	   was	   due	   to	   an	   inability	   of	   cells	   to	   generate	   cysteine	  
A" B"
C"
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through	   transsulfuration,	   HUVECs	   were	   incubated	   with	   media	   lacking	   both	  methionine	  and	  cysteine	  but	  containing	  0.063mg/ml	  NAC,	  a	  cysteine	  donor.	  Figure	  3.15B	   shows	   that	   the	   presence	   of	   NAC	   rescued	   GSH	   levels	   in	   HUVECs	   despite	  methionine	   being	   absent.	   Taken	   together	   these	   data	   suggest	   that	   an	   active	  transsulfuration	  pathway	  is	  not	  present	  in	  HUVECs.	  	  	  
	  
Figure	   3.15:	   NAC	   Rescues	   GSH	   Levels	   in	   HUVECs.	   A)	   A	   schematic	   diagram	  depicting	  the	  demethylation	  and	  transsulfuration	  pathways	  indicating	  the	  absence	  of	  methionine	  and	  cysteine	  and	  the	  addition	  of	  NAC	  leading	  to	  GSH	  rescue.	  B)	  Total	  GSH	   levels	   in	   HUVECs	   when	   cysteine	   and	   methionine	   are	   removed	   from	   tissue	  culture	   media	   (Met(-­‐)/Cys(-­‐)),	   when	   methionine	   is	   supplemented	   at	   0.4mg/ml	  (Met(+)/Cys(-­‐))	  and	  when	  0.063mg/ml	  NAC	   is	  added	  (NAC(+)/Met(-­‐)/Cys(-­‐))	   for	  24	   hours.	   N=3,	   ***	   =	   P<0.001,	   ****	   =	   P=<0.0001.	   Statistical	   analysis	   performed	  using	  a	  one-­‐way	  ANOVA	  and	  a	  Tukeys	  post-­‐hoc	  test.	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3.2.15	  Nox4	  Overexpression	  Increases	  H2S	  Levels	  in	  Tissue	  Culture	  Media	  	  In	  addition	  to	  transsulfuration,	  CSE	  is	  also	  a	  primary	  mediator	  of	  H2S	  production	  in	  the	  endothelium.	  To	  determine	  whether	  the	  Nox4-­‐induced	  increase	  in	  CSE	  protein	  expression	   functioned	   to	   increase	   H2S	   generation	   in	   HUVECs,	   H2S	   levels	   were	  determined	   in	   the	   culture	  media	  of	  HUVECs	  overexpressing	  Nox4	  or	  B	  Gal	  using	  the	   methylene	   blue	   assay.	   Figure	   3.16	   shows	   that	   H2S	   levels	   are	   slightly,	   but	  significantly	   increased	   in	   the	   tissue	   culture	   media	   of	   cells	   overexpressing	   Nox4	  compared	  to	  B	  Gal	  controls.	  Taken	  together	  with	  the	  transsulfuration	  data	  shown	  above,	  these	  data	  suggest	  that	  CSE	  is	  likely	  to	  be	  functioning	  in	  the	  production	  of	  H2S	  and	  not	  in	  the	  de	  novo	  synthesis	  of	  cysteine	  in	  HUVECs.	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3.2.16	  CSE	  Splice	  Variants	  1	  and	  2	  are	  Up-­‐regulated	  in	  Response	  to	  Nox4	  
Overexpression	  
	  The	  mechanism	   by	   which	   CSE	   switches	   between	   canonical	   transsulfuration	   and	  H2S	  biosynthesis	  is	  unknown.	  However,	  the	  human	  CSE	  gene	  is	  known	  to	  give	  rise	  to	   at	   least	   3	   protein-­‐coding	   splice	   variants	  (http://www.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000116761;r=1:70411218-­‐70439851)	   whose	   expression	   may	   provide	   clues	   as	   to	  their	  functional	  significance.	  	  	  To	   investigate	  which	   of	   these	   are	   expressed	   in	   HUVECs,	   primers	  were	   designed	  that	   could	   detect	   all	   3	   variants	   and	   the	   expression	   of	   these	   isoforms	   was	  determined	  by	  PCR	  and	  subsequently	  confirmed	  by	  DNA	  sequencing.	  Figure	  3.17	  indicates	  the	  presence	  of	  splice	  variants	  1	  and	  2	  in	  HUVECs,	  while	  splice	  variant	  3	  was	   not	   readily	   detectable.	   Of	   the	   2	   variants	   observed,	   variant	   1	   appears	   to	   be	  more	  abundantly	  expressed	  than	  variant	  2.	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3.18B	   shows	   that	   there	   is	   no	  difference	   in	   the	   relative	  Nox4-­‐induced	   increase	   in	  both	  variant	  1	  and	  2.	  	  
	  
Figure	   3.18:	   CSE	   Splice	   Variants	   1	   and	   2	   both	   Respond	   to	   Nox4	  
Overexpression.	   A)	   QPCR	   data	   depicting	   the	   relative	   expression	   of	   CSE	   splice	  variants	  1	  and	  2	  between	  B	  Gal	  (B	  Gal	  O.E)	  and	  Nox4-­‐overexpressing	  (Nox4	  O.E)	  HUVECs.	  B)	  a	  comparison	  of	  the	  relative	  Nox4-­‐induced	  increase	  in	  CSE	  expression	  between	  variant	  1	  and	  2.	  All	  data	  normalised	   to	  β	  Actin	  mRNA	  expression.	  O.E	  =	  Overexpression	  N=3.	  
	  
3.2.17	  Nox4	  Does	  Not	  Affect	  the	  Expression	  of	  3MST	  in	  HUVECs	  	  A	   third	   H2S-­‐generating	   enzyme,	   known	   as	   3MST,	   is	   also	   present	   in	   endothelial	  cells63.	  To	  investigate	  whether	  Nox4	  was	  involved	  in	  regulating	  3MST	  expression,	  Nox4	  overexpression	  and	  silencing	  experiments	  were	  performed	  as	  above.	  Figure	  3.19	  A	  and	  B	  demonstrate	  that	  neither	  overexpression	  nor	  silencing	  of	  Nox4	  have	  any	   significant	   effect	   on	   3MST	  mRNA	  expression	   levels.	   Thus	   these	   data	   suggest	  that	   in	   HUVEC,	   Nox4	   overexpression	   results	   in	   increased	   CSE	   transcription	   that	  subsequently	  increases	  the	  production	  of	  the	  gasotransmitter	  H2S.	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Figure	   3.19:	   3MST	   mRNA	   Expression	   Remains	   Unchanged	   In	   Response	   to	  
Nox4	  Overexpression.	   A)	  QPCR	  data	  depicting	   the	  relative	  mRNA	  expression	  of	  3MST	  resulting	  from	  the	  overexpressing	  B	  Gal	  (B	  Gal	  O.E)	  and	  Nox4	  (Nox4	  O.E)	  in	  HUVECs	   and	  B)	   HUVEC	   in	  which	   Nox4	   has	   been	   silenced	   (siNox4)	   compared	   to	  control	   cells	   (siScram).	   All	   data	   normalised	   to	   β	   Actin	   mRNA	   expression.	   N=3.	  Statistical	  analysis	  performed	  using	  an	  unpaired	  Students	  t-­‐test.	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3.3	  Discussion	  	  	  
3.3.1	  Endothelial	  Nox4	  Regulates	  CSE	  Expression	  	  	  Various	   aspects	   of	   hcy	   metabolism	   and	   H2S	   biosynthesis	   have	   previously	   been	  shown	   to	   be	   redox	   regulated,	   particularly	   with	   regard	   to	   the	   post-­‐translational	  activation	  of	  CBS92,	  156	  and	  the	  transcriptional	  regulation	  of	  CSE99,	  100.	  Interestingly,	  indirect	  evidence	  derived	  from	  the	  use	  of	  broad-­‐spectrum	  Nox	  and	  ROS	  inhibitors	  suggest	  that	  these	  redox	  mechanisms	  may	  be	  Nox	  dependent100.	  Moreover,	  direct	  genetic	   evidence	   derived	   from	   a	   genome-­‐wide	   association	   study	   point	   to	   the	  involvement	   of	   Nox4	   in	   regulating	   hcy	   levels157.	   Bioinformatic	   analysis	   revealed	  that	  the	  SNP	  in	  Nox4	  identified	  by	  this	  study	  is	  located	  in	  an	  intron,	  suggesting	  that	  it	  may	  be	  potentially	  involved	  in	  either	  the	  positive	  or	  negative	  regulation	  of	  Nox4	  expression.	   Indeed,	   this	   may	   hold	   functional	   significance	   since	   Nox4	   activity	   is	  thought	   to	   be	   regulated	   at	   the	   gene	   expression	   level133.	   Collectively	   these	   data	  allude	  to	  Nox4	  as	  a	  potential	  source	  of	  ROS	  involved	  in	  the	  regulation	  of	  hcy/H2S	  metabolism.	  	  	  To	   investigate	   whether	   endothelial	   Nox4	   is	   involved	   in	   regulating	   hcy/H2S	  metabolism	   in	  vitro,	  Nox4	  was	  misexpressed	   in	  HUVECs	  and	  the	  gene	  expression	  levels	   of	   core	   enzymes	   involved	   in	   hcy	   metabolism	   were	   analysed.	   Nox4	  misexpression	   was	   shown	   to	   have	   little	   effect	   on	   the	   mRNA	   expression	   of	  methionine-­‐	   and	   folate-­‐cycle	   associated	   enzymes.	   By	   contrast,	   Nox4	  overexpression	   promoted	   a	   highly	   significant	   and	   robust	   up-­‐regulation	   in	   the	  mRNA	  expression	  of	  both	   the	   transsulfuration-­‐associated	  enzymes,	  CBS	  and	  CSE.	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Moreover,	   Nox4	   was	   shown	   to	   be	   the	   most	   abundantly	   expressed	   p22phox-­‐associating	  Nox	  isoform	  in	  HUVECs	  and	  the	  silencing	  of	  both	  endogenous	  Nox4	  and	  p22phox	   significantly	   reduced	  CSE	  expression.	  Collectively	   these	  data	   suggest	   that	  Nox4	  is	  a	  physiological	  regulator	  of	  endothelial	  CSE	  expression.	  	  	  The	  endothelial	  protein	  expression	  of	  CSE	  is	  debated	  by	  some	  research	  groups63,	  64.	  However,	  CSE	  silencing	  experiments	  performed	  here	  demonstrate	  that	  CSE	  protein	  is	   indeed	  detectable	  at	  baseline	   in	  HUVECs,	  a	   finding	  consistent	  with	  some	  other	  studies67.	   Nox4	   overexpression	   was	   shown	   to	   significantly	   enhance	   CSE	   protein	  expression,	   an	   effect	   that	   was	   reversed	   by	   Nox4	   silencing.	   Interestingly,	   CBS	  protein	  expression	  was	  unchanged	   in	   response	   to	  Nox4	  misexpression,	  despite	  a	  robust	  increase	  in	  its	  mRNA	  expression	  upon	  Nox4	  overexpression.	  This	  suggests	  that	  post-­‐transcriptional	  mechanisms	  may	  be	  in	  place	  to	  regulate	  CBS	  translation	  in	   the	   endothelium.	   Furthermore,	   it	   appears	   that	   the	   redox-­‐driven	   post-­‐translational	   regulation	  of	  CBS	   is	   an	   important	   factor	   in	   regulating	   its	   function92,	  
156.	  These	  data	   shed	   light	  on	  a	   role	   for	   endothelial	  Nox4	  as	   a	  potential	   source	  of	  ROS	  involved	  the	  regulation	  of	  CSE	  gene	  expression	  and	  further	  contribute	  to	  the	  growing	  body	  of	  evidence	  that	  suggests	  that	  CSE	  transcription	  is	  redox	  regulated99,	  
100.	  	  	  
3.3.2	  Exogenous	  Oxidants	  and	  Antioxidants	  on	  CSE	  Expression	  	  As	   mentioned	   above,	   previous	   studies	   have	   shown	   that	   CSE	   transcriptional	  expression	   is	   regulated	  by	  H2O299	  and	  have	  suggested	   that	  Nox-­‐derived	  H2O2	  can	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also	   regulate	  CSE	  activity101.	  Nox4	   is	   considered	   to	  mediate	   its	   cellular	   functions	  through	  its	  regulation	  of	  redox-­‐dependent	  signalling	  pathways	  by	  producing	  H2O2.	  	  Previous	   studies	   using	   the	   same	   Nox4	   adenovirus	   utilised	   in	   the	   experiments	  conducted	   here,	   have	   shown	   that	   it	   produces	   significant	   levles	   of	   H2O2	   in	  HUVECs47.	   Investigations	   were	   therefore	   performed	   to	   interrogate	   the	  involvement	  of	  Nox4-­‐derived	  ROS	  in	  the	  transcriptional	  regulation	  of	  CSE.	  Perhaps	  surprisingly,	   exogenous	   application	   of	   peroxide,	   to	   mimic	   the	   effects	   of	   Nox4	  overexpression,	  failed	  to	  increase	  CSE	  expression	  significantly	  at	  the	  mRNA	  level,	  although	   a	   slight	   trend	   toward	   an	   increase	   was	   observed.	   These	   data	   are	  somewhat	  inconsistent	  with	  previous	  findings	  showing	  that	  CSE	  expression	  can	  be	  regulated	   by	   H2O2	   in	   COS7	   cells,	   although	   that	   study	   concluded	   that	   the	   H2O2-­‐induced	   regulation	   of	   CSE	   expression	  was	   complex	   and	   biphasic99.	   Furthermore,	  studies	  performed	  here	  assessed	  CSE	  expression	  after	  a	  24	  hour	  H2O2	   incubation	  period,	   whereas	   these	   previous	   reports	   assessed	   the	   H2O2-­‐induced	   induction	   of	  CSE	   expression	   after	   a	   maximum	   of	   1.5	   hours.	   These	   differences	   in	   time-­‐points	  may	   suggest	   the	   existence	   of	   a	   temporal	  window	   in	  which	  H2O2	   can	   induce	   CSE	  expression.	   Alternatively,	   H202	  may	   be	   unstable	   and	   therefore	   lose	   its	   signalling	  efficiency	  at	  longer	  time	  points.	  It	  should	  also	  be	  noted	  that	  the	  use	  of	  exogenous	  ROS	   to	   recapitulate	   the	   effects	   of	   endogenously-­‐generated	   ROS	   are	   not	   always	  consistent161,	  162.	  A	  potential	  explanation	  for	  this	  lies	  in	  the	  fact	  that	  exogenous	  ROS	  are	  not	  compartmentalised	  in	  the	  same	  way	  that	  endogenously-­‐produced	  ROS	  are	  expected	  to	  be.	  Indeed,	  in	  the	  case	  of	  Nox4,	  its	  signalling	  capacity	  is	  thought	  to	  be	  discrete	  and	  environment-­‐	  specific,	  owing	  to	  its	  occupation	  of	  specific	  subcellular	  locations129.	  Taken	  together,	   it	  seems	  that	  although	  treating	  cells	  with	  exogenous	  ROS	   can	   prove	   useful	   in	   helping	   to	   decipher	   the	   redox	   regulation	   of	   a	   signalling	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pathway161	   it	   does	   not	   directly	  mimic	   the	   effect	   of	   endogenously-­‐generated	  ROS	  such	   as	   that	   produced	  by	  Nox4.	  This	  may	   therefore	   explain	  why	   exogenous	  ROS	  does	  not	   increase	  CSE	  expression	  in	  the	  same	  way	  that	  Nox4	  does,	  at	   least	  at	  the	  time-­‐points	  assessed	  here.	  	  	  Antioxidants	  and	  Nox	  inhibitors	  have	  been	  frequently	  used	  to	  study	  the	  effects	  of	  Nox	  functionality	  in	  various	  systems163.	  DPI	  is	  a	  broad-­‐spectrum	  Nox	  inhibitor	  that	  functions	  by	  inhibiting	  flavoproteins.	  Surprisingly,	  DPI	  promoted	  the	  effect	  of	  Nox4	  overexpression	  in	  the	  endothelium,	  an	  effect	  that	  contrasts	  to	  the	  blunting	  of	  CSE	  expression	   observed	   in	   DPI-­‐treated	   mesangial	   cells100.	   This	   suggests	   that	   in	  endothelial	  cells	  Nox4	  overexpression	  in	  the	  presence	  of	  DPI,	  further	  activates	  CSE	  expression.	  A	  potential	  explanation	  for	  this	  lies	  in	  the	  fact	  that	  DPI	  is	  non-­‐specific	  and	   inhibits	   all	   flavoproteins	   including	   other	   Nox	   isoforms	   as	   well	   as	   the	  gasotransmitter	   producing	   enzyme,	   eNOS.	   Furthermore,	   DPI	   has	   been	   shown	   to	  induce	  GSH	  efflux	   from	  some	  cell	   types	   leading	  to	  apoptosis164	  suggesting	  that	   in	  addition	   to	   oxidant	   inhibition,	   cellular	   antioxidant	   defence	   is	   also	   perturbed.	  Indeed,	  the	  complex	  cross	  talk	  and	  homeostatic	  balance	  integral	  to	  redox	  systems	  as	  well	  as	  between	  gasotransmitter	  signalling	  may	  mean	  that	  interventions	  such	  as	  DPI	   administration	   further	   displace	   the	   Nox4-­‐induced	   imbalance	   in	   redox	  homeostasis	  that	  leads	  to	  CSE	  transcription,	  resulting	  in	  increased	  CSE	  expression.	  	  	  PEG-­‐Cat	  is	  an	  antioxidant	  involved	  in	  converting	  H2O2	  into	  water.	  Treatment	  with	  PEG-­‐catalase	   resulted	   in	   a	   small	   but	   significant	   blunting	   in	   Nox4-­‐induced	   CSE	  expression.	  These	  data	  support	  a	  role	   for	  Nox4-­‐derived	  H2O2	   in	   the	  regulation	  of	  CSE	  expression	  but	  the	  effect	  is	  perhaps	  surprisingly	  small.	  Nox4	  was	  expressed	  at	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a	   high	  MOI	   of	   20,	  which	  would	   result	   in	   dramatically-­‐enhanced	  ROS	  production.	  PEG-­‐cat	  was	  used	  at	  500U/ml	  and,	  being	  an	  enzyme,	  it	  may	  have	  rapidly	  reached	  its	  maximal	  velocity	  (Vmax)	  in	  the	  presence	  of	  high	  amounts	  of	  Nox4-­‐derived	  H2O2.	  The	  small	  blunting	  effect	  observed	  could	  therefore	  be	  a	  result	  of	  Nox4	  continuing	  to	   signal	  when	   catalase	   activity	   is	   saturated.	   This	   discrepancy	   could	   possibly	   be	  resolved	  by	  further	  increasing	  the	  amount	  of	  catalase	  used	  or	  reducing	  the	  MOI	  of	  the	   Nox4	   adenovirus,	   thereby	   changing	   the	   stoichiometry	   of	   the	   reaction.	   In	  addition,	   studies	   in	   bacteria	   have	   shown	   that	   sulphide	   can	   inhibit	   catalase165,	  suggesting	  that	  H2S	  produced	  by	  CSE	  could	  potentially	  inactivate	  PEG-­‐cat	  and	  thus	  prevent	   a	  more	   robust	  blunting	   in	   the	  Nox4-­‐induced	   increase	   in	  CSE	  expression.	  Finally,	  with	  regard	  to	  all	  antioxidants	  and	  exogenous	  ROS	  used	  in	  these	  assays,	  an	  important	   factor	   that	   has	   not	   been	   investigated	   is	   the	   temporal	   relationship	  between	   the	   ROS-­‐induced	   CSE	   expression	   and	   antioxidant	   treatment.	   It	   may	   be	  that	   antioxidants	   can	   blunt	   CSE	   expression	   in	   response	   to	  Nox4	   overexpression,	  but	   only	   when	   applied	   at	   a	   specific	   time-­‐point	   or	   for	   a	   longer	   duration.	   This	   is	  something	  that	  merits	  further	  work.	  	  	  
3.4.3	   HUVECs	   Do	   Not	   have	   a	   Functional	   Transsulfuration	   Pathway	   but	  
can	  Generate	  Increased	  H2S	  levels	  in	  Response	  to	  Nox4	  	  	  CBS	   and	   CSE	   have	   been	   shown	   to	   be	   bi-­‐functional	   enzymes,	   in	   that	   they	   can	  perform	   canonical	   transsulfuration	   which	   involves	   the	   conversion	   of	   hcy	   into	  cysteine,	  as	  well	  as	  generating	  H2S	  from	  cysteine,	  homocyteine	  and	  cystine166.	  Most	  of	   the	   literature	   surrounding	   the	   role	   of	   endothelial	   CSE	   focuses	   on	   its	   H2S-­‐	  generating	   capacity	   as	   opposed	   to	   its	   role	   in	   transsulfuration20,	   67,	   79,	   83,	   101.	   To	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determine	  whether	  HUVECs	  were	  able	   to	  mediate	   transsulfuration	  and	   therefore	  provide	   clues	   as	   to	   the	   endogenous	   function	   of	   CSE	   in	   endothelial	   cells,	  HUVECs	  were	  grown	  in	  media	  lacking	  in	  cysteine	  but	  containing	  increasing	  concentrations	  of	   the	   indirect	   substrate	   for	   transsulfuration,	   methionine.	   To	   assess	   cysteine	  bioavailability	   arising	   from	   transsulfuration	   activity,	   GSH	   levels	   were	   used	   as	   a	  measure	  as	  reported	  previously97,	  98.	  Methionine	  failed	  to	  increase	  GSH	  levels	  in	  a	  time-­‐	  and	  dose-­‐dependent	  manner	   in	  HUVECs,	  and	  only	   the	  repletion	  of	  cysteine	  by	   the	   addition	   of	   NAC	   could	   recue	   GSH	   levels.	   These	   data	   demonstrate	   that	  HUVECs	   are	   unable	   to	   generate	   cysteine	   via	   the	   transsulfuration	   pathway	   and	  therefore	   suggest	   that	   endothelial	   CSE	   likely	   functions	   in	   the	   generation	   of	   H2S.	  Indeed,	   the	   assessment	   of	   H2S	   production	   in	   HUVECs	   showed	   a	   small	   but	  significant	   elevation	   in	   the	   levels	   of	   H2S	   detected	   in	   tissue	   culture	   media	   upon	  Nox4	  overexpression.	  It	  would	  also	  appear	  from	  these	  data	  that	  the	  Nox4-­‐induced	  increase	   in	  H2S	   levels	   is	   a	   result	   of	   increased	   CSE	   expression	   and	   not	   due	   to	   an	  effect	   of	   other	   H2S-­‐generating	   enzymes.	   Thus	   CBS	   protein	   expression	   failed	   to	  change	  in	  response	  to	  Nox4	  overexpression,	  and	  3MST	  mRNA	  expression	  was	  not	  augmented	  upon	  Nox4	  misexpression.	  	  
3.4.4	  Experimental	  Caveats	  in	  H2S	  measurements	  using	  Methylene	  Blue	  	  The	   methylene	   blue	   assay	   is	   the	   most	   commonly	   used	   analytical	   procedure	   for	  measuring	   sulphide	   as	   it	   has	   a	   low	  detection	   limit	   (micromolar),	   is	   cheap	   and	   is	  simple	  to	  perform.	  Despite	  this,	   there	  are	  a	  number	  of	  caveats	  associated	  with	   it.	  Firstly,	   the	  assay	  relies	  on	  the	  use	  of	  strong	  acid	  to	   liberate	  H2S	  from	  a	  zinc	  trap,	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and	  this	  acid	  can	  mobilise	  H2S	  from	  cellular	  acid	  labile	  stores,	  leading	  to	  errors	  in	  endogenous	  enzymatically-­‐	  produced	  H2S	  measurements.	  However,	  this	  is	  unlikely	  to	   affect	   the	   experimental	   protocol	   used	   in	   this	   investigation,	   since	   extracellular	  H2S	   was	   being	   measured	   and	   acid	   labile	   stores	   are	   found	   in	   primarily	   in	   the	  mitochondria167,	   168.	   Furthermore,	   methylene	   blue	   has	   been	   shown	   to	   produce	  monomers,	   dimers	   and	   trimers	  when	   reacted	  with	  H2S	   and	   therefore	  measuring	  absorbance	   at	   670nm	   (corresponding	   to	   the	   dimeric	   product)	   may	   lead	   to	  erroneous	   read-­‐outs,	   since	   trimeric	   products	   are	   not	   considered168-­‐170.	   The	  experimental	   protocol	   used	   here	   involved	   the	   removal	   of	  media	   from	   incubated	  cells	   to	   take	   a	   “snapshot”	   of	   H2S	   levels.	   This	   is	   difficult	   to	   achieve	   since	   H2S	   is	  readily	  oxidised	  and	  dissipates	  quickly	  in	  air	  preventing	  accurate	  quantification	  of	  its	  cellular	  levels.	  Overexpression	  of	  Nox4,	  and	  its	  subsequent	  enhancement	  in	  ROS	  production,	  may	   therefore	  deplete	  H2S	   through	  oxidation	  and	   further	   complicate	  its	   accurate	   quantification171.	   In	   spite	   of	   this,	   the	   assay	   continues	   to	   be	   used	  extensively	   in	   measuring	   H2S	   levels	   in	   tissue	   as	   well	   as	   cells,	   and	   can	   be	   used	  relatively	   reliably	   to	   compare	   levels	   of	   H2S.	   Despite	   these	   caveats,	   the	   data	  presented	  here	  suggest	   that	   the	  Nox4-­‐induced	   increase	   in	  CSE	  expression	  results	  in	  a	  concomitant	  increase	  in	  H2S	  levels	  in	  HUVECs.	  	  
3.4.5	  CSE	  Splice	  Products	  	  Alternative	  splicing	  is	  reported	  to	  occur	  in	  around	  40-­‐60%	  of	  genes	  and	  this	  form	  of	   regulation	   is	   important	   in	   controlling	   the	   differential	   activities	   of	   specific	  genes172.	  Human	  CSE	  is	  known	  to	  have	  at	  least	  3	  protein-­‐coding	  splice	  variants	  that	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differ	  from	  each	  other	  by	  the	  absence	  of	  either	  exon	  5	  (splice	  variant	  2)	  or	  exon	  3	  (splice	  variant	  3).	  It	  is	  currently	  unknown	  what	  the	  functional	  significance	  of	  each	  splice	  variant	   is.	   It	  was	  shown	  here	   that	  variants	  1	  and	  2	  are	  present	   in	  HUVECs	  with	   variant	   1	   being	   the	   most	   abundantly	   expressed.	   Interestingly,	   Nox4	   up-­‐regulates	   the	   expression	   of	   both	   variant	   1	   and	   variant	   2,	   and	   a	   comparison	  between	   the	   relative	   Nox4-­‐induced	   increase	   between	   variants	   reveals	   that	   both	  transcripts	  are	  up-­‐regulated	  to	  a	  similar	  extent.	  These	  data	  suggest	  that	  CSE	  splice	  variants	  1	  and	  2	  are	  both	   responsive	   to	  Nox4	  overexpression	  and	  may	   therefore	  play	  a	  role	  in	  H2S	  production.	  	  To	   summarise,	   the	   data	   collected	   in	   this	   chapter	   demonstrate	   that	   endothelial	  Nox4	   is	   a	   physiological	   regulator	   of	   CSE	   expression,	   an	   effect	   that	   appears	   to	   be	  important	   for	   H2S	   generation.	   These	   data	   contribute	   to	   the	   growing	   body	   of	  evidence	  that	  suggest	  that	  ROS	  can	  regulate	  CSE	  expression	  and	  further	  implicates	  endothelial	  Nox4	  as	  a	  potential	  source	  of	  ROS	  in	  this	  process.	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4.1	  Introduction	  
	  In	  the	  previous	  chapter	  data	  are	  presented	  which	  describe	  a	  physiological	  role	  for	  Nox4	  in	  the	  regulation	  of	  CSE	  mRNA	  and	  protein	  expression,	  which	  appears	  to	  be	  important	  in	  the	  generation	  of	  the	  gasotransmitter,	  H2S.	  CSE	  and	  H2S	  are	  known	  to	  be	  mediators	   of	   blood	   pressure	   regulation79	   and	   vascular	   tone20,	  81,	   in	   that	   they	  have	   been	   shown	   to	   induce	   vasorelaxation,	   potentially	   in	   an	   endothelium-­‐	  dependent	  manner20.	  With	   this	   in	  mind,	  eNox4	  Tg	  mice	  were	  used	   to	   investigate	  the	  effect	  of	  Nox4	  overexpression	  on	  CSE	  expression	  and	  activity	  ex	  vivo.	  	  
Aim	  
	  To	  determine	  whether	   endothelial-­‐specific	   overexpression	  of	  Nox4	   in	   the	  mouse	  also	   functions	   to	   regulate	   CSE	   expression	   and	   to	   determine	   the	   functional	  significance	  of	  this.	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4.2	  Results	  	  
4.2.1	  Genotyping	  eNox4	  Transgenic	  Mice	  	  	  The	  following	  studies	   involve	  the	  use	  of	  eNox4	  Tg	  mice	  which	  were	  generated	   in	  our	   laboratory.	   The	   transgene	   comprises	   the	   previously-­‐described	   endothelial-­‐specific	  Tie2	  promoter/enhancer	  construct173	  driving	  the	  expression	  of	  the	  entire	  mouse	   Nox4	   cDNA	   coding	   region.	   Heterozygous	   Tg/WT	   crosses	   were	   set	   up	   in	  order	  to	  generate	  equal	  numbers	  of	  WT	  and	  eNox4	  Tg	  mice,	  and	  the	  presence	  or	  absence	  of	  the	  Nox4	  transgene	  was	  determined	  by	  genotyping.	  Figure	  4.1	  depicts	  a	  representative	  genotyping	  result	   for	  the	  eNox4	  Tg	  mouse	  line.	  Here,	  two	  WT	  and	  one	  eNox4	  Tg	  mouse	  are	  present	  among	  the	  litter.	  The	  Nox4	  transgene	  is	  identified	  as	  a	  band	  at	  ~120bp	  which	  is	  apparent	  in	  the	  positive	  control	  DNA	  isolated	  from	  a	  previously	  characterised	  	  eNox4	  Tg	  mouse.	  Primers	  which	  detect	  a	  genomic	  region	  corresponding	  to	  a	  GAPDH	  pseudogene	  were	  used	  as	  a	  positive	  control	  to	  confirm	  that	  the	  PCR	  reactions	  were	  successful.	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Figure	  4.1:	  Genotyping	   eNox4	  Tg	  Mice.	  A	  Representative	  genotyping	  result	   for	  eNox4	  Tg	  mice.	  PCR	  analyses	  and	  subsequent	  gel	  electrophoresis	  of	  genomic	  DNA	  derived	  from	  an	  eNox4	  Tg	  mouse	  litter.	  eNox4	  Tg	  mice	  are	  identifiable	  by	  a	  band	  at	  ~120bp	  corresponding	  to	  the	  Nox4	  transgene.	  GAPDH	  control	  primers	  generate	  a	  band	  at	  ~300bp	  and	  were	  used	  as	  a	  control	  to	  confirm	  successful	  PCR.	  	  	  
4.2.2	  Determination	  of	  CSE	  mRNA	  Expression	  in	  eNox4	  Tg	  Mice	  	  In	  order	  to	  determine	  whether	  the	  Nox4-­‐induced	  up-­‐regulation	  in	  CSE	  mRNA	  and	  protein	  expression	  observed	  in	  vitro	  was	  recapitulated	  in	  endothelial	  cells	  in	  vivo,	  endothelial	  cells	  were	  isolated	  from	  the	  hearts	  of	  WT	  and	  eNox4	  Tg	  mice.	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Willebrand	   Factor	   (vWF)	   mRNA	   (an	   endothelial-­‐specific	   marker174)	   was	  determined	   in	   “input”	   (total	   cell	   isolate)	   and	   “output”	   samples	   (CD31-­‐affinity-­‐isolated	   endothelial	   cells).	   Figure	   4.2A	   depicts	   a	   schematic	   flow	   diagram	   of	   the	  steps	  undertaken	  in	  this	  protocol	  highlighting	  when	  “input”	  and	  “output”	  samples	  were	  harvested.	  Figure	  4.2B	  and	  C	  show	  that	  in	  both	  WT	  and	  eNox4	  Tg	  isolations	  vWF	  mRNA	  was	  enriched	  in	  the	  “output”	  sample	  compared	  to	  the	  “input”	  sample.	  	  	  	  	  
	  	  	  
Figure	  4.2:	  Enrichment	  for	  vWF	  Following	  Endothelial	  Cell	  Affinity-­‐isolation.	  
A)	   A	   flow	   diagram	   indicating	   the	   steps	   taken	   in	   the	   endothelial	   cell	   affinity	  isolation	   method.	   B,C)	   QPCR	   data	   comparing	   input	   and	   output	   samples	   for	  enrichment	  of	  vWF	  in	  B)	  WT	  and	  C)	  eNox4	  Tg	  mouse	  lines	  before	  and	  after	  affinity	  isolation.	  All	  data	  normalised	  to	  β	  Actin	  mRNA	  expression.	  N=3	  preparations,	  each	  preparation	  representing	  a	  pool	  of	  2-­‐3	  hearts/genotype	  of	  mixed	  sexes.	  
A" B"
C"
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4.2.4	  Nox4	  mRNA	  Expression	  is	  Potentially	  Increased	  in	  eNox4	  Tg	  Mice	  	  Endothelial	  cells	   isolated	  from	  WT	  and	  eNox4	  Tg	  mice	  hearts	  were	  compared	  for	  expression	  of	  Nox4.	  Figure	  4.3A	  and	  B	  show	  that	  Nox4	  mRNA	  expression	  is	  greatly	  increased	  in	  the	  endothelium	  of	  eNox4	  Tg	  mice	  compared	  to	  WT	  littermates.	  	  	  	  
	  
Figure	   4.3:	   Endothelial	   Nox4	   mRNA	   Expression	   is	   Increased	   in	   eNox4	   Tg	  
Mice.	   QPCR	   data	   comparing	   the	   endothelial	   expression	   of	   Nox4	  mRNA	   between	  WT	   and	   eNox4	   Tg	   lines.	  A)	   data	   normalised	   to	   vWF	  mRNA	   expression,	  B)	   data	  normalised	   to	   β	   Actin	   mRNA	   expression.	   N=3	   preparations,	   each	   preparation	  representing	  a	  pool	  of	  2-­‐3	  hearts/genotype	  of	  mixed	  sexes.	  	  	  
4.2.5	  CSE	  mRNA	  Expression	  is	  Potentially	  Increased	  in	  eNox4	  Tg	  Mice	  	  To	  investigate	  whether	  CSE	  expression	  was	  increased	  in	  endothelial	  cells	  isolated	  from	  eNox4	  Tg	  mice,	   compared	  with	  WT	   littermates,	   CSE	  mRNA	  expression	  was	  measured	   by	   QPCR.	   Figure	   4.4A	   and	   B	   shows	   that	   CSE	   mRNA	   expression	   is	  increased	  in	  eNox4	  Tg	  mice	  compared	  to	  WT	  littermates.	  	  
A" B"
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Figure	  4.4:	  Endothelial	  CSE	  mRNA	  Expression	  is	  Increased	  in	  eNox4	  Tg	  Mice.	  	  QPCR	  data	  comparing	   the	  endothelial	  expression	  of	  CSE	  mRNA	  between	  WT	  and	  eNox4	  Tg	  lines.	  A)	  data	  normalised	  to	  vWF	  mRNA	  expression,	  B)	  data	  normalised	  to	  β	  Actin	  mRNA	  expression.	  N=3	  preparations,	   each	  preparation	   representing	   a	  pool	  of	  2-­‐3	  hearts/genotype	  of	  mixed	  sexes.	  	  
4.2.6	  CSE	  Protein	  Expression	  is	  Significantly	  Increased	  in	  eNox4	  Tg	  Mice	  	  To	   determine	   whether	   the	   observed	   increase	   in	   CSE	   mRNA	   expression	  corresponded	  to	  a	  change	  in	  CSE	  protein	  expression,	  endothelial	  cell	  isolates	  from	  WT	   and	   eNox4	   Tg	   mice	   were	   harvested	   for	   immunoblotting	   and	   CSE	   protein	  expression	  was	   compared.	   Figure	   4.5A	   and	   B	   shows	   that	   CSE	   protein	   levels	   are	  significantly	   elevated	   in	   eNox4	   Tg	   mice	   compared	   to	   WT	   littermates.	   Taken	  together	  with	   the	  mRNA	  data	  depicted	  above,	   these	  data	  demonstrate	   that	  Nox4	  regulates	  CSE	  expression	  in	  the	  vascular	  endothelium,	  in	  vivo.	  	  
A" B"
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Figure	   4.5:	   Endothelial	   CSE	  Protein	   Expression	   is	   Significantly	   Increased	   in	  
eNox4	   Tg	   Mice.	   	  A)	   Immunoblot	   data	   comparing	   CSE	   protein	   expression	   in	   the	  endothelium	  of	  WT	  and	  eNox4	  Tg	  lines.	  B)	  Corresponding	  densitometric	  analysis	  of	   CSE	   protein	   expression.	   Data	   normalised	   to	   β	   Actin	   protein	   expression.	   N=3	  preparations,	   each	   preparation	   representing	   a	   pool	   of	   2-­‐3	   hearts/genotype	   of	  mixed	  sexes.	  *	  =	  P<0.05.	  Statistical	  analysis	  performed	  using	  an	  unpaired	  Students	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4.2.7	  Measuring	  H2S	  Levels	  ex	  vivo	  using	  a	  Polarographic	  Sensor	  	  To	  investigate	  whether	  the	  Nox4-­‐induced	  increase	  in	  CSE	  expression	  observed	  in	  eNox4	  Tg	  mice	  resulted	  in	  changes	  in	  tissue	  H2S	  levels,	  a	  polarographic	  H2S	  sensor	  probe	  based	  on	  that	  developed	  by	  Kraus	  et	  al	  175	  was	  utilised.	  	  	  
4.2.8	   The	   Polarographic	   H2S	   Sensor	   can	   Detect	   Increasing	   H2S	  
Concentrations	  in	  NaHS	  Standard	  Controls	  	  	  In	   order	   to	   test	   the	   efficiency	   of	   the	   H2S	   sensor,	   the	   probe	  was	   assessed	   for	   its	  ability	  to	  detect	  H2S	  in	  known	  standard	  control	  solutions	  containing	  NaHS.	  Figure	  4.6	   shows	   that	   the	   probe	   detects	   H2S	   levels	   in	   a	   dose-­‐dependent	   manner	  confirming	  the	  manufacturers	  observations	  and	  guidelines.	  	  
	  	  
	  
Figure	  4.6:	  Dose-­‐dependent	  Detection	   of	  H2S	   using	   a	   Polarographic	   	  Micro-­‐	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4.2.9	  H2S	  Levels	  were	  Unchanged	  in	  the	  Livers	  of	  WT	  and	  eNox4	  Tg	  Mice	  	  The	  liver	  contains	  a	  high	  abundance	  of	  the	  H2S-­‐generating	  enzymes	  CBS	  and	  CSE,	  and	   therefore	  provides	   a	  useful	  positive	   control	   for	   the	  detection	  of	   endogenous	  H2S.	  To	  test	  whether	  the	  probe	  was	  capable	  of	  detecting	  endogenously	  generated	  H2S	  in	  the	  liver,	  the	  level	  of	  H2S	  was	  compared	  between	  WT	  and	  eNox4	  Tg	  isolated	  mouse	  liver	  pieces.	  Figure	  4.7A	  shows	  a	  representative	  trace	  for	  these	  experiments	  indicating	   that	   H2S	   levels	   could	   be	   detected	   in	   the	   liver	   when	   the	   substrate,	   L-­‐cysteine	  was	  supplied.	  Figure	  4.7B	  shows	   that	  no	  overall	  difference	   in	  H2S	   levels	  were	  detectable	  between	  WT	  and	  eNox4	  Tg	  livers	  when	  normalised	  to	  weight.	  	   	  
	  	  
Figure	  4.7:	  H2S	  Levels	  are	  Unchanged	  between	  the	  Livers	  of	  WT	  and	  eNox4	  Tg	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4.2.10	  H2S	  was	  Undetectable	  in	  Lung	  and	  Heart	  Tissue	  	  To	  determine	  whether	  differences	  in	  H2S	  levels	  could	  be	  detected	  in	  more	  vascular	  tissues,	  the	  H2S	  probe	  was	  used	  to	  measure	  H2S	  in	  pieces	  of	  mouse	  lung	  and	  heart	  isolated	   from	   WT	   and	   eNox4	   Tg	   mice.	   Figure	   4.8A	   and	   B	   show	   that	   H2S	   was	  undetectable	  in	  these	  organ	  samples	  even	  after	  prolonged	  incubation	  with	  the	  CSE	  substrate,	  L-­‐cysteine,	  suggesting	  that	  the	  probe	  was	  not	  sensitive	  enough	  to	  detect	  the	  small	  levels	  of	  H2S	  expected	  to	  be	  released	  from	  the	  vasculature.	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4.2.11	  Vascular	  Contractility	  	  	  CSE	   has	   been	   shown	   to	   have	   roles	   in	   regulating	   vascular	   tone79.	   To	   investigate	  whether	  the	  increase	  in	  endothelial	  CSE	  protein	  expression	  observed	  in	  the	  eNox4	  Tg	  mouse	  impacted	  on	  vascular	  contractility,	  aortic	  vessel	  tension	  was	  compared	  between	  WT	  and	  eNox4	  Tg	  mice	  using	  ex	  vivo	  wire	  myography.	  	  
4.2.12	   Aortic	   Vessel	   Constriction	   to	   60	   mM	   KCl	   Remains	   Unchanged	  
Between	  WT	  and	  eNox4	  Tg	  mice	  	  	  To	   begin	   to	   assess	   whether	   WT	   and	   eNox4	   Tg	   aortae	   exhibit	   a	   difference	   in	  vasoconstriction,	   peak	   aortic	   constriction	   to	   the	   depolarising	   agent	  KCl	  was	   first	  measured.	  Figure	  4.9	  shows	  that	  no	  difference	  in	  the	  aortic	  contractility	  to	  KCl	  was	  apparent	  between	  the	  two	  genotypes.	  
	  	  
Figure	   4.9:	   High	   KCl	   Induces	   Equivalent	   Constriction	   in	  WT	   and	   eNox4	   Tg	  
Aortae.	  A	  comparison	  of	   total	  aortic	  contraction	   to	  60	  mM	  KCl	  between	  WT	  and	  eNox4	   Tg	  mice.	  WT	  N=	   8	   (12rings),	   eNox4	   Tg	  N=6	   (9	   rings).	   Statistical	   analysis	  performed	  using	  an	  unpaired	  Students	  t-­‐test.	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4.2.13	   eNox4	   Tg	   Aortae	   are	   Hypo-­‐contractile	   Compared	   to	   WT	  
Littermates	  in	  Response	  to	  Phenylephrine	  (PE)	  	  	  	  To	   further	   assess	   whether	   a	   difference	   in	   contractility	   exists	   between	   WT	   and	  eNox4	  Tg	  aortae,	  vessels	  were	  constricted	   to	   increasing	  concentrations	  of	   the	  α1	  adrenoreceptor	   agonist,	   phenylephrine	   (PE).	   Figure	   4.10	   shows	   that	   eNox4	   Tg	  aortae	  are	  significantly	  less	  contractile	  in	  response	  to	  PE	  than	  WT	  littermates.	  	  
	  
Figure	  4.10:	  eNox4	  Tg	  Aortae	  are	  Hypo-­‐contractile	  compared	  to	  WT	  Controls.	  A	   comparison	   of	   PE-­‐induced,	   dose-­‐dependent	   aortic	   constriction	   (up	   to	   30	   μM)	  between	  WT	  and	  eNox4	  Tg	  mice.	  WT	  N=	  8	  (12rings),	  eNox4	  Tg	  N=6	  (9	  rings).	  *	  =	  P<0.05,	  **	  =	  P<0.01.	  Statistical	  analysis	  performed	  using	  a	  2	  way	  ANOVA,	  followed	  by	  a	  Tukeys	  post-­‐hoc	  test.	  	  	  	  
4.2.14	  The	  eNox4	  Tg	  Hypo-­‐contractile	  Phenotype	  is	  H2O2-­‐independent	  	  To	   determine	   whether	   Nox4-­‐derived	   H2O2	   was	   responsible	   for	   the	   hypo-­‐contractile	  phenotype	  observed	  in	  eNox4	  Tg	  mice,	  aortae	  were	  pre-­‐incubated	  with	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PEG-­‐catalase	  prior	  to	  PE-­‐induced	  constriction.	  Figure	  4.11	  shows	  that	  PEG-­‐catalase	  had	   no	   effect	   on	   the	   hypo-­‐contractile	   phenotype	   observed	   in	   eNox4	   Tg	   mouse	  aortae	  with	   respect	   to	  WT	   littermates,	   over	   the	   time	   scale	   of	   these	   experiments.	  These	  data	  suggest	  that	  Nox4-­‐derived	  H2O2	  is	  not	  involved	  in	  the	  hypo-­‐contractile	  phenotype,	  at	  least	  in	  an	  acute	  manner.	  	   	  
	  	  	  
Figure	   4.11:	   PEG-­‐Catalase	   Does	   Not	   Affect	   the	   eNox4	   Tg	   Hypo-­‐contractile	  
Phenotype.	  A	  comparison	  of	  PE-­‐induced,	  dose-­‐dependent	  aortic	  constriction	  (up	  to	   30	   μM)	   between	  WT	   and	   eNox4	   Tg	  mice,	   with	   and	   without	   20	  minutes	   pre-­‐incubation	  with	  2000U/5	  ml	  PEG-­‐catalase	  (PEG-­‐Cat).	  WT	  N=	  7	  (13rings),	  eNox4	  Tg	  N=4	  (5	  rings),	  WT	  +PEG-­‐Cat	  N=5	  (8	  rings),	  eNox4	  Tg	  +	  PEG-­‐Cat	  N=5	  (8	  rings).	  *	  =	  P<0.05	  (*	  compares	  WT	  with	  eNox4	  Tg),	  +	  =	  P<0.05,	  ++	  =	  P<0.01	  (+	  compares	  WT	  +	  PEG-­‐Cat	  with	  eNox4	  Tg	  +	  PEG-­‐Cat).	  	  Statistical	  analyses	  performed	  using	  a	  2	  way	  ANOVA,	  followed	  by	  a	  Tukeys	  post-­‐hoc	  test.	  	  	  
4.2.15	  The	  eNox4	  Tg	  Hypo-­‐contractile	  Phenotype	  is	  Dependent	  on	  CSE	  
Activity	  	  To	   investigate	   whether	   the	   increased	   expression	   of	   CSE	   seen	   in	   the	   eNox4	   Tg	  mouse	  was	  responsible	  for	  the	  observed	  hypo-­‐contractile	  phenotype,	  aortae	  were	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pre-­‐incubated	  with	  the	  CSE	  inhibitor,	  propargylglycine	  (PPG),	  prior	  to	  PE-­‐induced	  constriction.	   Figure	  4.12	   shows	   that	   administration	  of	   PPG	  normalises	   eNox4	  Tg	  constriction	  to	  the	  same	  level	  as	  WT	  aortae	  treated	  with	  PPG,	  completely	  ablating	  the	   hypo-­‐contractile	   phenotype	   observed	   in	   eNox4	   Tg	   vessels.	   These	   data	   are	  consistent	   with	   a	   role	   for	   increased	   CSE	   expression	   in	   mediating	   the	   hypo-­‐contractile	  phenotype	  observed	   in	   the	  eNox4	  Tg	  mouse.	  WT	  vessels	   treated	  with	  PPG	   also	   showed	   an	   increase	   in	   contractility	   but	   this	   difference	   did	   not	   reach	  significance	  at	  the	  sample	  size	  assessed	  in	  these	  experiments.	  	  	  
	  
Figure	   4.12:	   CSE	   Inhibition	   Ablates	   the	   eNox4	   Tg	   Hypo-­‐contractile	  
Phenotype.	  A	  comparison	  of	  PE-­‐induced,	  dose-­‐dependent	  aortic	  constriction	  (up	  to	   30	   μM)	   between	  WT	   and	   eNox4	   Tg	  mice,	   with	   and	   without	   30	  minutes	   pre-­‐incubation	  with	   20	  mM	   PPG.	  WT	   N=	   8	   (12	   rings),	   eNox4	   Tg	   N=6	   (9	   rings),	  WT	  +PPG	  N=8	  (13	  rings),	  eNox4	  Tg	  +	  PPG	  N=9	  (16	  rings).	   *	  =	  P<0.05,	  **	  =	  P<0.01	  (*	  compares	   WT	   with	   eNox4	   Tg),	   +++	   =	   P<0.001,	   ++++	   =	   P<0.0001	   (+	   compares	  eNox4	   Tg	  with	   eNox4	   Tg	   +	   PPG).	   	   Statistical	   analyses	   performed	   using	   a	   2	  way	  ANOVA,	  followed	  by	  a	  Tukeys	  post-­‐hoc	  test.	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4.2.16	   Endothelial-­‐specific	   Nox4-­‐Null	   Mice	   show	   no	   Difference	   in	  
Contractility	  to	  PE	  at	  Baseline	  	  	  The	   following	   studies	   involve	   the	   use	   of	   endothelial-­‐specific	   Nox4-­‐null	   mice	  (eNox4-­‐/-­‐).	   These	   mice	   were	   generated	   by	   crossing	   Nox4flox/flox	   mice	   with	  endothelial-­‐specific	  Tie2-­‐Cre	  overexpressing	  transgenic	  mice	  (Nox4flox/flox	  Cre+	  )173.	  Nox4flox/flox	  females	  were	  crossed	  with	  Nox4flox/flox	  Cre+	  males	   in	  order	  to	  generate	  equal	  numbers	  of	  control	  Nox4flox/flox	  	  and	  eNox4-­‐/-­‐	  mice.	  The	  presence	  or	  absence	  of	   the	   Cre-­‐recombinase	   transgene	   was	   determined	   by	   genotyping.	   Figure	   4.13	  depicts	   a	   representative	   genotyping	   result	   for	   the	   eNox4-­‐/-­‐	  mouse	   line.	  Here	  one	  Nox4flox/flox	   and	   one	   eNox4-­‐/-­‐	   mouse	   are	   present	   among	   the	   litter.	   The	   eNox4-­‐/-­‐	  mouse	   can	   be	   identified	   by	   a	   band	   at	  ~200bp	   corresponding	   to	   the	   presence	   of	  Cre-­‐recombinase.	   Primers	   which	   detect	   a	   genomic	   region	   corresponding	   to	   a	  GAPDH	   pseudogene	   were	   used	   as	   a	   positive	   control	   to	   confirm	   that	   the	   PCR	  reactions	  were	  successful.	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To	  determine	  whether	  differences	  also	  exist	  between	  the	  contractility	  of	  eNox4-­‐/-­‐	  and	  Nox4flox/flox	  vessels,	  aortic	  vessel	  contractility	  was	  compared	  in	  response	  to	  KCl	  and	   PE.	   Figure	   4.14A	   and	   B	   show	   that	   both	   contractile	   stimuli	   induced	   similar	  levels	  of	  response	  in	  vessels	  irrespective	  of	  genotype.	  	  	  	  
	  	  	  
Figure	   4.14:	   Nox4flox/flox	  and	   eNox4-­‐/-­‐	   Aortae	   Contract	   Similarly	   to	   Both	   KCl	  
and	   PE	   treatments.	  A)	   A	   comparison	   of	   total	   aortic	   contraction	   to	   60	  mM	   KCl	  between	  WT	  and	  eNox4-­‐/-­‐	  mice.	  B)	  A	  comparison	  of	  PE-­‐induced,	  dose-­‐dependent	  aortic	   constriction	   between	   Nox4flox/flox	   and	   eNox4-­‐/-­‐	   mice.	   Nox4flox/flox	   N=	   6	  (12rings),	   eNox4-­‐/-­‐	   N=5	   (13	   rings).	   Statistical	   analysis	   performed	   using	   an	  unpaired	  Students	  t-­‐test	  for	  total	  constriction	  to	  KCl	  and	  a	  2	  way	  ANOVA	  followed	  by	  Tukeys	  post-­‐hoc	  test	  for	  PE-­‐induced	  dose	  dependent	  constriction.	  	  	  	  	  	  	  	  	  	  	  	  	  	  
A" B"
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4.3	  Discussion	  	  
4.3.1	  Nox4	  Regulates	  CSE	  Expression	  in	  Murine	  Endothelial	  Cells	  	  Data	  presented	  in	  the	  previous	  chapter	  of	  this	  thesis	  demonstrate	  that	  endothelial	  Nox4	   overexpression	   is	   capable	   of	   up-­‐regulating	   CSE	   mRNA	   and	   protein	  expression	   in	   vitro.	   Consistent	  with	   these	   results,	   data	   described	   in	   this	   chapter	  demonstrate	   that	   CSE	   mRNA	   and	   protein	   expression	   are	   also	   up-­‐regulated	   in	  endothelial	   cells	   isolated	   from	   the	   hearts	   of	   eNox4	   Tg	   mice,	   compared	   to	   WT	  controls.	  Collectively,	  these	  data	  further	  support	  a	  role	  for	  Nox4	  in	  the	  regulation	  of	   CSE	   transcriptional	   expression	   and	   contribute	   to	   the	   emerging	   literature	  surrounding	   a	   role	   for	   Nox	   proteins100	   as	   well	   as	   ROS99	   in	   the	   control	   of	   CSE	  transcription.	  	  
4.3.2	  Nox4	  and	  the	  Regulation	  of	  Vascular	  Tone	  	  	  The	  endothelium	  regulates	  blood	  flow	  and	  tissue	  perfusion	  through	  its	  modulation	  of	   vascular	   tone7.	   This	  process	   is	   governed	  by	   a	  number	  of	   biomolecules	   and,	   of	  these,	   ROS	   are	   emerging	   as	   key	   mediators.	   Furthermore,	   it	   is	   thought	   that	  vasodilation	   and	   constriction	   are	   differentially	   regulated	   by	   both	   the	   type	   and	  source	  of	  ROS	  involved.	   Indeed,	  H2O2	  is	  considered	  to	  play	  a	  physiological	  role	  as	  an	   EDHF19	   45	   and	   can	   thus	   induce	   vasorelaxation.	   By	   contrast,	   O2-­‐	   is	   involved	   in	  vasoconstriction176	   where,	   amongst	   other	   mechanisms,	   it	   can	   deplete	   NO	  bioavailability	   through	   the	   formation	   of	   peroxynitrite177.	   Accordingly,	   Nox4	   has	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been	  shown	  to	  have	  a	  number	  of	  vaso-­‐protective	  effects,	  underscored	  by	  its	  ability	  to	   synthesise	   H2O247,	   151.	   Indeed,	   the	   eNox4	   Tg	   mice	   utilised	   here	   were	   shown	  previously	   to	   have	   improved	   endothelial	   function,	   vasodilation	   and	   lower	   blood	  pressure	   when	   compared	   to	   WT	   controls47.	   Furthermore,	   Nox4	   gene	   deletion	  models	   indicate	   that	   Nox4	   contributes	   to	   vasorelaxation	   potentially	   through	   its	  regulation	   of	   eNOS151.	   In	   line	  with	   a	   role	   for	   Nox4	   in	   the	   regulation	   of	   vascular	  tone,	  aortae	  isolated	  from	  eNox4	  Tg	  mice	  were	  shown	  here	  to	  be	  significantly	  less	  contractile	  in	  response	  to	  PE	  than	  WT	  control	  vessels.	  These	  findings	  are	  perhaps	  not	  fully	  consistent	  with	  previously	  published	  data	  obtained	  from	  the	  same	  mouse	  model	  in	  which	  only	  a	  small	  (non-­‐significant)	  reduction	  in	  PE-­‐induced	  contractility	  was	   observed47.	   However,	   Craige	   et	   al	   demonstrated	   that	   VE-­‐cadherin-­‐driven	  endothelial-­‐specific	   Nox4	   overexpressing	   aortae	   also	   displayed	   significantly	   less	  contractility	  to	  PE,	  therefore	  supporting	  our	  observation150.	  These	  discrepancies	  in	  contractile	   function	   might	   be	   explained	   by	   differences	   in	   the	   methods	   and	  protocols	  employed	  to	  measure	  vascular	  tone.	  Thus	  Ray	  et	  al	  used	  an	  organ	  bath	  method47	  whereas	  a	  wire	  myograph,	  specially	  designed	  to	  detect	  subtle	  changes	  in	  resistance	   vessel	   tension,	  was	   utilised	   here.	   This	   could	   potentially	   lead	   to	   better	  delineation	   of	   contractile	   differences	   between	   genotypes,	   and	   account	   for	   the	  discrepancies	   apparent	   in	   these	   results.	   Furthermore,	   a	   number	   of	   experimental	  factors	   have	   been	   shown	   to	   influence	   vascular	   contractility,	   including	   dissection	  skills,	   optimal	   resting	   tension,	   age	   of	   the	   animals,	   composition	   of	   the	   buffer	  solutions,	   temperature	   of	   the	   dissecting	   medium,	   and	   vessel	   isolation	   time.	  Therefore	   subtle	   alterations	   in	   experimental	   protocol	   may	   account	   for	   the	  observed	  differences	  in	  contractility178.	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4.3.4	  CSE	  Expression	  and	  Activity	  Leads	  to	  Hypo-­‐contractility	  	  To	  assess	  the	  potential	   involvement	  of	  the	  enhanced	  CSE	  expression,	  observed	  in	  eNox4	  Tg	   endothelial	   cells,	   in	  mediating	   the	   hypo-­‐contractile	   phenotype,	   vessels	  were	  pre-­‐incubated	  with	  the	  CSE	  inhibitor,	  PPG,	  as	  previously	  reported75.	  Here,	  the	  addition	  of	  PPG	  normalised	  contractility	  between	  eNox4	  Tg	  and	  WT	  vessels	  to	  PE,	  completely	   ablating	   the	   Nox4-­‐induced	   hypo-­‐contractile	   phenotype.	   These	   data	  strongly	  suggest	  that	  CSE	  is	  a	  key	  mediator	  of	  this	  phenotype	  and	  are	  potentially	  consistent	  with	   the	  emerging	   role	  of	  CSE	   in	  H2S	  generation.	   Indeed,	  a	  number	  of	  studies	  have	  characterised	  CSE	  as	  a	  major	  vascular	  generator	  of	  H2S	  that	  has	  been	  shown	   to	   induce	   endothelium-­‐dependent	   vasodilation75,	   79,	   83.	   Furthermore,	  exogenous	  application	  of	  H2S	  to	  vessels	  using	  NaS,	  NaHS	  or	  the	  slow-­‐releasing	  H2S	  donor	   drug,	   GYY4137, have	   previously	   been	   shown	   to	   induce	   vasorelaxation	   in	  aortae	   assessed	   by	   wire	   myogrpahy	   or	   in	   organ	   bath	   experiments65	   73,	   75-­‐77.	   To	  support	   this,	   data	   demonstrating	   that	   incubation	   of	   (sub-­‐maximally	   constricted)	  aortae	   with	   PPG	   exacerbated	   constriction,	   suggesting	   a	   role	   for	   CSE	   in	   the	  regulation	   of	   basal	   tone75.	   This	   is	   further	   corroborated	   by	   data	   derived	   from	   a	  study	   in	   rats	   showing	   that	   PPG	   alone	   could	   increase	   blood	  pressure179,	   an	   effect	  consistent	  with	   the	  hypertensive	  phenotype	  observed	   in	  CSE-­‐/-­‐	  mice79.	  Thus,	   it	   is	  apparent	  from	  these	  studies	  that	  CSE	  is	  a	  contributor	  to	  both	  basal	  and	  inducible	  vascular	   tone.	   Furthermore,	   it	   appears	   that	   the	   Nox4-­‐induced	   hypo-­‐contractile	  phenotype	  observed	  here,	  is	  likely	  due	  to	  the	  enhanced	  expression	  and	  activity	  of	  CSE	  in	  the	  endothelium	  of	  the	  eNox4	  Tg	  mouse.	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4.3.5	  Acute	  Nox4-­‐induced	  Hypo-­‐contractility	  is	  H2O2-­‐independent	  	  The	   mechanisms	   that	   underscore	   the	   biochemical	   actions	   of	   H2S	   remain	  contentious.	  At	  physiological	  pH	  levels,	  H2S	  is	  predominantly	  deprotonated	  	  (HS-­‐),	  and	   is	   therefore	   membrane-­‐impermeable.	   In	   this	   state	   its	   cell-­‐cell	   signalling	  potential	   is	   possibly	   limited	   to	   its	   transmission	   through	   intercellular	   junctions.	  Recently	  it	  has	  been	  suggested	  that	  ROS,	  such	  as	  H2O2,	  can	  oxidise	  H2S	  leading	  to	  its	  conversion	  into	  polysulfide	  species	  that	  are	  relatively	  membrane-­‐permeable.	  In	  this	   state,	   polysulphides	   can	   enter	   adjacent	   smooth	   muscle	   to	   modify	   muscle	  dynamics	  without	  the	  need	  for	  cell-­‐cell	  junctions73	  57.	  	  	  Previous	   reports	   by	   Ray	   et	   al	   demonstrated	   that	   the	   enhanced	   endothelium	  dependent	   vasodilation	   to	   ACh,	   observed	   in	   eNox4	   Tg	   mice,	   was	   catalase-­‐inhibitable.	   This	   suggests	   an	   acute	   involvement	   of	   Nox4-­‐derived	   H2O2	   in	   this	  process47,	   perhaps	   consistent	   with	   a	   role	   for	   H2O2	   in	   the	   oxidation	   of	   H2S	   to	  promote	   its	   signalling	   capabilites.	   To	   elaborate	   on	   these	   findings	   and	   further	  assess	   whether	   Nox4-­‐derived	   H2O2	   was	   also	   acutely	   involved	   in	   mediating	   the	  hypo-­‐contractile	   phenotype,	   potentially	   through	   a	   reaction	   with	   H2S	   and	  subsequent	   polysulphide	   formation,	   aortae	   were	   pre-­‐incubated	   with	   the	  peroxidase	  enzyme,	  PEG-­‐catalase.	  Here,	  short-­‐term	  administration	  of	  PEG-­‐catalase	  failed	   to	   normalise	   the	   Nox4-­‐induced	   hypo-­‐contractile	   phenotype,	   suggesting	   a	  H2O2-­‐independent	  mechanism	   (at	   least	   in	   an	   acute	  manner).	   These	  data	   indicate	  that	  the	  hypo-­‐contractile	  phenotype	  is	   likely	  due	  to	  the	  Nox4-­‐induced	  increase	  in	  CSE	   expression	   and	   subsequent	   actions	   of	   H2S,	   which	   do	   not	   involve	   its	   ROS-­‐dependent	  conversion	  to	  polysulphide.	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Taking	  these	  observations	  together,	  it	  appears	  that	  Nox4	  may	  act	  both	  to	  promote	  the	  endothelial-­‐expression	  of	  CSE	  and	  H2S	  production,	  and	  additionally	   to	  enable	  endothelial-­‐derived	   H2S	   to	   signal	   within	   VSMCs	   upon	   cholinergic	   stimulation	  through	   the	   generation	   of	   polysulphides.	   In	   this	   setting,	   scavenging	   by	   catalase	  would	   act	   acutely	   to	   prevent	   endothelium-­‐derived	  H2S	   signalling	   by	   diminishing	  polysulphide	   formation.	   However,	   the	   role	   of	   gap	   junctional	   intercellular	  communication,	  both	  among	  and	  between	  endothelial	  cells	  and	  VSMCs,	  is	  known	  to	  be	   involved	   in	   the	   regulation	   of	   vascular	   tone180.	   Gap	   junctions	   provide	   partial	  cytoplasmic	   continuity	   between	   cells,	   allowing	   the	   intercellular	   flux	   of	   second	  messenger	   molecules	   between	   cell	   types.	   Pharmacological	   evaluations	   have	  demonstrated	   the	   importance	   of	   gap	   junctions	   in	   the	   modulation	   of	   contractile	  responses	   elicited	   by	   α1-­‐adrenergic	   stimulation181.	   	   It	   is	   therefore	   possible	   that	  stimulation	   by	   PE	   acts	   to	   promote	   gap	   junction	   formation	   resulting	   in	   the	   free	  intercellular	   movement	   of	   HS-­‐	   without	   the	   necessity	   for	   oxidation	   by	   H2O2	  (and	  hence	   the	   lack	  of	   inhibition	  by	   catalase	   in	   this	  process).	  Therefore	  differences	   in	  agonist	  induced	  signalling	  may	  account	  for	  the	  apparent	  phenotypic	  discrepancies	  discussed	  above.	  	  	  To	   further	   assess	   the	   involvement	   of	   endothelial	   Nox4	   in	   vascular	   constriction,	  Nox4flox/flox	   and	   eNox4-­‐/-­‐	   mice	   aortae	   were	   analysed	   using	   wire	   myography	   as	  described	  above.	  No	  difference	  in	  contractility	  to	  KCl	  or	  PE	  was	  observed	  between	  genotypes.	  Nox4	  is	  thought	  to	  be	  stress-­‐inducible	  at	  the	  level	  of	  transcription	  and	  therefore	   the	   loss	  of	  Nox4	  may	  not	  confer	  an	  effect	  under	  unstressed	  conditions.	  Indeed,	  studies	  performed	  in	  global	  Nox4-­‐null	  mice	  revealed	  the	  requirement	  for	  a	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stress	   stimulus	   (angiotensin	   II)	   in	   order	   to	   observe	   a	   phenotypic	   difference	   in	  aortic	  relaxation151.	  	  	  An	  assessment	  of	  CSE	  expression	  in	  eNox4-­‐/-­‐	  endothelial	  cells	  was	  not	  performed	  here.	  However,	  based	  on	  data	  presented	  in	  this	  thesis	  in	  which	  Nox4	  was	  ablated	  in	   HUVEC,	   in	   vitro,	   the	   removal	   of	   endogenous	   Nox4	  might	   also	   be	   expected	   to	  reduce	  CSE	   levels	   in	  endothelial	   cells	   in	  vivo.	  However,	  differences	   in	   complexity	  between	   in	   vitro	   and	   in	   vivo	   systems	   may	   mean	   that	   CSE	   expression	   remains	  unchanged	   in	   these	   animals.	   An	   assessment	   of	   CSE	   expression	   in	   eNox4-­‐/-­‐	  endothelial	   cells	   will	   therefore	   be	   considered	   for	   future	   work,	   together	   with	   an	  assessment	   of	   aortic	   contractility	   when	   eNox4-­‐/-­‐	   mice	   are	   placed	   under	   a	  physiological	  or	  pathophysiological	  stress.	  	  	  To	   conclude,	   Nox4	   has	   been	   shown	   to	   regulate	   CSE	   expression	   in	   murine	  endothelial	   cells	   at	   both	   the	   mRNA	   and	   protein	   level,	   resulting	   in	   a	   hypo-­‐contractile	  phenotype,	   in	  response	  to	  PE.	  This	  phenotype	  was	  ablated	  by	  the	  CSE	  inhibitor	  PPG	  and	  appears	   to	  be	  H2O2-­‐independent	   at	   an	  acute	   level.	   Collectively	  these	  data	  contribute	  to	  existing	  reports	  detailing	  a	  functional	  role	  for	  both	  Nox4	  and	   CSE	   in	   the	   regulation	   of	   vascular	   tone,	   and	   further	   implicate	   Nox4	   as	   a	  regulator	  of	  the	  production	  of	  the	  gasotransmitter,	  H2S	  in	  the	  endothelium.	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4.3.6	  Experimental	  Limitations	  	  
4.3.6.1	  Measuring	  H2S	  levels	  ex	  vivo	  	  CSE	   protein	   expression	   was	   increased	   in	   the	   endothelium	   of	   eNox4	   Tg	   mice.	  Attempts	   were	   therefore	   made	   to	   assess	   H2S	   levels	   in	   these	   animals	   using	   a	  polarographic	   H2S	   microsensor175.	   H2S	   levels	   in	   the	   liver,	   an	   organ	   known	   to	  express	  high	   levels	   of	   CBS	   and	  CSE182,	  were	  detectable,	   but	   showed	  no	   apparent	  differences	   between	   genotypes.	   This	   is	   likely	   due	   to	   the	   relatively	   small	  contribution	  of	  the	  endothelium	  to	  H2S	  generation	  in	  this	  organ.	  Unfortunately,	  H2S	  production	   was	   undetectable	   using	   the	   aforementioned	   probe,	   in	   tissues	   other	  than	   the	   liver,	   including	   highly	   vascularised	   tissues	   such	   as	   the	   lung	   and	   heart.	  Previous	   studies,	   using	   different	   H2S	   detection	   methods,	   have	   successfully	  quantified	   vascular	   H2S	   levels79	   albeit	   at	   low	   levels179.	   Therefore,	   the	   results	  described	   here	   may	   reflect	   the	   sensitivity	   of	   the	   probe	   used,	   which	   may	   be	  insufficient	  to	  detected	  the	  small	  amounts	  of	  H2S	  that	  are	  expected	  to	  be	  released	  from	  the	  endothelial	  cell	  monolayer.	  	  	  
4.3.6.2	  Endothelial	  Cell	  Affinity	  Isolation	  Caveats.	  	  Endothelial	  cell	  isolations	  were	  performed	  on	  the	  basis	  of	  their	  affinity	  to	  an	  anti-­‐CD31	   antibody.	   CD31	   is	   commonly	   used	   as	   an	   endothelial	   cell	   marker174,	   and	  immunoprecipitation	  with	  antiCD31	  antibodies	  should	  therefore	   lead	  to	  selective	  affinity	   isolation	  of	   endothelial	   cells.	   It	   should	  be	  noted,	   however,	   that	   other	   cell	  types,	   such	  as	   leucocytes	   (monocytes	  and	  neutrophils183),	  also	  express	  CD31	  and	  may	   therefore	   lead	   to	   cellular	   contamination	   of	   endothelial	   isolates.	   This	   is	   a	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caveat	   inherent	   to	   the	  crude	   isolation	  method	  used	  here.	  To	  overcome	   this,	  vWF	  mRNA	   expression	   was	   used	   as	   a	   comparative	   marker	   before,	   and	   after,	   affinity	  isolation.	   All	   “output”	   samples	   were	   successfully	   enriched	   for	   vWF	   indicating	  preferential	  isolation	  of	  endothelial	  cells	  using	  this	  method.	  	  
4.3.6.3	  Wire	  Myography	  and	  Aortic	  Vessel	  Tension.	  	  
Ex	   vivo	   wire	  myography	   has	   been	   used	   extensively	   to	   assess	   vascular	   tone	   in	   a	  number	  of	  different	  vessel	  types178.	  Here,	  this	  technique	  was	  implemented	  in	  order	  to	  measure	  vascular	  tone	  in	  the	  aorta.	  Although	  the	  use	  of	  aortae	  provide	  proof	  of	  principle	  that	  the	  Nox4-­‐induced	  increase	  in	  CSE	  expression	  affected	  vascular	  tone,	  its	   physiological	   implications	   are	   limited,	   as	   large	   conduit	   vessels	   do	   not	   affect	  blood	   pressure	   to	   the	   same	   extent	   as	   smaller	   vessels	   such	   as	   resistance	   vessels.	  Thus,	  a	  more	  appropriate	  vessel	  type	  for	  analysis	  might	  be	  mesenteric	  resistance	  vessels	  which	  are	  more	   integral	   to	  blood	  pressure	   regulation.	  Another	   limitation	  arising	  from	  these	  experiments	  involves	  the	  use	  of	  PPG.	  While	  PPG	  has	  been	  used	  by	   other	   groups	   as	   a	   CSE	   inhibitor,	   non-­‐specific	   off-­‐target	   effects	   cannot	   be	  excluded.	  To	  overcome	  this,	  and	  to	  directly	  confirm	  the	  involvement	  of	  CSE	  in	  the	  hypo-­‐contractile	   phenotype,	   the	   effect	   of	   endothelial-­‐specific	   overexpression	   of	  Nox4	  in	  a	  CSE-­‐null	  genetic	  background	  would	  prove	  valuable.	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5.1	  Introduction	  
	  The	  data	  presented	   in	   the	  previous	   two	  chapters	  suggest	   that	  Nox4	   is	  a	  positive,	  physiological	   regulator	   of	   CSE	   transcriptional	   expression	   in	   vitro	   and	   in	   vivo,	   an	  effect	   that	   appears	   to	   be	   important	   for	   H2S	   biosynthesis.	   The	   molecular	  mechanisms	   underscoring	   this	   transcriptional	   regulation	   were	   therefore	  investigated.	  	  
5.1.1	  General	  Transcriptional	  Control	  	  Eukaryotic	   gene	   expression	   is	   a	   highly	   complex	   and	   stringently-­‐regulated	   event	  involving	  the	  collective	  activity	  of	  numerous	  proteins184.	  The	  process	  involves	  the	  binding	   of	   transcription	   factors	   to	   cognate	   binding	   sequences	   present	   at	   either	  proximal	  or	  distal	  DNA	  regions,	  relative	  to	  the	  core	  promoter.	  The	  transcriptional	  pre-­‐initiation	  complex	  (PIC);	  composed	  of	  multiple	  proteins	  with	  varied	  functions	  such	  as	  promoter	  recognition,	  histone	  modification	  and	  nucleosome	  unwinding	  is	  assembled	   at	   the	   core	   promoter.	   A	   central	   component	   of	   this	   complex	   is	   RNA	  polymerase	   II	   (Pol	   II)185,	   an	   enzyme	   that	   is	   responsible	   for	   mediating	   the	  transcription	  of	  genomic	  DNA	  into	  messenger	  RNA	  (mRNA).	  Transcription	  by	  Pol	  II	  proceeds	   in	  a	  processive	  manner	   through	   three	   stages;	   initiation,	   elongation	  and	  termination	   during	   which	  mRNA	   is	   capped	   and	  modified	   co-­‐transcriptionally	   to	  form	   a	  mature,	   spliced	   and	   polyadenylated	  mRNA	   product.	   Of	   these	   events,	   the	  binding	  of	  transcriptional	  activators	  to	  their	  cognate	  enhancer	  element	  represents	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the	  point	  at	  which	  specific	  cellular	  signals	  converge	  to	  promote	  the	  transcription	  of	  a	  defined	  set	  of	  genes184,	  186.	  	  	  
5.1.2	  Transcriptional	  Regulation	  of	  CSE	  Gene	  Expression	  	  A	  number	  of	   signalling	  pathways	   and	   transcription	   factors	  have	  previously	  been	  suggested	   to	   regulate	   CSE	   gene	   expression187.	   	   Studies	   conducted	   in	   human	  hepatocellular	  carcinoma	  cell	  lines	  have	  demonstrated	  that	  CSE	  expression	  can	  be	  regulated	  through	  the	  phosphatidylinositol-­‐3-­‐kinase	  (PI3K)-­‐Akt-­‐Specific	  Protein	  1	  (SP1)	   transcription	   factor-­‐signalling	   network188.	   Here,	   it	   was	   shown	   that	   the	  inhibition	  of	  PI3K	  or	  deletion	  of	  Akt	  resulted	  in	  a	  reduction	  in	  CSE	  expression.	  By	  contrast,	   experimentally-­‐induced	   activation	   of	   Akt	   increased	   CSE	   expression.	   It	  was	  also	  found	  that	  the	  -­‐592/+139bp	  region	  of	  the	  human	  CSE	  gene	  (relative	  to	  the	  cap	   site)	   represented	   the	   CSE	   core	   promoter,	   and	   luciferase	   reporter	   assays	  further	   confirmed	   the	   involvement	   of	   the	   PI3K/Akt/Sp1	   pathway	   in	   CSE	  transcriptional	  regulation.	  Consistent	  with	  this,	  SP1	  was	  shown	  to	  bind	  directly	  to	  the	  CSE	  promoter	  in	  chromatin	  immunoprecipitation	  (ChIP)	  assays189.	  	  	  In	  addition	  to	  SP1,	  studies	  performed	  in	  rat	  mesangial	  cells	  have	  suggested	  a	  role	  for	   the	  known	  redox-­‐sensitive	   transcription	   factor,	  Nrf2,	   in	   the	  regulation	  of	  CSE	  expression100.	   Here	   it	   was	   shown	   that	   platelet-­‐derived	   growth	   factor-­‐BB	   was	  capable	   of	   inducing	   Nrf2	   activation	   and	   its	   translocation	   to	   the	   nucleus,	   with	   a	  subsequent	   increase	   in	   CSE	   transcription.	   This	   observed	   increase	   in	   CSE	  expression	   was	   abolished	   in	   response	   to	   NADPH	   oxidase	   inhibition,	   or	   ROS	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scavenging	  by	  DPI	  and	  NAC	  respectively.	  Furthermore,	  mesangial	  cells	  from	  Nrf2-­‐null	  mice	  displayed	  reduced	  CSE	  expression	  that	  failed	  to	  increase	  in	  response	  to	  PDGF100.	  	  	  The	  integrated	  stress	  response	  (ISR)	  has	  a	  number	  of	  signalling	  arms,	  one	  of	  which	  involves	  the	  phosphorylation	  of	  eukaryotic	  translation	  initiation	  factor	  2α	  (eIF2α)	  by	  4	  eIF2α	  kinases190;	  PKR-­‐like	  ER	  Kinase	  (PERK),	  protein	  kinase	  double-­‐stranded	  RNA-­‐dependent	  kinase	  (PKR),	  general	  control	  non-­‐derepressible-­‐2	  Kinase	  (GCN2)	  and	   haem-­‐regulated	   inhibitor	   kinase	   (HRI)	   leading	   to	   the	   subsequent	   protein	  expression	  of	  the	  basic	  leucine-­‐zipper	  transcription	  factor,	  activating	  transcription	  factor	   4	   (ATF4)191	   (Figure	   5.1).	   This	   pathway	   has	   been	   shown	   to	   regulate	   CSE	  expression	  in	  a	  number	  of	  studies.	  Thus	  mouse	  embryonic	  fibroblasts	  (MEFs)	  with	  a	  genetic	  deletion	  in	  ATF4	  (ATF4-­‐/-­‐	  MEFs)	  exhibited	  a	  dramatic	  baseline	  reduction	  in	  CSE	  protein	  expression.	  To	  further	  demonstrate	  that	  CSE	  was	  regulated	  by	  the	  ISR,	   ISR	   inducing	   agents,	   tunicamycin	   and	   thapsigargin,	  were	   shown	   to	   increase	  CSE	  protein	  expression	  in	  wild	  type	  MEFs192.	  To	  support	  this,	  data	  obtained	  by	  Han	  
et	  al	  demonstrated	  that	  the	  mRNA	  expression	  of	  CSE	  was	  increased	  in	  response	  to	  tunicamycin,	   and	   that	   this	  effect	  was	  abolished	   in	   the	  absence	  of	  ATF4193.	  Taken	  together,	   these	   findings	  suggest	   that	  CSE	   is	  a	  key	   transcriptional	   target	  activated	  by	  the	  ISR.	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5.1.3	  Nox4	  Signalling	  and	  the	  Regulation	  of	  Transcription	  	  At	  the	  physiological	  and	  molecular	  level,	  Nox4	  has	  been	  shown	  to	  have	  pleiotropic	  effects	   in	   the	   cardiovascular	   system148.	   An	   integral	   component	   underscoring	   its	  ability	  to	  induce	  this	  diverse	  array	  of	  phenotypes	  stems	  from	  its	  ability	  to	  generate	  the	  secondary	  messenger	  molecule,	  H2O2148.	  At	  the	  cellular	  level,	  Nox4	  is	  involved	  in	   the	   activation	   and	   inhibition	   of	   numerous	   signalling	   pathways	   and	   can	   exert	  control	   over	   specific	   transcriptional	   responses151.	   The	   Kelch-­‐like	   ECH-­‐associated	  protein1	   (KEAP1)/Nrf2	   transcriptional	   signalling	   module	   represents	   a	   well-­‐characterised	   ROS-­‐induced	   system	   that	   (as	   discussed	   previously)	   has	   previously	  been	  shown	   to	   regulate	  CSE	  expression100	   (Figure	  5.2).	   In	  unstressed	  conditions,	  KEAP1	   sequesters	   Nrf2	   in	   the	   cytoplasm	   where	   it	   is	   targeted	   for	   ubiquitin-­‐mediated	  degradation.	  However	  under	  oxidative	   stress,	   critical	   cysteine	   residues	  in	   KEAP1	   are	   oxidised	   resulting	   in	   the	   liberation	   of	   Nrf2	   and	   its	   subsequent	  translocation	   to	   the	   nucleus	   where	   it	   drives	   the	   expression	   of	   a	   battery	   of	  antioxidant	   and	   detoxifying	   genes196.	   Nox4	   has	   been	   shown	   to	   regulate	   Nrf2-­‐dependent	   gene	   expression	   in	   the	   hearts	   of	   mice	   with	   cardiac-­‐specific	   Nox4	  overexpression	   (csNox4	   Tg)158.	   Here,	   a	   microarray	   screen	   of	   csNox4	   Tg	   hearts	  revealed	  that	  a	  number	  of	  Nrf2	  target	  genes	  were	  up-­‐regulated,	  compared	  to	  WT	  littermates,	   resulting	   in	   higher	   levels	   of	   GSH.	   This	   effect	   was	   attributed	   to	   an	  increase	   in	   the	  expression	  of	  Nrf2-­‐target	  genes,	   since	   this	   change	   in	  GSH	  did	  not	  occur	   in	   an	  Nrf2-­‐null	   background158.	   In	   support	   of	   these	   findings,	   Schroder	   et	  al	  demonstrated	   that	   endothelial	   Nox4	   controls	   basal	   Nrf2	   activity151.	   Here,	  tamoxifen-­‐induced	   global	   Nox4	   deletion	   resulted	   in	   a	   reduction	   in	   Nrf2	   protein	  expression	   and	   reporter	   gene	   activity.	   HO-­‐1,	   a	   known	   Nrf2	   target,	   was	   also	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reduced	   in	   its	   expression	   when	   Nox4	   was	   deleted151.	   Taken	   together,	   Nox4	  appears	   to	   play	   a	   role	   in	   the	   regulation	   of	   cellular	   antioxidant	   gene	   expression	  through	  Nrf2	  and	  could	  potentially	  regulate	  CSE	  expression	  through	  this	  pathway.	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Collectively,	  these	  data	  provide	  evidence	  that	  CSE	  transcription	  may	  be	  regulated	  by	  multiple	  signalling	  pathways	  and	  transcription	  factors	  that	  are	  also	  associated	  with	  Nox4	  activity.	  It	  is	  tempting	  to	  speculate	  that	  the	  previously-­‐defined	  role	  for	  Nox4	  in	  the	  regulation	  of	  CSE	  transcription	  described	  in	  this	  thesis	  may	  involve	  the	  activation	  of	  one	  or	  more	  of	  these	  pathways.	  	  
Aim	  	  To	   determine	   the	   components	   of	   the	   molecular	   signalling	   pathways	   and	  transcription	   factors	   that	   drives	   the	  Nox4-­‐induced	   increase	   in	  CSE	   expression	   in	  endothelial	  cells.	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5.2	  Results	  
5.2.1	  The	  Regulation	  of	  CSE	  Transcription	  	  As	   stated	   previously,	   a	   number	   of	   transcription	   factors	   have	   been	   shown	   to	  regulate	  CSE	  expression.	  In	  order	  to	  investigate	  which	  transcription	  factor(s)	  was	  responsible	   for	   the	   Nox4-­‐induced	   up-­‐regulation	   of	   CSE	   mRNA	   expression	   in	  endothelial	   cells	   several	   previously-­‐characterised	   transcription	   factors	   were	  silenced	  in	  the	  presence	  of	  Nox4	  overexpression.	  	  Figure	  5.3A-­‐F	  shows	  the	  results	  of	   this	   screen.	   Here,	   all	   three	   transcription	   factors;	   Nrf2,	   Sp1	   and	   ATF4	   were	  successfully	   silenced	   at	   the	   mRNA	   level	   in	   HUVECs	   (A,C,E).	   Figure	   5.3E	   and	   F	  shows	   that	   the	   silencing	   of	   ATF4	   results	   in	   a	   complete	   ablation	   of	   the	   Nox4-­‐induced	  up-­‐regulation	   in	  CSE	  mRNA	  expression,	   an	   effect	   that	  was	  not	   observed	  upon	  Nrf2	  or	  SP1	  silencing.	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Figure	   5.3:	   Nox4	   Activates	   CSE	   Expression	   in	   HUVEC	   via	   ATF4.	  A,C,E)	  QPCR	  data	   showing	   that	  Nrf2,	   SP1	  and	  ATF4	  were	   successfully	   silenced	   following	  a	  48	  hour	   targeted	   a	   siRNA	   treatment	   compared	   to	   scrambled	   siRNA	   controls	   in	  HUVECs.	  B,D,F)	   shows	  the	  effect	  of	  48	  hour	  Nrf2,	  SP1	  and	  ATF4	  silencing	  on	  the	  Nox4-­‐induced	  up-­‐regulation	  in	  CSE	  expression	  in	  HUVEC	  overexpressing	  B	  Gal	  (B	  Gal	  O.E)	  or	  Nox4	  (Nox4	  O.E)	  for	  24	  hours.	  The	  red	  box	  highlights	  the	  observation	  that	  ATF4	  silencing	  ablates	  the	  Nox4-­‐induced	  increase	  in	  CSE	  expression.	  All	  data	  normalised	  to	  β	  Actin	  mRNA	  expression.	  N=1.	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statistical	  significance.	  Figure	  5.4A-­‐C	  shows	  the	  results	  of	  this	  experiment.	  Figure	  5.4B	   demonstrates	   that	   ATF4	   can	   be	   successfully	   silenced	   at	   the	  mRNA	   level	   by	  siRNA-­‐mediated	   ablation	   and	   that	   upon	   Nox4	   overexpression	   ATF4	   mRNA	  expression	  is	  significantly	  increased.	  	  Figure	  5.4C	  further	  shows	  that	  this	  silencing	  of	   ATF4	   completely	   ablates	   the	   Nox4-­‐induced	   up-­‐regulation	   in	   CSE	   mRNA	  expression.	  	  
	  	  
Figure	  5.4:	  ATF4	  Silencing	  Ablates	  Nox4-­‐induced	  CSE	  Expression:	  QPCR	  data	  for	   A)	   Nox4,	   B)	   ATF4	   and	   C)	   CSE	   mRNA	   expression	   following	   48	   hours	   ATF4	  silencing	   (siATF4)	   or	   scrambled	   siRNA	   controls	   (siScram)	  with	   or	   without	   a	   24	  hour	   Nox4	   overexpression	   (Nox4	   O.E)	   or	   B	   Gal	   overexpression	   (B	   Gal	   O.E)	   in	  HUVECs.	  All	  data	  normalised	   to	  β	  Actin	  mRNA	  expression.	  O.E	  =	  Overexpression.	  	  N=3,	  *=<0.05,	  **	  =	  P<0.01,	  ****	  =	  P=<0.0001.	  Statistical	  analysis	  performed	  using	  one-­‐way	  ANOVA	  using	  a	  Tukeys	  post-­‐hoc	  test.	  	  
	  To	   determine	   whether	   the	   Nox4-­‐induced	   increase	   in	   ATF4	   mRNA	   expression	  resulted	  in	  a	  concomitant	  increase	  in	  ATF4	  protein	  expression,	  immunoblots	  were	  performed	  on	  HUVECs	  overexpressing	  Nox4	   in	  the	  presence	  or	  absence	  of	  siRNA	  targeted	   to	   ATF4.	   Figure	   5.5	   shows	   that	   Nox4	   overexpression	   significantly	  increased	   ATF4	   protein	   expression	   and	   that	   this	   effect	   was	   lost	   upon	   ATF4	  silencing.	  
A" B""" C"
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Figure	   5.5:	   ATF4	   Protein	   Expression	   is	   Increased	   in	   Response	   to	   Nox4	  
Overexpression.	   A)	   A	   representative	   immunoblot	   for	   ATF4	   and	   Nox4	   protein	  expression	   following	   48	   hours	   ATF4	   silencing	   (siATF4)	   or	   scrambled	   siRNA	  controls	  (siScram)	  with	  either	  a	  24	  hour	  Nox4	  overexpression	  (Nox4	  O.E)	  or	  B	  Gal	  overexpression	   (B	  Gal	  O.E)	   in	  HUVECs.	  B)	   Corresponding	   densitometric	   analysis	  for	   ATF4	   protein	   expression	   normalised	   to	   β	   Actin	   protein	   levels.	   N=3,	   *=<0.05.	  Statistical	  analysis	  performed	  using	  one-­‐way	  ANOVA	  using	  a	  Tukeys	  post-­‐hoc	  test.	  	  	  
5.2.3	   ATF4	   and	   CSE	   mRNA	   Expression	   Increase	   in	   a	   Time	   Dependent	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Figure	  5.6:	  Nox4	  Induces	  A	  Time-­‐dependent	  Increase	  in	  ATF4	  and	  CSE	  mRNA	  
Expression.	  A-­‐C)	  QPCR	  data	   for	  A)	  Nox4,	  B)	  ATF4	  and	  C)	  CSE	  mRNA	  expression	  following	  Nox4	  overexpression	  (Nox4	  O.E)	  for	  6,	  12	  and	  24	  hours	  compared	  to	  B	  Gal	  overexpressing	  (B	  Gal	  O.E)	  control	  HUVECs.	  Data	  normalised	  to	  β	  Actin	  mRNA	  expression.	  O.E	  =	  Overexpression.	  N=3,	  **	  =	  P≤0.01,	  ***	  =	  P<0.01	  ****	  =	  P=<0.0001.	  Statistical	  analysis	  performed	  using	  one-­‐way	  ANOVA	  using	  a	  Tukeys	  post-­‐hoc	  test.	  	  	  To	  further	  assess	  the	  involvement	  of	  ATF4	  in	  the	  regulation	  of	  CSE	  transcription,	  ATF4	  overexpression	  experiments	  were	  performed.	  Figure	  5.7A	  and	  B	  show	  that	  ATF4	  was	   successfully	   overexpressed	   in	  HUVECs.	   Figure	   5.7C	   demonstrates	   that	  CSE	  mRNA	  expression	  was	  significantly	  up-­‐regulated	  upon	  ATF4	  overexpression.	  Taken	   together	  with	  ATF4	  silencing	  data	  depicted	  above,	   these	  data	  suggest	   that	  ATF4	   expression	   is	   necessary	   to	   increase	   CSE	   transcription	   in	   endothelial	   cells	  upon	  Nox4	  overexpression,	  and	  is	  sufficient	  in	  itself	  to	  up-­‐regulate	  this	  expression.	  	  	  	  	  	  	  
A" B" C"
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Figure	   5.7:	   ATF4	   Overexpression	   Significantly	   Increases	   CSE	   mRNA	  
Expression.	   A)	   A	   representative	   immunoblot	   demonstrating	   ATF4	   protein	  expression	  following	  24	  hours	  ATF4	  (ATF4	  O.E)	  or	  empty	  vector	  control	  PCDNA3.1	  overexpression	  (PCDNA3.1)	   in	  HUVECs.	  B)	  Corresponding	  densitometric	  analysis	  for	   ATF4	   protein	   expression	   normalised	   to	   β	   Actin	   protein	   levels.	  C)	   QPCR	   data	  showing	   CSE	   mRNA	   expression	   for	   the	   same	   experiment	   normalised	   to	   β	   Actin	  mRNA	   expression.	   N=3,	   ***=<0.001.	   Statistical	   analysis	   performed	   using	   an	  unpaired	  Students	  t-­‐test.	  O.E	  =	  Overexpression.	  
	  
5.2.4	   ATF4	   Activates	   CSE	   Transcription	   via	   cis-­‐regulatory	   Sequence(s)	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whether	  either	  of	  the	  proximal	  upstream	  promoter	  regions	  described	  above	  were	  involved	  in	  mediating	  the	  ATF4-­‐induced	  increase	  in	  CSE	  expression.	  Thus	  HEK293	  cells	  were	  transfected	  with	  the	  promoter	  constructs;	  -­‐764bp-­‐luc	  and	  -­‐6415bp-­‐luc	  in	  the	  presence	  or	  absence	  of	  ATF4	  overexpression.	  Figure	  5.8A	  schematically	  depicts	  the	   constructs	   used	   in	   these	   experiments	   and	   shows	  where	   they	  map	   to	   on	   the	  human	   CSE	   gene.	   Figure	   5.8B	   shows	   that	   both	   -­‐764bp-­‐luc	   and	   -­‐6415bp-­‐luc	   were	  greatly	   increased	  in	  their	  promoter	  activity	  compared	  to	  empty	  vector	  (PGL4.22)	  controls.	   This	   demonstrates	   that	   both	   reporter	   constructs	   were	   successfully	  cloned,	   transfected	   and	   active	   in	   HEK293	   cells.	   However,	   upon	   ATF4	  overexpression	  the	  -­‐764bp-­‐luc	  construct	  was	  significantly	  reduced	  in	  its	  luciferase	  activity,	  while	  the	  -­‐6415bp-­‐luc	  construct	  showed	  no	  significant	  change	  in	  activity,	  although	   this	   also	   trended	   toward	   a	   reduction.	   These	   data	   demonstrate	   that	  sequences	  upstream	  of	  the	  CSE	  core	  promoter	  are	  not	  likely	  to	  be	  involved	  in	  the	  ATF4-­‐induced	  increase	  in	  CSE	  transcription.	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Figure	  5.8:	  ATF4	  Overexpression	  does	  not	  Increase	  the	  Luciferase	  Activity	  of	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position	   +938,	   (relative	   to	   the	   transcriptional	   start	   site)	   within	   intron	   one.	  Intriguingly,	   although	   ATF4	   ChIP-­‐Seq	   data	   for	   the	   human	   genome	   has	   not	   been	  reported,	  sequences	  within	  the	  first	  intron	  of	  CSE	  are	  indicated	  as	  being	  potentially	  regulatory	  due	   to	  sequence	  and/or	  altered	  chromatin	  structure	  on	   the	  Ensemble	  genome-­‐browser;	  	  http://www.ensembl.org/Homo_sapiens/Gene/Regulation?db=otherfeatures;g=1491;r=1:70411218-­‐70440114.	  	  	  To	   assess	   whether	   these	   sequences	   were	   involved	   in	   mediating	   the	   ATF4	  transcriptional	  transactivation	  of	  CSE,	  a	  2.4Kb	  genomic	  fragment,	  comprising	  this	  (potentially	   regulatory)	   intronic	   sequence	   was	   cloned	   downstream	   of	   the	  polyadenylation	   site	   of	   the	   luciferase	   gene	   (Figure	   5.9A,	   fragment	   C),	  within	   the	  “basal”	   promoter	   construct	   -­‐764bp-­‐luc,	   to	   generate	   -­‐764bp-­‐luc-­‐IE.	   HEK293	   cells	  were	   transfected	   with	   the	   promoter	   constructs;	   -­‐764bp-­‐luc	   and	   -­‐764bp-­‐luc-­‐IE	   in	  the	  presence	  or	  absence	  of	  ATF4	  overexpression.	  Figure	  5.9A	  schematically	  depicts	  the	  constructs	  used	  in	  this	  experiment	  showing	  how	  they	  map	  to	  the	  human	  CSE	  gene.	  Figure	  5.9B	  shows	  that	  the	  -­‐764bp-­‐luc	  construct	  was	  significantly	  reduced	  in	  its	  luciferase	  activity	  upon	  ATF4	  overexpression	  consistent	  with	  previous	  findings.	  However,	   the	   -­‐764bp-­‐luc-­‐IE	   construct	  showed	  a	  dramatic	  and	  significant	   increase	  in	   its	   luciferase	   activity	   upon	   ATF4	   overexpression.	   Taken	   together,	   these	   data	  suggest	   that	   ATF4	   acts	   to	   increase	   CSE	   expression	   through	   a	   downstream	   cis-­‐acting	  intronic	  enhancer	  region	  present	  within	  intron	  one	  of	  the	  human	  CSE	  gene.	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Figure	  5.9:	  ATF4	  Regulates	  CSE	  Expression	  Through	  an	  Intronic	  Enhancer.	  A)	  A	  schematic	  illustration	  of	  the	  reporter	  constructs	  used	  in	  this	  experiment;	  -764bp-­‐
luc	  and	  -­‐764bp-­‐luc-­‐IE	  respectively,	  showing	  where	  they	  map	  to	  on	  the	  human	  CSE	  gene.	  B)	  Luciferase	  reporter	  assay	  data	  for	  empty	  vector	  PGL4.22,	  -764bp-­‐luc	  and	  -­‐
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5.2.5	  ATF4	  Binds	  Directly	  to	  the	  Intronic	  Enhancer	  Element	  in	  the	  CSE	  
Gene	  	  	  In	  order	  to	  determine	  whether	  the	  transcriptional	  up-­‐regulation	  of	  CSE	  mediated	  by	  ATF4	  results	  from	  the	  direct	  binding	  of	  ATF4	  to	  sequences	  within	  the	  identified	  intronic	   enhancer,	   ChIP	   analyses	   were	   performed.	   The	   ATF4-­‐binding	   region,	  previously	   identified	   by	   ChIP-­‐seq,	  within	   the	   first	   intron	   of	   the	  mouse	   CSE	   gene	  does	  not	  comprise	  a	  canonical	  ATF4	  binding	  motif.	  To	  determine	  the	  likely	  ATF4-­‐binding	   site	   within	   the	   human	   intronic	   sequence,	   a	   short	   60bp	   sequence	  comprising	  the	  previously	  identified	  mouse	  ATF4-­‐binding	  element	  was	  compared	  to	   the	   2.4Kb	   human	   intronic	   enhancer	   sequence	   using	   an	   online	   alignment	   tool	  (www.ebi.ac.uk/Tools/msa/clustalo/).	  This	  identified	  a	  short	  region	  of	  significant	  homology	  (12/14bp	  identity)	  that	  mapped	  between	  822bp	  to	  835bp	  of	  intron	  one	  (Figure	  5.10A).	  Primers	  were	  thus	  designed	  to	  span	  this	  region	  and	  test	  for	  ATF4	  binding	  using	  ChIP	  analyses	  (Primer	  site	  A).	   	  HEK293	  cells	  were	  transfected	  with	  the	   -­‐764bp-­‐luc-­‐IE	   construct,	  with	   or	  without	   co-­‐transfected	  ATF4-­‐overexpressing	  plasmids,	   and	   chromatin	   was	   prepared	   from	   this	   for	   analysis.	   Figure	   5.10B	  demonstrates	  specific	  binding	  of	  ATF4	  to	  this	  region	  of	  the	  human	  CSE	  intron	  upon	  ATF4	  overexpression.	  	  By	  contrast,	  a	  region	  within	  the	  endogenous	  human	  exon	  3	  (RLP30)	  as	  well	  as	  a	  region	  downstream	  of	  the	  previously-­‐identified	  ATF4	  binding	  site	  (Primer	  site	  B)	  served	  as	  negative	  controls	  and	  did	  not	  bind	  ATF4	  in	  control	  or	  ATF4-­‐overexpressing	  HEK	  cells	  (Figure	  5.10C).	  As	  expected,	  both	  genomic	  regions	  were	  shown	  to	  bind	  to	  histone	  H3.	  Specificity	  of	  binding	  was	  further	  demonstrated	  since	  neither	  region	  bound	  to	  normal	  rabbit	  IgG.	  (Figure	  5.10B).	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Figure	   5.10:	  ATF4	   Regulates	   CSE	   Transcription	   via	   Direct	   Binding	   to	   a	   cis-­‐	  
regulatory	   Intronic	   Site.	  A)	   A	   Schematic	   illustration	   showing	   the	   alignment	   of	  putative	  ATF4	  binding	  sites	  within	  intron	  1	  of	  mouse	  and	  human	  CSE	  gene	  loci.	  B,	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5.2.6	   Nox4	   Overexpression	   Induces	   eIF2α	   Phosphorylation	   Leading	   to	  
ATF4	  Protein	  Expression	  
	  Upstream	  of	  ATF4	  is	   the	  eIF2α	  signalling	  module.	   In	  conditions	  of	  cellular	  stress,	  eIF2α	  becomes	  phosphorylated	  at	  serine	  51,	  leading	  to	  increases	  in	  ATF4	  protein	  levels.	   To	   investigate	   whether	   the	   Nox4-­‐induced	   increase	   in	   ATF4	   protein	  expression	   was	   preceded	   by	   an	   increase	   in	   eIF2α	   phosphorylation,	   HUVECs-­‐	  overexpressing	   Nox4	  were	   harvested	   for	   immunoblotting	   and	   the	   levels	   of	   total	  and	   phosphorylated	   eIF2α	   were	   analysed.	   Figure	   5.11A	   and	   B	   show	   that	   eIF2α	  phosphorylation	   at	   serine	   51	   is	   significantly	   increased	   following	   Nox4	  overexpression,	  whilst	   total	  eIF2α	  expression	  remains	  unchanged	  (Figure	  5.11C).	  Figure	   5.11D	   shows	   that	   the	   Nox4-­‐induced	   increase	   in	   eIF2α	   phosphorylation	  correlates	  with	  a	  significant	  increase	  in	  ATF4	  protein	  expression.	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Figure	   5.11:	   Nox4	   Overexpression	   Increases	   eIF2α	   Phosphorylation	   and	  
ATF4	  Protein	  Expression.	  A,	  D)	  Representative	  immunoblots	  for	  phosphorylated	  eIF2α	  (Pi-­‐eIF2α	  (Ser51)),	  total	  eIF2α,	  ATF4	  and	  Nox4	  protein	  expression	  following	  24	  hours	  Nox4	  (Nox4	  O.E)	  or	  B	  Gal	  control	  overexpression	  (B	  Gal	  O.E)	  in	  HUVECs.	  Corresponding	  densitometric	  analyses	  for	  B)	  Pi-­‐eIF2α,	  C)	  total	  eIF2α	  and	  E)	  ATF4	  and	  total	  eIF2α	  protein	  expression	  is	  normalised	  to	  β	  Actin	  protein	  levels	  (C,	  E),	  Pi-­‐eIF2α	  expression	  normalised	  to	  total-­‐eIF2α	  levels	  (C).	  O.E	  =	  Overexpression.	  N=3,	  **=P<0.001.	  Statistical	  analysis	  performed	  using	  an	  unpaired	  Students	  t-­‐test.	  	  	  
5.2.7	  Silencing	  HRI	  Significantly	  Blunts	  the	  Nox4-­‐induced	  Increase	  in	  CSE	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these	  kinases;	  PERK	  and	  HRI,	  have	  been	  shown	  previously	   to	  be	  up-­‐regulated	   in	  response	   to	   ROS199,	   200.	   To	   assess	   the	   involvement	   of	   these	   two	   kinases	   in	   the	  Nox4-­‐induced	   up-­‐regulation	   in	   CSE	   transcription,	   they	   were	   systematically	  silenced	   in	   the	  presence	  of	  Nox4	  overexpression.	  Figure	  5.12A	  and	  C	   shows	   that	  both	  PERK	  and	  HRI	  were	  successfully	  silenced	  at	  the	  mRNA	  level.	  Interestingly,	  the	  silencing	   of	   PERK	   led	   to	   a	   further	   enhancement	   in	   CSE	   expression	   upon	   Nox4	  overexpression	  (Figure	  5.12	  B).	  The	  silencing	  of	  HRI,	  however,	  resulted	  in	  a	  highly	  significant	   decrease	   in	   CSE	  mRNA	   levels	   following	   Nox4	   overexpression	   (Figure	  5.12D).	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Figure	  5.12:	  Silencing	  HRI	  Decreases	  Nox4-­‐induced	  CSE	  mRNA	  Expression.	  A-­‐
D)	   An	   assessment	   of	   two	   redox-­‐regulated	   eIF2α	   kinases	   in	   the	   Nox4-­‐induced	  regulation	  of	  CSE	  expression	  in	  HUVECs.	  A,C)	  QPCR	  data	  showing	  the	  silencing	  of	  PERK	  and	  HRI	   respectively	   (48hours)	   in	   the	  presence	  or	   absence	  of	   either	  Nox4	  overexpression	  (Nox4	  O.E)	  or	  B	  Gal	  overexpression	  (B	  Gal	  O.E)	  for	  24	  hours.	  B,D)	  show	  the	  effect	  of	  PERK	  and	  HRI	  silencing	  on	   the	  Nox4-­‐induced	  up-­‐regulation	   in	  CSE	  expression	  respectively.	  All	  data	  normalised	  to	  β	  Actin	  mRNA	  expression.	  Red	  box	  shows	  that	  HRI	  silencing	  significantly	  blunts	  the	  Nox4-­‐induced	  increase	  in	  CSE	  expression.	  N=3.	   **	   =	   P<0.01,	   ***	   =	   P<0.01	   ****	   =	   P=<0.0001.	   Statistical	   analysis	  performed	  using	  one-­‐way	  ANOVA	  and	  a	  Tukeys	  post-­‐hoc	  test.	  	  	  
5.2.8	   siRNA-­‐mediated	   Ablation	   of	   HRI	   Reduces	   eIF2α	   Phosphorylation	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was	  silenced	  in	  the	  presence	  of	  Nox4	  overexpression	  in	  HUVECs.	  Immunoblotting	  of	   protein	   extracts	   harvested	   from	   these	   cells	   shows	   that	   Nox4	   overexpression	  significantly	  increases	  eIF2α	  phosphorylation	  and	  that	  this	  is	  significantly	  reduced	  when	  HRI	  is	  silenced	  (Figure	  5.13A	  and	  B).	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Figure	  5.14:	  siRNA-­‐mediated	  Silencing	  of	  HRI	  Decreases	  Nox4-­‐induced	  ATF4	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5.3	  Discussion	  
	  A	   role	   for	   Nox4	   in	   the	   regulation	   of	   CSE	   gene	   expression	   was	   previously	  characterised	   in	   chapters	   3	   and	   4.	   Here	   an	   investigation	   into	   the	   molecular	  mechanisms	  underscoring	  this	  observation	  was	  performed.	  	  	  
5.3.1	  ATF4	  Regulates	  CSE	  Expression	  in	  HUVECs	  	  Previous	  studies	  have	  shown	  that	  CSE	  transcription	  can	  be	  regulated	  by	  multiple	  transcription	  factors,	  some	  of	  which,	  such	  as	  Nrf2100	  and	  ATF4193,	  have	  also	  been	  shown	   to	   be	   associated	   with	   Nox4	   signalling	   responses158,	   197.	   Data	   shown	   here	  indicate	  that	  Nox4	  overexpression	  enhanced	  ATF4	  mRNA	  and	  protein	  expression,	  an	   effect	   that	   occurred	   in	   a	   time-­‐dependent	   manner	   at	   the	   mRNA	   level.	   This	  increase	  in	  ATF4	  expression	  correlated	  with	  an	  increase	  in	  CSE	  mRNA	  expression.	  Indeed,	  siRNA-­‐mediated	  silencing	  of	  ATF4,	  upon	  Nox4	  overexpression,	  resulted	  in	  a	   complete	   ablation	   in	   the	   Nox4-­‐induced	   increase	   in	   CSE	   transcriptional	  expression.	  Furthermore,	  ATF4	  overexpression	  was	  shown	  to	  enhance	  CSE	  mRNA	  levels	  significantly.	  Taken	  together,	  these	  data	  collectively	  demonstrate	  a	  definitive	  role	   for	  ATF4	   in	   the	  Nox4-­‐induced	   regulation	   of	   CSE	   expression	   in	  HUVECs,	   and	  are	   consistent	   with	   previous	   reports	   showing	   that	   ATF4	   can	   regulate	   CSE	  expression.	   Thus	   two	   activators	   of	   ATF4,	   tunicamycin	   and	   thapsigargin,	   were	  shown	   to	   increase	  CSE	  protein	   expression	   in	  WT	  MEFs192.	   Consistent	  with	   these	  findings,	  CSE	  mRNA	  levels	  were	  shown	  to	  increase	  in	  response	  to	  tunicamycin,	  but	  failed	   to	   do	   so	   in	   an	   ATF4-­‐null	   background193.	   Furthermore,	   Lee	   et	   al	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demonstrated	   using	   a	   micro-­‐array	   screen	   that	   cysteine	   deprivation,	   a	   known	  activator	   of	   the	   eIF2α/ATF4	   cascade,	   increased	   the	   expression	   of	   a	   number	   of	  genes	  involved	  in	  sulphur	  metabolism	  and	  oxidative	  stress	  (such	  as	  CSE)	  in	  human	  hepatoma	  cells201.	  	  	  In	  line	  with	  a	  role	  for	  ATF4	  in	  the	  regulation	  of	  CSE	  expression,	  luciferase	  reporter	  assays	   performed	   here	   demonstrated	   that	   ATF4	   overexpression	   enhanced	   the	  luciferase	  activity	  of	  a	  CSE	  reporter	  construct	  containing	  a	  2.4Kb	  intronic	  region	  of	  the	   CSE	   gene.	   This	   region	   contains	   sequences	   that	   are	   indicated	   as	   being	  potentially	  regulatory	  due	  to	  sequence	  and/or	  altered	  chromatin	  structure	  on	  the	  Ensemble	   genome	   browser.	   Consistent	   with	   this,	   data	   shown	   here	   demonstrate	  that	   this	   intronic	   region	   confers	   enhancer	   activity	   in	   response	   to	   ATF4	  overexpression.	  Moreover,	  previous	  reports	  using	  ChiP	  Seq	  analyses	  revealed	  that	  ATF4	  could	  directly	  bind	  to	  a	  homologous	  region	  within	  the	  mouse	  CSE	  gene,	  but	  this	   was	   not	   functionally	   validated193.	   Consistent	   with	   this,	   ChIP	   analyses	  performed	   here	   revealed	   that	   ATF4	   could	   bind	   directly	   to	   the	   human	   intronic	  enhancer	  (IE)	  of	   the	  CSE	  gene,	   therefore	  corroborating	  these	  previous	  reports193.	  Taken	  together,	  the	  functional	  validation	  of	  the	  IE	  using	  luciferase	  reporter	  assays,	  as	  well	  as	  ChIP	  data	  showing	  the	  direct	  binding	  of	  ATF4	  to	  this	  region,	  indicate	  that	  CSE	  is	  a	  direct	  transcriptional	  target	  of	  ATF4.	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5.3.2	   EIF2α	   Phosphorylation	   is	   Increased	   in	   Response	   to	   Nox4	  
Overexpression	  	  ATF4	  is	  a	  basic	  lucine-­‐zipper	  transcription	  factor	  whose	  expression	  is	  regulated	  via	  the	   ISR191.	   It	   has	   long	   been	   known	   that	   cellular	   stresses,	   such	   as	   the	   unfolded	  protein	  response	  (UPR),	  attenuate	  global	  translation	  but	  permit	  ATF4	  translation.	  The	  control	  of	  this	  process	  is	  governed	  by	  the	  phosphorylation	  of	  eIF2α	  at	  serine	  51(Figure	  5.15)202.	  	  
	  
	  
Figure	   5.15:	   Stress-­‐induced	   eIF2α	   Phosphorylation.	   	   A	   schematic	   illustration	  depicting	  eIF2α	   inhibition	  upon	  phosphorylation.	   In	  unstressed	  conditions	  eIF2α	  becomes	   GTP-­‐bound,	   an	   effect	   mediated	   by	   the	   guanine	   nucleotide	   exchange	  factor,	  eIF2B.	   In	  this	  state,	  global	  translation	  is	  permitted	  but	  ATF4	  translation	  is	  inhibited.	   Upon	   stress	   induction,	   eIF2α	   becomes	   phosphorylated	   at	   serine	   51	  leading	   to	   eIF2B	   sequestering	   and	   subsequent	   loss	   in	   its	   GTP	   exchange	   activity.	  EIF2α	   therefore	   remains	   GDP-­‐bound	   and	   inactive,	   attenuating	   global	   translation	  but	  permitting	  ATF4	  translation.	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EIF2α	   phosphorylation	   at	   serine	   51	   results	   in	   the	   reduced	   assembly	   rate	   of	   the	  cell’s	   translational	   machinery,	   therefore	   decreasing	   global	   protein	   synthesis.	   By	  contrast,	  ATF4	  translation	  is	  enhanced	  under	  these	  conditions.	  ATF4	  mRNA	  has	  2	  untranslated	   open	   reading	   frames	   (uORFs).	   The	   second	   uORF	   overlaps	  with	   the	  open	  reading	  frame	  (ORF)	  responsible	  for	  ATF4	  protein	  coding.	  During	  stress,	  a	  lag	  in	   translational	   reinitiation	   at	   uORF2	   results	   in	   its	   bypass	   and	   subsequent	  translational	   reinitiation	  at	   the	  ORF	  encoding	   full-­‐length	  ATF4	  protein203	   (Figure	  5.16).	   Here	   it	   was	   shown	   that	   Nox4	   overexpression	   increased	   ATF4	   protein	  expression	   and	   that	   this	   subsequently	   correlated	   with	   a	   significant	   increase	   in	  eIF2α	   phosphorylation	   at	   serine	   51.	   This	   is	   consistent	   with	   the	   classical	  mechanism	  of	  ATF4	  activation	  discussed	  above.	  It	  should	  also	  be	  noted	  that	  ATF4	  mRNA	   expression	   also	   increased	   with	   Nox4	   overexpression	   suggesting	   that	   in	  addition	  to	   the	  classic	  mechanism	  of	  ATF4	  activation,	  other	  modes	  of	  action	  may	  also	  facilitate	  this	  process,	  such	  as	  mRNA	  stabilisation.	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Figure	   5.16:	   	   The	   Mechanism	   of	   ATF4	   Translation.	   	   A	   schematic	   illustration	  depicting	   ATF4	   translation.	  A)	   ATF4	  mRNA	   structure	   containing	   2	   untranslated	  open	   reading	   frames	   (uORF).	   B)	   In	   unstressed	   conditions	   eIF2α-­‐GTP	   bound	  associates	   with	   the	   40S	   and	   60S	   ribosomal	   subunits	   and	   translates	   a	   short	  polypeptide	  at	  uORF1.	  This	   then	  dissociates	  and	  reinitiates	   translation	  at	  uORF2,	  translation	  proceeds	  past	   the	  ORF	   for	  ATF4	   and	   is	   then	  prematurely	   terminated	  preventing	   ATF4	   protein	   expression.	   C)	   Upon	   stress	   induction,	   eIF2α	  phosphorylation	  at	   serine	  51	   leads	   to	  a	   lag	   in	   translational	   reinitiation	  at	  uORF2	  resulting	   in	   it	  being	  bypassed	  and	   initiation	   subsequently	   reinitiating	  at	   the	  ORF	  for	  ATF4,	  thus	  permitting	  ATF4	  translation	  and	  protein	  expression203.	  	  	  
5.3.3	   HRI	   Mediates	   eIF2α	   Phosphorylation,	   ATF4	   Activation	   and	   CSE	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stress	  signals.	  	  The	  four	  family	  members	  include;	  PERK,	  PKR,	  GCN2	  and	  HRI190.	  Of	  these,	   the	   activities	   of	   PERK	   and	   HRI	   have	   been	   shown	   to	   be	   up-­‐regulated	   in	  response	  to	  ROS199,	  200.	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5.3.4	  HRI	  Activation	  and	  Regulation	  	  	  	  Classical	  HRI	   activation	   occurs	   under	   conditions	   of	   haem	  depletion	   in	   red	   blood	  cells	   where	   it	   ensures	   that	   globin	   mRNA	   translation	   is	   only	   permissible	   when	  sufficient	  haem	  is	  available	  to	  be	  incorporated	  into	  the	  final	  haemoglobin	  protein	  product200.	   The	   HRI	   protein	   is	   composed	   of	   5	   domains;	   an	   N-­‐	   and	   C-­‐terminal	  domain,	   2	   kinase	   domains	   and	   a	   central	   kinase	   insert	   domain.	   Consistent	   with	  other	   eIF2α	   kinase	   family	   members,	   the	   C-­‐terminal	   kinase	   domain	   is	   highly	  conserved	   and	   is	   responsible	   for	   the	   phosphorylation	   of	   serine	   51	   on	   eIF2α.	  However	   the	   N-­‐terminal	   domain	   is	   distinctly	   different	   between	   eIF2α	   kinase	  family	  members	   and	   represents	   the	   regulatory	   region.	   In	   the	   case	  of	  HRI,	   the	  N-­‐terminus	  contains	  a	  stable	  haem-­‐binding	  site	  as	  well	  as	  a	  reversible	  haem-­‐binding	  pocket	  located	  in	  the	  kinase	  insert	  domain,	  which	  is	  responsible	  for	  governing	  HRI	  activation	  and	  inhibition190.	  	  	  A	   number	   of	   studies	   have	   been	   devoted	   to	   elucidating	   the	   mechanisms	   that	  underpin	   HRI	   activation.	   As	   a	   result,	   Chen	   et	   al	   have	   subsequently	   proposed	   a	  three-­‐stage	  activation	  scheme	  to	  explain	   this	  process.	   	  Stage	  one	   involves	  newly-­‐	  synthesised	  HRI	  monomers	  rapidly	  associating	  to	  form	  a	  dimer	  that	  is	  bound	  at	  its	  N-­‐termini	  by	  stable	  haem.	  This	  dimer	  then	  autophosphorylates	   to	   from	  a	  ProHRI	  complex.	  ProHRI	  subsequently	  enters	  stage	  2	  of	  its	  activation	  that	  involves	  further	  autophosphorylation	  events	  and	  the	  acquisition	  of	  its	  ability	  to	  reversibly	  bind	  to	  haem	   in	   its	   kinase	   insert	   domain.	   In	   the	   final	   stage,	   complete	   HRI	   activation	   is	  governed	   by	   the	   presence	   of	   haem.	  When	   haem	   is	   in	   abundance,	   it	   binds	   to	   the	  haem-­‐binding	   pockets	   present	   in	   the	   kinase	   insert	   domain	   resulting	   in	   its	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inactivation.	   By	   contrast,	   under	   conditions	  where	   haem	   is	   limiting,	   haem	   is	   lost	  from	  its	  binding	  pocket	  and	  a	  conformational	  change	  in	  the	  protein	  subsequently	  elicits	   further	   autophosphorylation	   events	   leading	   to	   the	   phosphorylation	   of	  Threonine	  485	  in	  the	  activation	  loop	  of	  the	  C-­‐terminal	  kinase	  domain.	  This	  results	  in	   full	   kinase	   activity,	   subsequent	   phosphorylation	   of	   eIF2α	   and	   a	   halt	   in	   global	  translation.	  Fully	  active	  HRI	  is	  then	  thought	  to	  be	  ‘switched	  off’	  via	  its	  degradation	  in	   the	   proteasome	   204,	   205.	   	   Although	   many	   studies	   have	   focused	   on	   the	   haem-­‐induced	   regulation	   of	   HRI,	   it	   has	   also	   become	   apparent	   that	   other	   stressors	   can	  permit	   its	   activation	   including	   oxidative	   stress	   200,	   204.	   These	   observations	   are	  interesting	   when	   considered	   in	   light	   of	   data	   presented	   here	   demonstrating	   that	  Nox4	  regulates	  eIF2α	  phosphorylation	  through	  HRI.	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activation	  and	  eIF2α	  phosphorylation200.	   	   Furthermore,	   arsenite	  has	  been	  shown	  to	   promote	   O2-­‐	   and	   H2O2	   production,	   as	   well	   as	   NADPH	   oxidase	   activation	   in	  endothelial	   cells	   in	   vitro206,	   207.	   This	   collectively	   suggests	   a	   role	   for	   ROS	   in	   the	  oxidative	  regulation	  of	  HRI.	  Another	  explanation	   for	   the	  Nox4-­‐induced	  activation	  of	  HRI	  observed	  in	  this	  study	  comes	  from	  reports	  suggesting	  that	  H2O2	  is	  involved	  in	  the	  non-­‐enzymatic	  degradation	  of	  haem,	  where	  it	  is	  thought	  to	  split	  haem	  rings	  chemically208,	  209.	  It	  is	  therefore	  tempting	  to	  speculate	  that	  Nox4-­‐derived	  H2O2	  may	  enhance	  the	  degradation	  and	  hence	  the	  depletion	  of	  haem,	  subsequently	  leading	  to	  HRI	  activation	  via	  the	  classical	  mechanism	  outlined	  above.	  	  	  To	   conclude	   endothelial	   Nox4	   regulates	   CSE	   expression	   through	   the	  HRI/eIF2α/ATF4	  signalling	  module.	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6.1	  Introduction	  
	  The	  data	   collected	   together	   in	   this	   thesis	  begin	   to	  define	   a	  physiological	   role	   for	  endothelial	   Nox4	   in	   the	   regulation	   of	   CSE	   expression.	   It	   was	   demonstrated	   that	  Nox4	   induces	   the	   transcriptional	   transactivation	  of	  CSE	   through	   the	  activation	  of	  the	  HRI/eIF2α/ATF4	  signalling	  module	  in	  HUVECs	  (Figure	  6.1).	  Furthermore,	  the	  Nox4-­‐induced	   regulation	   of	   CSE	   was	   shown	   to	   function	   in	   the	   regulation	   of	  vascular	  contractility	  in	  isolated	  aortae.	  The	  broader	  implications	  of	  these	  findings	  will	  now	  be	  discussed.	  
	  
6.2	   Endothelial	   Nox4	   as	   a	   Source	   of	   ROS	   in	   the	   Regulation	   of	  
Gasotransmitter	  Production.	  	  	  Endothelial	  dysfunction	  has	   repeatedly	  been	  recognised	  as	  a	   common	   factor	   in	  a	  number	   of	   CVD	   states	   such	   as	   hypertension3.	   Indeed,	   the	   endothelium	   has	  well-­‐documented,	   homeostatic	   roles	   in	   the	   control	   of	   blood	   flow	  and	   tissue	  perfusion	  through	   its	  modulation	  of	  vascular	   tone11,	  210.	  This	  process	   is	  highly	  complex	  and	  involves	   the	   interaction	   of	   many	   extracellular	   and	   intracellular	   vasoactive	  mediators	   that	   collectively	   regulate	   vasodilation	   and	   vasoconstriction.	  Perturbations	   in	   the	   levels	   or	   activities	   of	   these	   mediators	   can	   be	   a	   cause	   or	  consequence	   of	   endothelial	   dysfunction	   that	   can	   subsequently	   lead	   to	   impaired	  tonal	  regulation11.	  Thus,	  an	  impetus	  toward	  gaining	  a	  further	  understanding	  of	  the	  molecular	  mechanisms	  that	  underscore	  the	  endothelium-­‐dependent	  regulation	  of	  vascular	  tone	  has	  been	  established.	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Much	   research	   attention	   has	   focused	   on	   the	   importance	   of	   gasotransmitter	  signalling	   in	   the	   regulation	   of	   vascular	   tone16,	   20,	   54,	   79.	   Unlike	   peptide	   signalling	  molecules,	   gasotransmitters	   are	   highly	   reactive	   gases	   (at	   least	   in	   the	   case	   of	  NO	  and	   H2S)	   that	   are	   not	   readily	   stored	   in	   vesicles.	   Accordingly,	   they	   must	   be	  synthesised	  as	  needed,	  close	  to	  their	  specific	  sites	  of	  action49.	  Consequently,	  both	  the	   expression	   and	   the	   activity	   of	   their	   biosynthetic	   enzymes	   must	   be	   tightly	  controlled.	   Within	   the	   endothelium,	   the	   relevant	   enzymes	   involved	   in	   the	  generation	   of	   these	   gases	   are	   eNOS	   (for	   NO)211,	   HO-­‐1	   (for	   CO)212	   and	   CSE	   (for	  H2S)213.	  The	  rapid	  turnover	  of	  gaseous	  signalling	  molecules	  presents	  a	  number	  of	  difficulties	   in	   the	   development	   of	   therapeutics.	   Firstly,	   gaseous	   molecules	   are	  volatile	   and	   readily	   reactive,	   reducing	   their	   pharmacokinetic	   properties.	   To	  overcome	   this,	   donor	   compounds	   have	   been	   developed	   which	   release	   their	  respective	   gases	   slowly.	   Unfortunately,	   the	   ubiquitous	   release	   of	   these	   gases	  makes	  them	  difficult	  to	  target	  to	  specific	  sites	  of	  action.	  As	  such,	  novel	  approaches	  involving	   the	  manipulation	   of	   the	   endogenous	   signalling	   pathways	   that	   regulate	  the	  expression	  and/or	  activity	  of	  gasotransmitter-­‐producing	  enzymes	  may	  prove	  fruitful.	  For	  this	  to	  become	  a	  viable	  therapeutic	  option,	  a	  better	  understanding	  of	  the	  endogenous	  regulation	  of	  gasotransmitter	  signalling	  is	  first	  required.	  	  	  It	   has	  become	  apparent	   that	  ROS	  may	  play	   a	   significant	   role	   in	   the	   regulation	  of	  gasotransmitter	  production	  and	  it	  would	  appear	  that	  Nox4	  is	  an	  important	  source	  of	  ROS	  in	  this	  process.	  Indeed,	  Nox4-­‐null	  mice	  display	  decreased	  eNOS	  expression	  and	  a	  subsequent	  reduction	  in	  NO	  formation151	  and	  possibly	  consistent	  with	  this,	  H2O2	  can	  promote	  vasodilation	  of	  rabbit	  aortae	  in	  an	  eNOS-­‐dependent	  manner153.	  Furthermore,	  Nox4	  has	  been	  shown	  to	  regulate	  Nrf2	  and	  induce	  HO-­‐1	  expression	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in	  cardiac-­‐specific	  Nox4-­‐overexpressing	  hearts158.	  Moreover,	  in	  vitro	  simulation	  of	  hemodynamic	   stress,	   using	   phenylephrine-­‐stimulated	   neonatal	   rat	   ventricular	  myocytes,	   resulted	   in	   an	   increase	   in	   Nox4	   and	   Nrf2	   protein	   expression,	   and	   a	  subsequent	  up-­‐regulation	  in	  HO-­‐1	  mRNA	  expression.	  This	  effect	  was	  ablated	  when	  either	  Nox4	   or	  Nrf2	  were	   silenced214.	   Consistent	  with	   these	   observations,	   global	  Nox4-­‐null	  mice	  display	  reduced	  HO-­‐1	  expression	  in	  isolated	  lung	  endothelial	  cells,	  leading	   to	   enhanced	   apoptosis.	   This	   has	   been	   attributed	   to	   perturbed	   CO	  production151.	   Interestingly,	   data	   compiled	   in	   this	   thesis	   demonstrate	   a	   further	  physiological	  role	  for	  endothelial	  Nox4	  in	  the	  transcriptional	  regulation	  of	  CSE,	  an	  endogenous	   generator	   of	   the	   third	   gasotransmitter,	   H2S.	   Nox4	   overexpression,	  which	  has	  been	  shown	  previously	  to	  generate	  significantly-­‐enhanced	  levels	  of	  H2O2	  in	   endothelial	   cells47,	   as	   well	   as	   Nox4	   silencing	   using	   siRNA,	   were	   shown	   to	  regulate	  both	  the	  mRNA	  and	  protein	  expression	  of	  CSE	  in	  HUVECs.	  	  	  The	  Nox4-­‐induced	  increase	  in	  CSE	  expression	  was	  found	  to	  correlate	  with	  a	  small	  increase	   in	  H2S	   levels.	   Indeed,	   these	   data	   are	   further	   supported	  by	   the	   apparent	  lack	  of	  canonical	  transsulfuration	  activity	  in	  HUVECs,	  which	  suggests	  that	  CSE	  may	  be	   functioning	   instead	   in	   H2S	   biosynthesis.	   These	   findings	   support	   previous	  reports	  that	  suggest	  that	  H2O2	  regulates	  CSE	  gene	  expression99	  and	  activity101,	  and	  demonstrate	  that	  Nox4	  acts	  a	  physiological	  cellular	  source	  of	  ROS	  in	  this	  process.	  Taken	   together	   with	   previously	   published	   data	   surrounding	   a	   role	   for	   Nox4	   in	  gasotransmitter	   signalling,	   it	   appears	   that	   Nox4	   may	   be	   a	   master	   regulator	   of	  gasotransmitter	  production	  within	  the	  endothelium.	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6.3	  Nox4,	  CSE	  and	  Vascular	  Tone	  	  ROS	  are	  emerging	  as	  novel	  signalling	  molecules	  involved	  in	  the	  control	  of	  vascular	  tone	  and	  it	  is	  thought	  that	  vasodilation	  and	  constriction	  are	  differentially	  regulated	  by	  both	  the	  type	  and	  source	  of	  ROS	  involved.	  Indeed,	  H2O2	  is	  considered	  to	  play	  a	  physiological	  role	  as	  an	  EDHF19	  45	  and	  can	  thus	  induce	  vasorelaxation.	  By	  contrast,	  O2-­‐	   is	   involved	   in	   vasoconstriction176,	   where	   it	   can	   deplete	   NO	   bioavailability	  through	   the	   formation	   of	   peroxynitrite177.	   Accordingly,	   Nox4	   has	   been	   shown	   to	  have	  a	  number	  of	  vaso-­‐protective	  effects,	  underscored	  by	  its	  ability	  to	  synthesise	  H2O247,	  151,	  215,	  216.	  Perhaps	  consistent	  with	  this,	  endothelial	  Nox4	  has	  been	  shown	  to	  participate	   in	   the	   regulation	   of	   vascular	   tone,	   in	   a	   mouse	   model	   in	   which	   its	  overexpression	   improved	   endothelial	   function,	   vasodilation	   and	   lowered	   blood	  pressure	   compared	   to	   WT	   littermate	   controls47.	   By	   contrast,	   Nox4	   deletion	  resulted	   in	   reduced	   endothelium-­‐dependent	   vasodilation	   following	   in	   vivo	   AngII	  infusion151.	   These	   effects	   differ	   markedly	   from	   the	   endothelial	   dysfunction	  associated	  with	  the	  expression	  and	  activity	  of	  vascular	  Nox1	  and	  Nox2138,	  217.	  	  The	  Nox4-­‐induced	   regulation	   of	   gasotransmitter	   production	  has	   previously	   been	  associated	  with	  preserved	  endothelial	  and	  vascular	  function151.	  Data	  shown	  in	  this	  thesis	   support	   these	   observations	   by	   demonstrating	   that	   eNox4	   Tg	  mice	   have	   a	  vascular	   hypo-­‐contractile	   phenotype	   when	   constricted	   with	   PE,	   a	   finding	  consistent	  with	  data	  obtained	  by	  Craige	  et	  al	  who	  observed	  the	  same	  phenotype	  in	  VE-­‐cadherin-­‐mediated	   endothelial-­‐specific	   Nox4-­‐overexpressing	   mice150.	  Moreover,	   CSE	  mRNA	   and	  protein	   expression	  were	   shown	   to	   be	   up-­‐regulated	   in	  endothelial	   cells,	   isolated	   from	   the	   hearts	   eNox4	   Tg	   mice.	   This	   is	   potentially	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responsible	   for	   the	   hypo-­‐contractile	   phenotype,	   since	   this	   phenotype	   was	  completely	   ablated	   when	   vessels	   were	   incubated	   with	   the	   CSE	   inhibitor,	   PPG.	  Interestingly,	   it	   would	   appear	   that	   this	   Nox4-­‐induced	   effect	   occurred	   due	   to	   a	  chronic	   change	   in	   CSE	   gene	   expression,	   rather	   than	   the	   acute	   action	   of	   Nox4	  signalling,	   since	   short-­‐term	   administration	   of	   PEG-­‐catalase	   failed	   to	   ablate	   the	  hypo-­‐contractile	  phenotype.	  	  	  A	  number	  of	  studies	  have	  characterised	  CSE	  as	  a	  major	  vascular	  generator	  of	  H2S	  that	  regulates	  vascular	  tone75,	  79,	  83.	  Exogenous	  application	  of	  H2S	  to	  vessels	  using	  NaS,	   NaHS	   and	   the	   slow-­‐releasing	   H2S	   donor,	   GYY4137 have	   previously	   been	  shown	   to	   induce	   vasorelaxation	   in	   ex	   vivo,	   wire	   myography	   models65	   73,	   75-­‐77.	  Moreover,	   in	   vivo	   data	   obtained	   using	   PPG179,	   as	   well	   as	   in	   CSE-­‐/-­‐	   mice79,	   have	  highlighted	  a	   crucial	   role	   for	  CSE	   in	   regulating	  both	  basal	  and	   inducible	  vascular	  tone.	   Data	   shown	   in	   this	   thesis	   attribute	   the	   pro-­‐relaxatory,	   hypo-­‐contractile	  phenotype	   to	   the	   endogenous	   up-­‐regulation	   of	   CSE	   induced	   by	   Nox4	  overexpression.	  Although	  H2S	   levels	  were	  not	   successfully	  measured	   in	  vivo,	   it	   is	  tempting	  to	  hypothesise,	  based	  on	  the	  wealth	  of	  data	  surrounding	  the	  vasodilatory	  actions	   of	   H2S	   and	   CSE,	   that	   H2S	   and/or	   an	   associated	   derivative	   (such	   as	  polysulphides)	  are	  involved	  in	  this	  process.	  	  	  
6.4	  Nox4,	  ATF4	  and	  the	  ISR.	  	  Nox4	  is	  a	  stress-­‐inducible	  protein	  whose	  activity	  is	  predominantly	  regulated	  at	  the	  gene	   expression	   level133.	  Many	   studies	   have	   demonstrated	   that	  Nox4	   expression	  
	   188	  
can	  be	  induced	  by	  a	  diverse	  array	  of	  cellular	  stresses	  including	  nutritional	  stress,	  pressure	   overload-­‐induced	   cardiac	   hypertrophy	   and	   hypoxia216,	  218,	  219.	   The	  well-­‐defined	  involvement	  of	  Nox4	  in	  stress-­‐associated	  responses	  is	  further	  highlighted	  by	  its	  signalling	  activity	  in	  the	  regulation	  of	  stress-­‐associated	  transcription	  factors.	  In	   cardiac-­‐specific	  Nox4-­‐overexpressing	   transgenic	  hearts,	  Nox4	  has	  been	  shown	  to	  regulate	  Nrf2	  activity158.	  Furthermore,	  this	  regulation	  is	  lost	  in	  the	  endothelium	  of	  Nox4-­‐null	  mice151.	  In	  addition	  to	  Nrf2,	  Nox4	  also	  regulates	  the	  activity	  of	  the	  ISR	  transcription	   factor,	  ATF4	   in	  cardiomyocytes197.	  Previous	  reports	  have	  suggested	  that	   CSE	   is	   a	   transcriptional	   target	   of	   both	   of	   these	   transcription	   factors100,	   193.	  Here,	  the	  Nox4-­‐induced	  regulation	  of	  CSE	  and	  its	  potential	  dependence	  upon	  either	  Nrf2	   or	   ATF4	   were	   interrogated	   in	   HUVECs	   and	   it	   was	   shown	   that	   the	   Nox4-­‐induced	  expression	  of	  CSE	  occurred	  in	  an	  ATF4-­‐	  dependent	  manner.	  Indeed,	  ATF4	  silencing	  upon	  Nox4	  overexpression	  resulted	   in	  a	  complete	  ablation	  of	   the	  Nox4-­‐induced	  increase	  in	  CSE	  transcriptional	  expression,	  and	  this	  was	  reversed	  by	  ATF4	  overexpression.	  Furthermore,	  a	  2.4Kb	  region	  of	  human	  CSE	  intron	  1	  was	  shown	  to	  function	   as	   an	   enhancer	   in	   response	   to	  ATF4	   overexpression,	   and	  ChIP	   analyses	  revealed	   that	  ATF4	   could	  bind	  directly	   to	   this	   region.	  Taken	   together	   these	  data	  indicate	   that	   Nox4	   regulates	   CSE	   expression	   through	   ATF4,	   which	   functions	   to	  increase	   CSE	   expression	   by	   binding	   (and	   functionally	   activating)	   an	   intronic	  enhancer	  element	  in	  intron	  1	  of	  the	  CSE	  gene.	  	  The	   ATF4	   arm	   of	   the	   ISR	   is	  mediated	   by	   the	   activation	   of	   four	   up-­‐stream	   eIF2α	  kinases;	   PERK,	   PKR,	   GCN2	   and	   HRI190.	   Previous	   studies	   in	   cardiomyocytes	   have	  shown	   that	   Nox4	   is	   induced	   in	   response	   to	   glucose	   deprivation	   and	   acts	   to	  promote	   autophagy	   through	   the	   activation	   of	   PERK.	   The	   oxidant	   target	   in	   this	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study	  was	  suggested	  to	  be	  PHD4,	  an	  ER	  resident	  PHD	  isoform197.	  Interestingly,	  the	  action	  of	  Nox4	  described	  here	  in	  endothelial	  cells	  was	  found	  not	  to	  be	  dependent	  on	  PERK	  but	  was	  significantly	  ablated	  by	  siRNA-­‐mediated	  silencing	  of	   the	  haem-­‐	  dependent	  kinase,	  HRI.	  Indeed,	  Nox4	  was	  shown	  to	  promote	  the	  activation	  of	  HRI	  leading	   to	   an	   increase	   in	   eIF2α	   phosphorylation,	   ATF4	   protein	   expression	   and	  subsequent	   CSE	   transcription.	   It	   is	   apparent	   from	   these	   studies	   that	   Nox4	   can	  differentially	   regulate	   ATF4	   activation	   through	   either	   PHD4	   and	   PERK	   or	   HRI.	  These	   discrepancies	   in	   Nox4-­‐medicated	   ATF4	   activation	   may	   arise	   from	  differences	   in	   the	   cell	   type	   used.	   Nox4	   is	   found	   in	   the	   ER	   of	   cardiomyocytes197,	  consistent	   with	   its	   activation	   of	   ER-­‐localised	   PHD4	   and	   PERK.	   However,	   in	  endothelial	  cells	  Nox4	  is	  present	  in	  a	  number	  of	  locations	  including	  the	  ER	  and	  the	  nucleus129,	  132.	  It	  is	  thought	  that	  the	  subcellular	  localisation	  of	  Nox4	  may	  influence	  its	   signalling	   potential	   and	   therefore	   lead	   to	   differential	   activation	   of	   specific	  cellular	   signalling	   pathways131.	   Accordingly,	   Nox4	   may	   induce	   ATF4	   activation	  through	  HRI	  in	  the	  endothelium,	  and	  through	  PHD4	  and	  PERK	  in	  cardiomyocytes.	  	  Alternatively,	   the	  relative	   levels	  of	  PHD4	   in	  cardiomyocytes	  and	  endothelial	   cells	  may	   be	   a	   factor	   in	   determining	   the	   target	   of	   Nox4	   in	   each	   cell	   type.	   Thus,	   if	  cardiomyocytes	   possess	   more	   PHD4	   than	   endothelial	   cells,	   this	   may	   lead	   to	  preferential	  Nox4-­‐induced	  PHD4/PERK	  activation	  in	  cardiomyocytes.	  	  The	   redox-­‐dependent	  mechanisms	   that	  underlie	  HRI	  activation	  are	  not	   currently	  understood,	   although	   previous	   studies	   in	   both	   erythroid	   cells	   and	   MEFs	   have	  reported	   its	   activation	   via	   “oxidative	   stress”	   induced	   by	   exposure	   to	   the	   heavy	  metal,	   arsenite200,	  207,	  220.	   Although	   a	   redox-­‐driven	  mechanism	   for	   HRI	   activation	  was	   not	   investigated	   here,	   some	   hypothetical	   explanations	   can	   be	   drawn.	   For	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example,	   it	   is	   possible	   that	   Nox4-­‐derived	  H2O2	   is	   involved	   in	   the	   non-­‐enzymatic	  degradation	   of	   haem208,	   209	   leading	   to	   haem	   depletion	   and	   subsequent	   HRI	  activation.	   Alternatively,	   the	   oxidation	   status	   of	   haem	   iron	   may	   play	   a	   role.	   In	  oxidising	  conditions,	  such	  as	  those	  induced	  by	  Nox4	  activation,	  ferrous	  iron	  (Fe2+)	  is	   oxidised	   to	   ferric	   iron	   (Fe3+)	  which	  may	   subsequently	   lead	   to	   changes	   in	   the	  structure	  of	  haem,	  preventing	   it	   from	  allosterically	   inhibiting	  HRI.	   In	  addition,	  as	  mentioned	  above,	  HO-­‐1	  is	  a	  well-­‐established	  transcriptional	  target	  of	  Nrf2	  that	  has	  previously	  been	  shown	  to	  become	  activated	  in	  response	  to	  Nox4214.	  Indeed,	  Nox4	  may	  promote	  HO-­‐1	  expression	  and	  thus	  the	  enzymatic	  degradation	  of	  haem,	  which	  could	  potentially	  lead	  to	  the	  indirect	  activation	  of	  HRI.	  However,	  data	  shown	  here	  suggest	  that	  Nrf2	  is	  not	  involved,	  as	  its	  silencing	  had	  no	  effect	  on	  the	  Nox4-­‐induced	  increase	   in	   CSE	   expression.	   Finally,	   one	   cannot	   rule	   out	   the	   possibility	   that	   HRI	  contains	   redox-­‐sensitive	   cysteine	   residues	   that	   can	  be	  modified	  by	  Nox4-­‐derived	  ROS	  in	  order	  to	  elicit	  a	  functional	  change	  in	  the	  protein.	  	  The	  silencing	  of	  HRI	  in	  the	  presence	  of	  Nox4	  overexpression	  in	  HUVECs	  led	  to	  only	  a	   partial	   reduction	   in	   the	   activity	   of	   the	   eIF2α/ATF4/CSE	   pathway.	   This	   might	  suggest	  that	  other	  kinases	  might	  also	  be	  able	  to	  regulate	  the	  pathway	  in	  response	  to	  Nox4	  activation.	  Indeed,	  PKR	  and	  GCN2	  represent	  two	  eIF2α	  kinases	  that	  were	  not	  tested	  in	  this	  study.	  It	  is	  possible	  that	  these	  kinases	  may	  also	  become	  active	  in	  response	   to	   Nox4	   overexpression,	   and	   could	   therefore	   account	   for	   the	   residual	  activation	   of	   the	   eIF2α/ATF4/CSE	   pathway	   when	   HRI	   is	   silenced.	   In	   order	   to	  investigate	   this,	   experiments	   involving	   the	   silencing	   of	   these	   two	   kinases	   using	  siRNA	   followed	   by	   Nox4	   overexpression	   would	   need	   to	   be	   performed.	   Another	  possibility	   is	   that	   HRI	   was	   not	   completely	   silenced	   at	   the	   protein	   level,	   and	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although	   the	   mRNA	   of	   HRI	   was	   highly	   reduced	   upon	   siRNA	   treatment,	   its	  corresponding	  protein	  expression	  may	  not	  have	  been	  completely	  ablated.	  	  	  Taken	   together,	   these	   data	   define	   a	   role	   for	   Nox4	   in	   the	   activation	   of	   the	  HRI/eIF2α/ATF4	  stress-­‐induced	  signalling	  module	   in	  endothelial	  cells.	  Figure	  6.1	  depicts	  a	  schematic	  illustration	  of	  the	  proposed	  mechanism	  underlying	  the	  Nox4-­‐induced	   regulation	   of	   CSE	   through	   a	   mechanism	   that	   potentially	   involves	   haem	  homeostasis	  or	  signalling.	  	  
	  
Figure	  6.1:	  The	  Mechanism	  of	   the	  Nox4-­‐induced	  Increase	   in	  CSE	  Expression	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6.5	  Haem	  as	  an	  Integral	  Component	  in	  Gasotransmitter	  Signalling	  	  The	   finding	   that	   haem	   levels	   might	   regulate	   CSE	   expression	   and	   hence	   H2S	  production	   in	  endothelial	  cells	   is	   intriguing	  when	  considered	  alongside	   the	  other	  gasotransmitters	  (NO	  and	  CO),	  which	  are	  both	  generated	  within	  the	  endothelium	  to	  regulate	  vascular	  tone,	  and	  require	  haem	  for	  their	  synthesis.	  eNOS	  binds	  haem	  within	   its	   oxygenase	   domain221,	   and	   HO-­‐1	   requires	   haem	   as	   its	   obligatory	  substrate222.	   Interestingly,	   considerable	   functional	   and	   regulatory	   cross-­‐talk	   has	  between	   shown	   to	   exist	   between	   the	   three	   gasotransmitters	   at	  multiple	   levels83,	  
223.	  It	  is	  therefore	  possible	  that	  down-­‐regulated	  eNOS	  or	  HO-­‐1	  activity,	  due	  to	  haem	  deficiency,	   may	   result	   in	   the	   activation	   of	   Nox4	   and	   subsequent	   CSE/H2S	  production,	   through	   HRI	   signalling.	   Thus,	   when	   haem	   becomes	   limiting	   H2S	  production	  may	  increase	  to	  compensate	  for	  the	  reduced	  bioavailability	  of	  NO	  and	  CO,	  with	  Nox4	  acting	  as	  a	  regulatory	  switch	  in	  this	  process.	  Here,	  the	  contribution	  of	  haem	  to	   the	  Nox4-­‐induced	  regulation	  of	  CSE	  expression	  could	  be	   interrogated	  by	  supplying	  hemin	  (a	  haem	  donor)	  in	  the	  presence	  of	  Nox4	  overexpression.	  Thus	  if	   low	  haem	  bioavailability	   is	   a	   factor	   in	   regulating	   this	  pathway,	  haem	  repletion	  should	  reduce	  the	  Nox4-­‐induced	  increase	  in	  CSE	  expression.	  Alternatively,	  the	  use	  of	  HO-­‐1	  inhibitors	  (that	  would	  increase	  cellular	  haem	  bioavailability)	  may	  lead	  to	  similar	   effects.	   In	   addition,	   experiments	   involving	   the	   inhibition	   of	   haem	  biosynthesis	  may	  prove	  useful	  in	  helping	  do	  decipher	  whether	  haem	  deficiency	  is	  up-­‐stream	  or	  down-­‐stream	  of	  Nox4.	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6.6	  Regulation	  of	  Nox4	  by	  Hypoxia	  	  Hypoxia	  occurs	  in	  conditions	  such	  as	  ischemia,	  where	  blood	  flow	  is	  restricted	  and	  tissue	  oxygen	  levels	  are	  reduced	  to	  a	  point	  where	  normal	  cellular	  metabolism	  and	  function	  become	  compromised.	  Previous	  studies	  have	  shown	  that	  the	  transcription	  of	   Nox4	   can	   be	   induced	   in	   response	   to	   ischemia,	   in	  vivo224,	  225,	   and	   hypoxia218	   in	  
vitro.	   Furthermore,	   at	   the	   molecular	   level,	   hypoxic	   induction	   of	   Nox4	   has	   been	  shown	  to	  be	  regulated	  by	  the	  binding	  of	  hypoxia-­‐inducible	  factor	  1α	  (HIF1α)	  to	  a	  proximal	  promoter	  region	   in	   the	  Nox4	  gene,	  which	   led	  to	  an	  enhancement	   in	   the	  expression	   of	   a	   linked	   luciferase	   reporter218.	   In	   addition	   to	   HIF,	   previous	   work	  conducted	   in	   our	   group,	   demonstrated	   that	   the	   Nox4	   promoter	   is	   positively	  regulated	  by	  E2F	  transcription	  factor	  family	  members226,	  which	  are	  also	  known	  to	  play	  a	  role	  in	  hypoxia-­‐mediated	  induction	  of	  transcription227.	  	  	  Interestingly,	  in	  addition	  to	  driving	  Nox4	  expression218,	  hypoxia	  also	  regulates	  the	  expression	  of	  CSE228.	  Based	  on	  the	  data	  presented	  here,	  as	  well	  as	  that	  published	  previously,	  it	  is	  tempting	  to	  hypothesise	  that	  hypoxic	  stress	  may	  represent	  an	  up-­‐stream	   physiological	   activator	   of	   Nox4	   that	   subsequently	   stimulates	   CSE	  expression	   and	   H2S	   production	   through	   the	   HRI/eIF2α/ATF4	   signalling	  module.	  Indeed,	   it	   is	   also	   known	   that	   CSE/H2S	   can	  dilate	   vessels65,	  79	   and	   that	   both	  Nox4	  and	  CSE	  are	  positively	   implicated	  in	  angiogenesis67,	  150,	   two	  processes	  that	  would	  prove	  beneficial	  in	  the	  recovery	  from	  conditions	  such	  as	  ischemic	  hypoxia.	  Thus	  it	  will	   be	   of	   potential	   importance	   to	   determine	   whether	   hypoxia	   or	   chemical	  inducers	  of	  hypoxia	  such	  as	  dimethyloxalylglycine	  (DMOG)	  or	  cobalt	  chloride	  are	  activators	  of	  this	  pathway.	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6.7	  Angiogenesis	  and	  Future	  Directions	  	  Much	   attention	   has	   been	   focussed	   upon	   the	   importance	   of	   all	   three	  gasotransmitters;	   NO211,	   CO229	   and	   (most	   recently)	   H2S213	   in	   the	   regulation	   of	  angiogenesis.	  In	  all	  cases	  the	  angiogenic	  properties	  of	  endothelial	  cells	  have	  been	  demonstrated	   in	   vitro	   to	   be	   promoted	   by	   the	   addition	   of	   donors	   of	   these	  gasotransmitters83,	   212,	   213.	   Consistent	   with	   their	   potential	   roles	   in	   promoting	  angiogenesis	  after	   ischemia,	  genetic	  depletion	  of	  each	  of	   these	  enzymes	  has	  been	  shown	  to	  result	  in	  impaired	  revascularisation	  following	  tissue	  ischemia230-­‐232.	  The	  expression	   and/or	   activities	   of	   these	   enzymes	  might	   also	   be	   expected	   to	   be	   up-­‐regulated	  by	  hypoxia/ischemia.	  Indeed,	  the	  transcriptional	  expression	  of	  both	  HO-­‐1	  and	  CSE	  are	  robustly	  up-­‐regulated	  in	  response	  to	  hypoxia.	  Thus,	  exposure	  of	  rats	  to	   hypoxia	   acts	   to	   increase	   HO-­‐1	   mRNA	   expression	   in	   several	   tissues,	   while	   in	  VSMCs	  hypoxia	  similarly	  acts	  to	  up-­‐regulate	  HO-­‐1	  transcription233.	  Moreover,	  CSE	  mRNA	   expression	   was	   shown	   to	   increase	   in	   ischemic	   tissue	   following	   femoral	  artery	  ligation	  in	  mice230.	  	  In	  addition,	  H2S	  production	  by	  CSE	  within	  rodent	  carotid	  bodies	  has	  been	  shown	  to	  be	  greatly	  increased	  in	  response	  to	  hypoxia234,	  although	  in	  this	  case	  CSE	  mRNA/protein	  levels	  were	  not	  assessed.	  The	  data	  presented	  here	  further	   demonstrate	   a	   role	   for	   ROS-­‐associated	   signalling	   in	   gasotransmitter	  production	   and	   strongly	   implicate	  Nox4	   as	   a	   physiological	   source	   of	   ROS	   in	   this	  process.	   As	   stated	   previously,	   Nox4	   expression	   is	   induced	   in	   response	   to	  hypoxia218.	  There	  is	  therefore	  a	  compelling	  case	  for	  the	  involvement	  of	  Nox4	  in	  the	  regulation	   of	   gasotransmitter-­‐dependent	   signalling	   in	   hypoxia-­‐induced	  angiongenic	  responses	  both	  in	  vitro	  and	  in	  vivo.	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6.8	  Summary	  	  To	   conclude,	   data	   shown	   in	   this	   thesis	   demonstrate	   that	   endothelial	   Nox4	   is	   a	  physiological	  regulator	  of	  CSE	  expression	  in	  vitro	  and	  in	  vivo	  and	  that	  this	  effect	  is	  mediated	   by	   the	   HRI/eIF2α/ATF4	   signalling	   module	   (Figure	   6.1).	   The	   Nox4-­‐	  induced	  regulation	  of	  CSE	  was	  also	  shown	  to	  have	  functional	  consequences	  in	  the	  regulation	   of	   vascular	   contractility	   elicited	   in	   response	   to	   PE.	   These	   findings	  provide	  a	  novel	  mechanism	  for	  the	  regulation	  of	  vascular	  tone	  by	  Nox4,	  that	  may	  be	   of	   potential	   therapeutic	   benefit.	   For	   example	   the	   identification	   and	   use	   of	  endogenous	  activators	  of	  CSE	  expression	  may	  lead	  to	  improved	  vascular	  function	  in	   endothelial	   dysfunction-­‐induced	   hypertension,	   where	   increased	   H2S	  bioavailability	  would	  prove	  beneficial.	  This	  work	  would	  also	  suggest	  that	  Nox4	  can	  act	   as	   a	   beneficial	   Nox	   isoform,	   a	   finding	   consistent	   with	   a	   number	   of	   other	  studies47,	  151,	  154,	  158,	  216,	  and	  might	  caution	  against	  potential	  therapeutic	  pitfalls	  that	  could	  arise	  from	  the	  development	  of	  pharmaceutical	  inhibitors	  of	  Nox4.	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